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The  outer-­‐‑leaflet  of  the  outer  membrane  of  Gram-­‐‑negative  bacteria  is  composed  
of   lipopolysaccharide   (LPS),   which   is   attached   to   the   membrane   via   a   hexa-­‐‑acylated  
saccharolipid   called   lipid   A.      The   fourth   step   of   lipid   A   biosynthesis   involves   the  
cleavage  of  the  pyrophosphate  group  of  UDP-­‐‑2,3-­‐‑diacyl-­‐‑GlcN  to  form  lipid  X;  this  step  
is  carried  out  by  LpxH  in  E.  coli  and  the  majority  of  β-­‐‑  and  γ-­‐‑proteobacteria.  LpxH  has  
been   previously   characterized,   however   sample   impurity   and   non-­‐‑optimized   assay  
conditions   hindered   meaningful   conclusions.      The   enzyme   was   suggested   to   contain  
signature   motifs   found   in   the   calcineurin-­‐‑like   phosphoesterase   (CLP)   family   of  
metalloenzymes,   however   the   extent   of   biochemical   data   fails   to   demonstrate   a  
significant  level  of  metal  activation  in  LpxH  assays.    We  report  cloning,  purification,  and  
detailed  enzymatic  characterization  with  a  highly  purified  sample  of  H.  influenzae  LpxH  
(HiLpxH).  HiLpxH  shows  over  600-­‐‑fold  stimulation  of  activity  in  the  presence  of  Mn2+.  
Furthermore,  EPR  studies  reveal   the  presence  of  a  Mn2+  cluster   in  LpxH.  Finally,  point  
mutants   of   residues   in   the   conserved  metal-­‐‑binding  motifs   of   the   CLP   family   greatly  
inhibit   HiLpxH   activity,   highlighting   their   importance   in   enzyme   function.      Overall,  
through   optimized   purification   and   assay   methods,   our   work   unambiguously  
establishes  LpxH  as  a  membrane-­‐‑associating  CLP  containing  a  Mn2+  cluster  coordinated  
by  conserved  residues.  These  results  set  the  scene  for  further  structural  investigation  of  
the  enzyme  and  for  design  of  novel  antibiotics  targeting  lipid  A  biosynthesis.  
  v  
Several  species  of  Gram-­‐‑negative  bacteria   lack  LpxH  orthologs,  yet   retain  other  
lipid  A  biosynthetic  enzymes  and  still  produce   lipid  A.     An  unrelated  protein,  LpxI,   is  
responsible   for  UDP-­‐‑DAGn  hydrolysis   is   several   such   organisms.      Interestingly,   some  
bacteria,  such  as  the  human  pathogen  Chlamydia  trachomatis,  have  neither  LpxH  nor  LpxI  
orthologs,   suggesting   the   presence   of   a   third   UDP-­‐‑DAGn   hydrolase.      Through  
implantation   of   a   novel   complementation   screen   that   used   a   C.   trachmatis   genomic  
library  and  a   conditional-­‐‑lethal   lpxH  mutant  E.   coli   strain,  we  were   able   to   identify   an  
open  reading  frame  encoding  an  new  enzyme  capable  of  lipid  X  production.    Due  to  its  
ability  to  complement  UDP-­‐‑DAGn  hydrolase  function  in  vivo  and  catalyze  the  formation  
of  lipid  X  in  vitro,  we  have  designated  the  enzyme  LpxG.    Further  biochemical  analysis  
with  purified  LpxG  revealed  it  facilitates  hydrolysis  through  attack  on  the  α  phosphate  
of  its  substrate  and  is  activated  by  Mn2+  in  vitro.  LpxG  is  in  the  same  CLP  superfamily  as  
LpxH,  however  it  shows  very  little  homology  to  LpxH  or  LpxI.     Identification  of  LpxG  
improves  our  understanding  of  the  lipid  A  biosynthetic  pathway  in  C.  trachomatis.    More  
broadly,  as  limited  genetic  tools  are  available  for  the  study  of  the  prevalent  pathogen,  it  
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1. Introduction  
It   is   estimated   that   the   global   population   of   bacteria   is   greater   than   1030   (1),  
making  these  prokaryotes  the  most  prevalent  organisms  on  the  planet.     Bacteria  play  a  
variety  of  different  roles  in  nature  and  occupy  a  gamut  of  environmental  niches,  ranging  
from  the  human  body  to  deep  ocean  vents.     Current  research  has  even  proved  that  the  
metabolic  power  of  these  organisms  can  be  harnessed  and  employed  for  bioremediation  
(2)  or  modified  to  generate  efficient  biotechnological  tools  (3).      Despite  their  usefulness,  
bacteria  are  also  responsible   for  causing   infection  and  disease  of  host  organisms,  often  
colonizing   the   respiratory   system,   gastrointestinal   tract,   and   skin.      An   increasing  
number  of  these  infections  are  being  acquired  in  a  hospital  setting;  in  the  United  States,  
infections  encountered  in  the  hospital  or  a  health  care  facility  affect  more  than  2  million  
patients,   cost   $4.5   billion,   and   contribute   to   88,000   deaths   in   hospitals   annually   (4,5).    
Due   to   the   genetic   plasticity   of   these   pathogens,   many   have   developed   resistance   to  
currently   available   antibiotic   treatment.      A   2013   CDC   report   estimated   that   2   million  
Americans  per  year  fall  ill  as  a  result  of  antibiotic  resistant  bacteria,  with  at  least  23,000  
of  those  infections  resulting  in  death.      
Due   to   their   threat   to   human   health,   as   well   as   their   applications   to  
biotechnology,  it  is  advantageous  to  ascertain  more  information  about  bacteria.    A  more  
complete  understanding  of  the  properties  of  these  organisms  will  yield  information  that  
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can  be  used  to  better  human  life.    The  work  presented  in  the  following  chapters  is  aimed  
at  such  a  goal  and  is  targeted  at  the  elucidating  bacterial  processes.    
1.1 Classification of Gram-negative Bacteria 
Bacteria  are  often  classified  by  the  structure  of  their  outer  membrane  through  use  
of   the  Gram   staining   procedure.        Gram-­‐‑positive   bacteria   are   surrounded   by   an   inner  
lipid  bilayer  that  is  encapsulated  by  a  thick  meshwork  of  sugars  and  amino  acids  (Fig.1,  
left).      This   structure,   termed   the   peptidoglycan,   traps   crystal   violet   during   the   Gram  
staining   procedure.      Conversely,   Gram-­‐‑negative   bacteria   have   a   much   thinner  
peptidoglycan   that   is   surrounded   by   a   second   lipid   bilayer,   designated   the   outer  
membrane  (Fig.  1,  right).    Because  of  the  thinner  peptidoglycan,  the  crystal  violet  can  be  
washed  away  and  the  bacteria  can  be  dyed  by  another  substance,  resulting  in  a  negative  










Cell Envelope   
Figure  1:  Gram  Classification  of  Bacterial  Cell  Envelope  
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1.2 Lipolysaccharide 
Besides   a   less   substantial   peptidoglycan,   a   defining   characteristic   of   Gram-­‐‑
negative  bacteria  is  the  presence  of  an  outer  membrane  (Fig.  2).    The  inner  membrane  in  
both   Gram-­‐‑positive   and   Gram-­‐‑negative   organisms   is   a   symmetric   lipid   bilayer  
composed   of   phospholipids   such   as   phosphotidylglycerol   and  
phosphotidylethanolamine   (6).      These   lipids   are   also   found   on   the   inner   leaflet   of   the  
outer   membrane   in   Gram-­‐‑negatives,   however   the   outer   leaflet   is   comprised   of  
lipopolysaccharide   (LPS)   (6).      LPS,   also   known   as   endotoxin,   is   a   complex   molecule  
consisting  of  a   long  chain  of  sugars  anchored   into   the  membrane  by  a  saccharolipid;   it  
can  be  sub-­‐‑divided  into  three  parts:  O-­‐‑antigen,  core  region,  and  lipid  A.     LPS  plays  an  
important   role   in   protection   of   organisms   from   the   environment,   especially   in   a   host  
organism  where  they  encounter  low  pH,  bile,  antimicrobial  peptides,  and  proteins  of  the  
complement   system   (6,7).      In   some  Gram-­‐‑negative   bacteria,  O-­‐‑antigen   and  part   of   the  
core  region  is  present,  resulting  in  the  designation  of  the  outer  membrane  moiety  as  LOS  
(lipid  oligosaccharide)  instead  of  LPS  (8).     While  the  identity  of  sugars  comprising  LPS  
can  vary  across  species   (core  region)  and  even  serotype   (O-­‐‑antigen  region),   the  overall  
structure  remains  conserved  (7).      
1.2.1 O antigen region 
The  most  distal  region  of  LPS,  the  O-­‐‑antigen,  is  also  the  most  variable  portion  of  
the  molecule  (7)  (Fig.  2).      In  some  species,   it   is  a   linear  chain  of  sugar  repeats,  while  in  
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others,  it  is  modified  with  phosphorylations  and  glycosidic  branches.    Variations  in  the  
O-­‐‑antigen   are   seen   within   the   same   organism,   with   non-­‐‑uniform   chain   lengths   and  
branch   sites   forming   LPS   heteropolymers.      This   variation   appears   to   be  modal,   and   a  
distinct  LPS  profile  is  usually  detectable  for  specific  organisms  (7).      
The   O-­‐‑antigen   plays   an   important   role   in   protecting   the   cell   from   its   outside  
environment.    It  can  also  assist  in  the  evasion  of  host  immune  responses,  protecting  the  
bacteria  from  the  complement  system  and  altering  its  sensitivity  to  neutrophil  response  
and   bactericidal   and   permeability-­‐‑increasing   proteins   (9).      Identity   of   the   O-­‐‑antigen  
often  designates  the  serotype  of  a  bacterial  species,  as  it  often  is  a  target  for  production  
of   host   antibodies.      There   are   170   O-­‐‑serotypes   of   Escherichia   coli,   speaking   to   the  
immense   diversity   of   the   O-­‐‑antigen.      Laboratory   strains   such   as   E.   coli  K-­‐‑12   lack   O-­‐‑
antigen.      
Genes  contained  in  the  rfb  locus  usually  carry  out  the  synthesis  of  the  O-­‐‑antigen  
(10).    These  encoded  enzymes  are  glycosyl  trasferases  that  employ  sugar  nucleotides  as  
substrates;  they  function  in  the  cytosol  or  on  the  periphery  of  the  inner  membrane.    The  
growing  polysaccharide  is  assembled  on  the  membrane  carrier  undecaprenyl  phosphate  
(UndP,  C55)  that  is  also  used  in  synthesis  of  peptidoglycan  and  lipid  A  modification  (11).    
The   formation   of   undecaprenyl   pyrophosphate-­‐‑linked   glycose   through   transfer   of   a  
sugar-­‐‑1-­‐‑phosphate   residue   to   UndP   traps   energy   in   the   pyrophosphate   bond.      This  
energy   is   later  used   to  drive   the   ligation   reaction   to   core   lipid  A  after  polymerization.    
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The  rfb  genes  are  not  essential  for  bacterial  survival,  particularly  in  a  laboratory  setting,  
however  they  do  enhance  survivability  in  the  host.    
1.2.2 Core Region 
The  core  region  is  found  proximal  to  the  O-­‐‑antigen  region  (Fig.  2).    In  E.  coli,  it  is  
subdivided  into  an  inner  and  outer  core,  with  the  outer  core  being  the  site  of  O-­‐‑antigen  
attachment.      In   many   mucosal   pathogens,   specifically   Neiserria   gonohorroae   (8)   and  
Chlamydia   trachomatis   (12),   there   is   no   outer   core   and   the   inner   core   extends   into  
branches;   these   branches   serve   to   determine   serological   specificity   in   such   organisms.    
The   structure   of   inner   and   outer   core   seems   to   be   well   conserved   in   Gram-­‐‑negative  
bacteria  on  the  genus  and  sometimes  the  family  level  (7).    In  fact,  similarity  can  be  seen  
in   the   inner   core   of   highly   divergent   species,   with   two   3-­‐‑deoxy-­‐‑D-­‐‑manno-­‐‑oct-­‐‑ulosonic  
acid  (Kdo)  comprising  this  region  in  nearly  all  Gram-­‐‑negative  bacteria  (7).    
Similar   to   the  O-­‐‑antigen,   the   core   plays   an   important   role   in   protecting  Gram-­‐‑
negative  bacteria  from  their  extracellular  environment.    Bacteria  with  mutations  in  core  
synthesis   enzymes   show   changes   in   hydrophilicity,   resulting   in   hypersensitivity   to  
hydrophobic   dyes,   detergents,   hydrophobic   antibiotics,   fatty   acids,   phenols,   and  
polycyclin   hydrocarbons   (13).      Such   mutants   have   also   been   noted   for   leaky   outer  
membranes,   releasing   proteins   into   the   cytosol   unless   high   concentrations   of  Mg2+   are  
present   in   growth  media.      Some  bacteria,   such   as  Salmonella  and  Pseudomonas,  modify  
their   core   LPS   sugars   with   phosphorylations.      Divalent   cations   bridge   these  
  6  
phosphorylations  on  neighboring  LPS,  creating  a  strong  protective  barrier  for  the  cell.    In  
Pseudomonas  aeruginosa,  such  phosphorylations  are  required  for  viability  (14).      
Also   like   O-­‐‑antigen   synthesis   enzymes,   core   synthesis   enzymes   are  
glycosyltransferases  that  use  sugar  nucleotide  donors  (10).     In  E.  coli,  these  proteins  are  
often  peripherally  associated  with  the   inner   leaflet  of   the   inner  membrane  and  directly  
add  carbohydrate  moieties  to  Kdo2  lipid  A.    As  discussed  below,  the  Kdo  portion  of  the  
inner   core   is   usually   incorporated   by   KdtA   (WaaA)   before   the   completion   of   lipid   A  
synthesis.      The   rest   of   the   core   is   assembled   by   enzymes   found   in   the   waa   operon  
working  in  sequence.    Outer  core  synthesis  genes  are  often  non-­‐‑essential  in  a  laboratory  
setting.    Inner  core  synthesis,  however,  does  seem  to  be  important  for  bacterial  viability.    
This  is  presumably  due  to  the  specificity  of  the  transport  machinery  that  exports  lipid  A  
across  the  inner  membrane  (see  below).        
1.2.3 Lipid A 
Lipid   A   serves   as   the   hydrophobic   anchor   to   LPS   (Fig.   2).      Its   acylated   di-­‐‑
glucosamine   structure   is   highly   conserved   throughout   LPS-­‐‑containing   Gram-­‐‑negative  
bacteria  (6).    Besides  indirectly  shielding  organisms  through  attaching  the  protective  O-­‐‑
antigen  and  core  region  to  the  membrane,  lipid  A  also  had  a  direct  role  in  defense.    The  
presence  of  many  saturated  hydrocarbon  chains  on  lipid  A  reduce  the  fluidity  of  outer  
membrane.      Lipid   A   is   usually   phosphorylated,   permitting   cation   bridging   between  
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negatively   charged   LPS   molecules   to   strengthen   the   impermeability   of   the   outer  
membrane.      
In   addition   to   a   role   in   permeability,   lipid   A   has   been   implicated   in   other  
bacterial  processes.    It  has  been  postulated  that  lipid  A  is  required  for  the  proper  folding  
and   function   of   proteins   in   the   outer  membrane.      Specifically,   the   crystal   structure   of  
receptor   FhuA   revealed   a   non-­‐‑covalently   attached   LPS  molecule  making   contact  with  
the  protein  in  the  lipid  A  region  (15).    Additionally,  the  outer-­‐‑membrane  protease  OmpT  
has  been  shown  to  rely  on  lipid  A  for  activity  (16).    Lipid  A  is  also  hypothesized  to  play  
a   role   in   outer   membrane   vesiculation   in   Porphyromonus   gingivalis   and   Pseudomonas  
aeruginosa,   either   through  protein  sorting,  vesicle   formation,  or   interaction  with   factors  
influencing  vesicle  formation  (17,18).      
Lipid  A  synthesis  is  required  for  viability  in  nearly  all  Gram-­‐‑negatives,  even  in  a  
laboratory   setting   (6).      Many   organisms   can   tolerate   non-­‐‑threatening   growth  
environments  in  the  absence  of  O-­‐‑antigen  and  core  region,  but  the  enzymes  synthesizing  
lipid  A  cannot  be  deleted.    A  noted  exception  is  Neiserria  meningitidis:  deletion  of  the  first  
gene   of   lipid   A   biosynthesis   results   in   a   viable   organism   (19).      This   mutant   does  
duplicate   slowly,   however,   and  only   exhibits   growth   in   a   laboratory   setting.     Another  
notorious  pathogen,  Chlamydia   trachomatis,  can  be   inhibited   in   lipid  A  synthesis  during  
replication,   however   this   inhibition   results   in   a   loss   of   infectious   progeny   (20).    
Additionally,   colistin-­‐‑resistant  Acinetobacter   baumannii   have   been   reported   to   lack   LPS  
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due   to   mutations   in   genes   of   the   lipid   A   biosynthetic   pathway   (21).      While   these  A.  
baumannii   variants   are   viable,   they   do   show   increased   sensitivity   to   host   cationic  
antimicrobials  (22).    Thus,  lipid  A  has  proved  essential  for  growth  and/or  infection  in  a  
host  environment  for  all  LPS-­‐‑containing  Gram-­‐‑negative  bacteria,  making  its  biosynthesis  
(carried   out   by   the   Raetz   pathway,   as   described   below)   a   promising   target   for   the  
























Figure  2:  Structure  of  Escherichia  coli  Cell  Envelope  
The  Gram-­‐‑negative  model  organism  E.  coli  exhibits  the  canonical  dual  membrane  structure.    The  
inner  membrane   is   composed   of:   phospholipids   (green),   specifically   phosphotidylglycerol   and  
phosphotidylethanolamine;  proteins  (blue),  which  span  the  membrane  or  be  associated  with  the  
periplasmic   or   cytosolic   face;   and   undecaprendyl   phosphate   (gray),   which   serves   to   shuttle  
sugars   into   the   periplasm.      A   meshwork   of   sugars   and   amino   acids   are   cross-­‐‑linked   in   the  
periplasm   to   form   the   peptidoglycan   (yellow).      The   outer  membrane   is   an   asymmetric   bilayer  
comprised  of  phospholipids  in  the  inner  leaflet  and  lipopolysaccharide  (LPS)  in  the  outer  leaflet.    
Proteins   (blue)   contained   in   the   outer   membrane   may   be   periplasmic-­‐‑facing,   or   membrane  
spanning,  serving  as  porins,  channels,  and  transporters.    LPS  is  made  up  of  a  long  chain  of  sugars  
(red)  anchored  into  the  outer  membrane  by  lipid  A  (purple).      
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1.3 Lipid A and the Immune Response 
Lipid  A  also  plays  a  crucial  role  in  Gram-­‐‑negative  infection  of  all  vertebrates  and  
assortment   of   invertebrates   (23).      Upon   invasion   of   a   host,   bacteria   shed   their   LPS  
molecules,  which  are  subsequently  recognized  by  soluble  LBP  (LPS  binding  protein)  and  
trafficked   to   immune   cells   (24)   (Fig.   3).      LBP-­‐‑LPS   then   interacts   with   the   monocyte  
differentiation   antigen  CD14,   facilitating   the  delivery   of   the  LPS   to   the  MD2-­‐‑Toll-­‐‑Like  
Receptor  4   (TLR4)   complex  on   the   surface  of  monocytes,   lymphocytes  and  endothelial  
cells   (25).      This   complex   is   a   known   pattern   recognition   receptor   (PRR)   that   is   an  
important  part  of  the  innate  immune  system.    In  the  case  of  TLR4,  the  activating  pattern  
is  the  lipid  A  moiety  of  LPS  (26).    Recognition  of  lipid  A  is  advantageous  to  the  immune  
system,   as   this   is   the   most   invariant   portion   of   LPS,   permitting   sensitivity   to   many  
Gram-­‐‑negative  organisms.      
Interaction   of   lipid   A   with   MD2-­‐‑TLR4   triggers   receptor   dimerization   (Fig.   3).    
This   dimerization   elicits   two   response   pathways  mediated   by   interaction   of   signaling  
proteins   with   TLR4’s   cytoplasmic   TIR   (toll   interleukin   receptor)   domain   (27).      In   the  
myeloid   differentiation   primary   response   protein   88   (MYD88)   pathway,   NF-­‐‑κB   is  
induced   to   upregulate   the   transcription   of   pro-­‐‑inflammatory   cytokines   such   as   TNF  
(tumor  necrosis  factor),  interleukin  6  (IL-­‐‑6),  and  IL-­‐‑2.    The  TRIF  (TIR  domain-­‐‑containing  
adaptor  inducing  interferon-­‐‑β)  pathway  leads  to  the  upregulation  of  interferon  β  (INF-­‐‑  
β)   and   interferon   response   proteins,   such   as   IFN-­‐‑γ-­‐‑induced   protein,   RANTES,   and  
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granulocyte   colony-­‐‑stimulating   factor   (G-­‐‑CSF).      These   serve   to   mount   the   host’s  
adaptive   immune   response.      TRIF   signaling   occurs   after   the   MD2-­‐‑TLR4   complex   is  
endocytosed  (28,29).      
Both  aspects  of  the  TLR4-­‐‑inducing  signaling  cascade  is  meant  to  clear  the  host  of  
infection   through   inflammation,   cytokine   release,   recruitment   of   effector   cells,  
phagocytosis,   cytotoxicity,  and  activation  of   the  complement  system  (30).     However,   if  
the  system  is  over-­‐‑stimulated,  these  responses  can  result  in  tissue  damage,  organ  failure,  
or   sepsis   (29).     The   latter   represents  a   severe  and  often   fatal   inflammatory   response  of  
the   body   to   the   overwhelming   presence   of   infection   and   is   characterized   by   organ  
failure.     Thus,   in  addition   to  species-­‐‑specific   infection  pathologies,   sepsis   can  also  be  a  
detrimental  outcome  of  Gram-­‐‑negative  infection.      
While   lipid  A   in   its  hexacylated   form   is   a  potent   activator  of   the  TLR4   system,  
modified   structures   of   lipid   A   dramatically   alter   the   immune   response   (26,31-­‐‑33).    
Studies  with   lipid  A   structure  variants  have   revealed   that   removal  of   the   1-­‐‑phosphate  
prevents  complete  interaction  with  TLR4,  resulting  in  the  inability  of  the  TIR  domain  to  
fully  induce  the  MYD88  pathway  (26).     Likewise,  removal  of  the  secondary  acyl  chains  
to   yield   a   tetra-­‐‑acylated   product   (lipid   IVA)   precludes   full   interaction  with  MD2,   also  
resulting   in   reduction   of   MYD88   signaling   (26).      This   ability   to   use   structural  
modification   of   lipid   A   to   separate   the   inflammatory   response   (MYD88)   from   the  
adaptive   immune   response   (TRIF)   has   led   to   the   development   of   lipid-­‐‑A   based  
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adjuvants   (28).     Specifically,  a  chemically  detoxified  mixture  of   lipid  A  from  Salmonella  
enterica   susp.   Serovar   Minnesota,   which   is   primarily   composed   of   3-­‐‑O-­‐‑deacyl-­‐‑4’-­‐‑
monophosphoryl   lipid  A,  has  been  approved  by   the  FDA  as  a  vaccine  adjuvant.     This  
adjuvant,   known   as  MLP,   is   a   TLR4   agonist   and  has   been   effectively  used   to   elicit   an  
immune  response   in  cancer  vaccines  against  human  papilloma  virus   (34).     Other  work  
has   shown   that   Salmonella   can   be   genetically   modified   to   produce   a   non-­‐‑toxic   yet  
strongly   immunogenic   form  of   lipid  A   for  use  as  a  whole-­‐‑cell  vaccine   (31,32).     Further  
research   on   the   interactions   between   lipid   A   and   TLR4   could   greatly   facilitate  











Upregulated Transcription of 
Pro-inflammatory Cytokines









Inflammation Adaptive Immune Response
NF-kB IRF-3
  
Figure  3:  LPS-­‐‑mediated  Immune  Response  
Caption  continues  on  next  page.  
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Figure   3:      In   the   event   of  Gram-­‐‑negative   infection,   lipid   binding  protein   (LPB)   associates  with  
LPS   shed   from   bacteria.      CD14   on   the   surface   of   immune   and   endothelial   cells   facilitates   the  
transfer  of  LPS  to  the  MD2-­‐‑TLR4  complex.    Subsequent  dimerization  elicits  structural  changes  in  
the   cytosolic   domain   of   TLR4,   leading   to   cell   signaling   cascades.      In   the   MYD88-­‐‑dependent  
pathway,  MAL  and  MYD88  initiate  NF-­‐‑κB  signaling  to  upregulate  transcription  of  cytokines  that  
leads   to  an   inflammatory  response.     Alternatively,   the  TRIF  pathway  can  be   triggered  after   the  
TLR4-­‐‑MD2   dimerized   complex   is   endocytosed.      This   results   in   the   upregulation   of   interferon-­‐‑
inducible  genes  by  IRF-­‐‑3,  leading  to  activation  of  the  adaptive  immune  system.      Figure  modified  
from  (29).  
  
1.4 Raetz Pathway of Lipid A Biosynthesis 
The  essentiality,  conservation,  and  immunogenic  properties  of  lipid  A  make  it  an  
intriguing   target   for   the   treatment  of   infections,  as   inhibitors  of   its   synthesis  would  be  
toxic  to  pathogens,  target  a  broad  spectrum  of  bacteria,  and  could  reduce  the  chance  of  
sepsis   in   infected  hosts.     Thus,   the  biosynthesis  of   lipid  A,  as   carried  out  by   the  Raetz  
pathway  (Fig.  4)  is  of  particular  relevance  to  study  of  Gram-­‐‑negative  bacteria.    While  the  
pathway   is   highly   conserved   in   most   Gram-­‐‑negative   bacteria,   it   has   been   most  
thoroughly   studied   in  E.   coli.      In   this   organism,   the   reactions   carried   out   by   the   nine  
constitutive   lipid   A   biosynthetic   enzymes   take   place   in   the   cytosol,   membrane  
periphery,  and  inner  leaflet  of  the  inner  membrane.          
1.4.1 Cytosolic Steps 
The  beginning  steps  of  the  Raetz  pathway  are  carried  out  by  soluble  proteins.      In  
the  first  step,  the  acyltransferase  LpxA  catalyzes  the  addition  of  a  R-­‐‑3-­‐‑hydroxymyristate  
to   the  3  position  of  UDP-­‐‑N-­‐‑acetyl-­‐‑glucosamine   (UDP-­‐‑GlcNAc),   employing  ACP  as   the  
acyl   donor   (35).      In   some   species,   the   dehydrogenase   GnnA   and   transaminase   GnnB  
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modify   UDP-­‐‑GlcNAc   before   its   use   in   lipid   A   biosynthesis   (36,37).      This   generates   a  
diamino   form   of   the   sugar   nucleotide   in  which   the   3-­‐‑OH   group   is   substituted   for   an  
amine.    Select  bacteria  have  LpxA  orthologs  that  are  specific  for  the  diamino  precursor,  
while  others  can  incorporate  both  the  modified  and  unmodified  sugar  (37).    
As  the  LpxA  reaction  is  unfavorable,  the  second  step,  catalyzed  by  LpxC,  is  the  
committed  step  of  the  pathway  (38).    LpxC  is  a  zinc-­‐‑dependent  enzyme  that  deacetylates  
the  glucosamine  ring  of  its  substrate.    Next,  LpxD  acylates  the  newly  modified  nitrogen  
substituent  at  the  2  position  of  the  sugar  ring  (39).    LpxD  is  similar  in  both  sequence  and  
structure  to  LpxA  and  also  utilizes  ACP  as  the  hydrocarbon  donor.     The  third  reaction  
yields  UDP-­‐‑2,3-­‐‑diacylglucosamine  (UDP-­‐‑DAGn).          
1.4.2 Peripheral Steps 
The   fourth   the   fifth   steps   of   the   Raetz   pathway   are   thought   to   occur   at   the  
periphery  of   the   inner  membrane;   the   enzymes   responsible   for   these   reactions   are  not  
embedded  within  the  lipid  bilayer,  but  do  indicate  membrane  association.    In  the  fourth  
step  of  the  pathway  in  E.  coli,  LpxH  hydrolyzes  the  pyrophosphate  bond  in  UDP-­‐‑DAGn  
to  generate  UMP  and  2,3-­‐‑diacyl-­‐‑glucosamine-­‐‑1-­‐‑phosphate   (lipid  X)   (40).     Many  Gram-­‐‑
negative  bacteria  do  not  contain  orthologs  for  LpxH  and  instead  employ  the  unrelated  
yet   functionally   identical   enzyme   LpxI   to   catalyze   UDP-­‐‑DAGn   hydrolysis   (discussed  
below)   (41).      In   both   LpxH-­‐‑   and   LpxI-­‐‑containing   pathways,   the   subsequent  metabolic  
step   relies   on   the   glycosyl   transferase   LpxB   to   join   lipid  X  with   a   second  molecule   of  
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UDP-­‐‑DAGn   (42).      This   yields   UDP   and   disaccharide   mono-­‐‑phosphate   (DSMP);   the  
formation  of  DSMP  is  characterized  by  a  β,1’-­‐‑6  linkage  between  the  glucosamine  units,  
which  is  a  hallmark  of  the  structure  of  lipid  A.   
1.4.3 Membrane-bound Steps  
After  being  produced  by  LpxB,  DSMP  is  phosphorylated  at  the  4’-­‐‑position  by  the  
P-­‐‑loop   kinase   LpxK   (43).      This   enzyme   is   integrated   into   the   inner   membrane   and  
generates  a  tetracylated  product  referred  to  as  lipid  IVA.    At  this  point,  a  portion  of  the  
inner   core   is   added   to   the   6’   hydroxyl  moiety   of   lipid   IVA   by  membrane-­‐‑bound  KdtA  
(WaaA)   (44).      In   E.   coli,   KdtA   is   bi-­‐‑functional   and   attaches   two   units   of   Kdo,   thus  
producing  Kdo2-­‐‑lipid  IVA;  KdtA  orthologs  in  other  bacterial  species  can  be  mono-­‐‑  or  tri-­‐‑
functional  (45).    Finally,  in  the  last  steps  of  the  pathway,  trans-­‐‑membrane  proteins  LpxL  
and  LpxM  add  secondary  lauryl  and  myristyl  moieties  to  the  hydroxyl  group  on  the  2’  
and   3’   acyl   chains,   respectively   (45,46).      This   generates   the   final   hexacylated   product,  






























































































































































































Figure  4:  Raetz  Pathway  of  Lipid  A  Biosynthesis  
In  E.  coli,  the  constitutive  synthesis  of  hexacylated  Kdo2-­‐‑lipid  A  is  carried  out  by  the  nine  denoted  
Lpx  enzymes  that  comprise  the  Raetz  pathway.    A  majority  of  the  pathway  is  conserved  in  nearly  
all  Gram-­‐‑negative  bacteria.        
  
1.5 Lipopolysaccharide Transport to the Outer Membrane 
After   its   synthesis,   Kdo2-­‐‑lipid   A   decorated   with   additional   core   sugars   by  
glycosyl   transferases   in   the   inner   leaflet  of   the   inner  membrane.      It   is   then   transported  
across   the   inner  membrane  by  MsbA  (Fig.  5).     This  enzyme  is  an  ABC  transporter   that  
presumably   uses   energy   from   ATP   hydrolysis   to   flip   core   LPS   into   the   periplasmic  
surface   of   the   inner   membrane   (47,48).      It   has   been   postulated   that   the   1   and   4’  
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phosphate  groups  of  lipid  A  serve  as  important  contacts  between  MsbA  and  its  substrate  
(49).     Genetic   studies  have   revealed   that  over-­‐‑expression  of  MsbA  can   compensate   for  
kdtA  deletion   in  E.   coli,  yielding  a  viable   strain  whose  LPS   consists   solely  of   lipid   IVA.    
This   suggests   that   while   the   transporter   has   lower   affinity   for   the   tetra-­‐‑acylated  
precursor  that  lacks  core  sugars,  it  can  still  flip  the  molecule  across  the  membrane  (50).    
Mutations   earlier   in   the   pathway   cannot   be   compensated   by   MsbA   over-­‐‑expression,  
indicating  the  importance  of  the  phosphate  moieties  for  flippase  function.    Interestingly,  
msbA   deletion   can   be   compensated   by   a   point   mutation   in   yhjD   (51).     Although   the  
function  of  yhjD  is  not  known,  it  is  hypothesized  that  alteration  of  this  gene  activates  an  
independent  transport  pathway.      
While  the  core  region  and  lipid  A  are  transported  together,  the  O-­‐‑antigen  of  LPS  
moves   separately   across   the   membrane,   employing   the   lipid   carrier   undecaprenyl  
phosphate  (Fig.  5).    There  are  three  pathways  by  which  this  may  occur  (7).    In  the  Wzy-­‐‑
dependent  pathway,  individual  O-­‐‑antigen  units  are  polymerized  in  the  cytosol  and  then  
flipped  to  periplasm  by  Wzx.    Once  there,  Wzy  links  them  into  repeating  units  and  then  
Wzz  generates  modal  distribution   of   chain   lengths   by   regulating   continued  branching  
by   Wzy   or   ligation   to   the   lipid   A   core.      Alternatively,   an   ABC-­‐‑transport   mediated  
pathway  can  be  utilized   for   linear  O-­‐‑antigens:  once   the  O-­‐‑antigen   is  assembled  on   the  
undecprenyl   phosphate,   an   ABC   transporter   flips   the   molecule   into   the   periplasm.    
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Finally,   in   the  synthase  dependent  pathway,   there   is  simultaneous  polymerization  and  
transfer  of  the  O-­‐‑antigen  chain  across  membrane.      
Once  in  the  periplasm,  the  O-­‐‑antigen  is  linked  to  the  core  region  of  lipid  A  by  the  
ligase   WaaL   to   generate   the   mature   form   of   LPS   (52).      This   LPS   molecule   is   then  
transported  across  the  periplasm  and  into  the  outer  membrane  by  the  Lpt  proteins  (Fig.  
5).    While  the  exact  mechanism  of  the  system  is  not  known,  the  small  periplasmic  protein  
LptA   is  hypothesized   to  chaperone  LPS  across   the  periplasm  (53).     The  method  of   this  
accompaniment   is   unclear,   however   it   has   been   suggested   that   LptA   forms   a   slightly  
helical  linear  filament  that  spans  the  periplasm  to  facilitate  transport  of  the  hydrophobic  
molecule  across  the  aqueous  environment  (53).     LptC,  LptF,  and  LptG  are  found  in  the  
inner  membrane  and  are  thought  to  serve  as  an  anchor  point  for  LptA  (54,55).     LptB,  a  
cytoplasmic  protein,  contains  an  ATP-­‐‑binding  cassette  and  is  thus  postulated  to  interact  
with  LptG  and  LptF   to  assist   in   the  acquisition  of  energy   to   fuel  LPS   transport   (53,56).    
After   traversing   the  periplasm,  LPS   is   incorporated   into   the  outer   surface  of   the  outer  
membrane  by   the  beta-­‐‑barrel  protein  LptD  and   its  partner   lipo-­‐‑protein  LptE.      It   is  not  
known  whether   LPS   is   incorporated   into   the   inner   leaflet   of   the   outer  membrane   and  
then   flipped   across   the   lipid   bilayer   or   transported   directly   to   the   outer   leaflet   in   a  































Figure  5:  Export  of  LPS  to  the  Outer  Membrane  
The  distal  O-­‐‑antigen  portion  of  LPS  is  synthesized  on  undecaprenyl  phosphate  on  the  cytosolic  
face  of  the  inner  membrane;  the  lipid  serves  as  a  carrier  to  transfer  the  carbohydrate  chain  to  the  
periplasmic  leaflet.    After  completion  of  the  Raetz  pathway  in  the  cystosol  and  inner  leaflet  of  the  
inner  membrane,  additional  sugars  are  added  to  Kdo2-­‐‑lipid  A  to  form  core  lipid  A.    Through  ATP  
hydrolysis,   the   ABC   transporter   MsbA   flips   core   lipid   A   into   the   outer   leaflet   of   the   inner  
membrane.    There,  WaaL  ligates  the  O-­‐‑antigen  to  the  outer  core,  creating  mature  LPS.    Next,  the  
Lpt   transport   system   facilitates   the  movement  of  LPS   across   the  periplasm  by   chaperone  LptA  
and   inner  membrane-­‐‑associated  proteins  LptCBFG.     Finally,  LptD  and   its  protein  partner  LptE  
deliver  LPS  to  the  cell  surface.      
  
1.6 Lipid A Modification 
While   the   final   product   of   the   Raetz   pathway   is   Kdo2-­‐‑lipid   A,   many   bacteria  
employ  enzymes  that  modify  the  molecule  after  its  synthesis  (Fig.  6).  These  alternations  
assist   bacteria   in   adapting   to   their   environment,   as   changes   in   lipid   A   structure   can  
mediate  membrane  permeability  and  interfere  with  the  host’s  ability  to  detect  LPS  (29).    
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Modifications  are  usually  only  required  for  a  portion  of  the  bacterial  life  cycle;  thus,  such  
enzymes  are  often  under  translational  and  post-­‐‑translational  control.    In  the  presence  of  
antimicrobial  peptides  or  in  depletion  of  cations,  E.  coli,  S.  typhimurium,  and  P.  aeruginosa  
employ   the   PhoPQ   and   PmrAB   systems   to   upregulate   proteins   that   strengthen   the  
integrity  of   the  outer  membrane   through  modification  of   lipid  A  (58,59).     Modification  
enzymes   can   also   be   regulated   directly   through   substrate   availability   (60)   and   small  
peptide   inhibitors   induced   by   stress   response   systems   (61-­‐‑63).      Furthermore,   indirect  
regulation   can   occur   through   action   of   other   modification   proteins,   as   chemical  
alterations  of  lipid  A  by  one  enzyme  can  reduce  another  modification  enzyme’s  affinity  
for  the  molecule  (64).    
Modifications   to   the   carbohydrate   moieties   of   Kdo2-­‐‑lipid   A   (Fig.   6)   are   often  
employed   to   increase   membrane   integrity,   particularly   for   protection   from   cationic  
antimicrobial  peptides  released  by  bacterial  hosts.     Such  modifications  usually  occur  in  
the  outer  leaflet  of  the  inner  membrane  after  MsbA  has  flipped  lipid  A  to  the  periplasm.    
In   E.   coli   and   Salmonella,   the   enzyme   ArnT   can   add   4-­‐‑amino-­‐‑4-­‐‑deoxy-­‐‑L-­‐‑arabinose  
(aminoarabinose)  to  the  4’  phosphate  group  of  core  lipid  A  in  the  periplasmic  side  of  the  
inner   membrane   (65).   The   aminoarabinose   substrate   of   ArnT   is   synthesized   in   the  
cytosol  and  then   transferred   to   the  periplasm  via  undecaprenyl  phosphate   (66).     Other  
modifications   include   attachment   of   phosphoethanolaime   to   the   1   phosphate   of   core-­‐‑
lipid  A   by  EptA   (67);.      In   absence   of  ArnT   activity,   this  modification   can   additionally  
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occur  at  the  4’  phosphate  (68).      A  related  enzyme,  EptB,  also  decorates  core-­‐‑lipid  A  with  
phosphoethanolamine,  albeit  on  the  outer  Kdo  residue  (69).  
Specific  enzymes  can  similarly  tailor  the  acylation  state  of  Kdo2-­‐‑lipid  A  (Fig.  6).    
Such  proteins  serve  to  alter  membrane  fluidity  and  assist  in  evasion  of  the  host  immune  
response,   as   six   hydrocarbon   chains   are   necessary   for   full   TLR4   activation.      PagP,   an  
outer  membrane  beta-­‐‑barrel  protein,  can  add  a  palmitate  to  the  hydroxyl  group  on  the  2-­‐‑
position  acyl  chain  through  use  of  a  phospholipid  donor  (70).    In  Salmonella  typhimurium  
and   other   inter-­‐‑cellular   pathogens,   the   outer  membrane   lipase   PagL   removes   the  R-­‐‑3-­‐‑
hydroxymyristol   chain   at   the   3   position   of   lipid   A   (71).      This   organism   also   contains  
another   outer   membrane   lipase   LpxR   which   removes   the   3’-­‐‑acyloxyacyl   substituent  
from  Kdo2-­‐‑lipid  A  (72).    Other  acyl  modification  can  occur  at  the  outer  leaflet  of  the  inner  
membrane  by  LpxO;  this  protein  hydroxylates  the  3’  secondary  acyl  chain  of  Kdo2-­‐‑lipid  
A  (73).  
In   addition   to   those   listed   above,   there   are   numerous   additional   enzymes   that  
modify   lipid   A   (29).      Some   of   these   enzymes   are   found   in   a   wide   variety   of   Gram-­‐‑
negative  bacteria,  while  others  are  very  specific   to  certain  species.     Modification  of   the  
structure  of  lipid  A  can  be  extremely  helpful  for  bacterial  survival.    However,  it  may  also  






Figure  6:  Common  Modifications  of  Lipid  A  in  E.  coli  and  Salmonella  
The   final   product   of   the   Raetz   pathway,   Kdo2-­‐‑lipid   A,   can   be   modified   to   assist   bacterial  
environmental  adaptation.    These  modifications  can  include  phosphethanolamine  additions  (red)  
to  the  carbohydrate  head  group  by  EptA  and  EptB.    ArnT  can  also  catalyze  the  attachment  of  4-
amino-4-deoxy-L-arabinose (aminoarabinose) to the 4’ phosphate (green).  An additional 
palmitate moiety (pink) may be added to the hydroxyl group on the 2 acyl chain by outer 
membrane protein PagP.  Outer membrane lipases PagL and LpxR remove the R-3-
hydroxymyristol chain at the 3 postion and the 3’-acyloxyacyl substituent, respectively (marked 
with yellow asterisk).  Hydroxylation of the 3’ secondary acyl chain of Kdo2-lipid A (light blue) is 
catalyzed by LpxO.  Enzymes not present in common laboratory strain E. coli K-12 are italicized.  
Figure modified from (6). 
  
1.7 Lipid A Biosynthesis and Antibiotic Development 
The   antibiotics   used   to   treat   Gram-­‐‑negative   infections   include   inhibitors   of  
cellular  processes,  such  as  protein  synthesis  and  DNA  replication  and  repair  (74).    Also  
included   are   those   altering   the   cell   envelope   such   as   vancomycin   and  drugs   of   the   β-­‐‑
lactam  family  that  act  by  preventing  proper  peptidoglycan  assembly  (74).    However,  all  
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of  these  classes  of  antibiotics  are  becoming  ineffective  as  the  prevalence  of  resistant  and  
multi-­‐‑drug   resistant  Gram-­‐‑negative  bacteria   is   rapidly  growing,   especially   in  hospitals  
and  long-­‐‑term  care  facilities  (75,76).    Other  pathways  required  for  bacterial  growth,  such  
as   the   Raetz   pathway,   are   potential   avenues   for   the   development   of   new   drugs.    
Presently,  there  has  been  significant  investigation  on  inhibitors  of  LpxC,  encompassing  
hydroxamate  (77),  hydantoin  (78),  and  sulfonamide  (79)  derivatives.    Other  compounds  
from  a  uridine-­‐‑based  library  have  also  been  identified  as  effective  inhibitors  of  early  Lpx  
enzymes  (80);   they  are  assumed  to  compete  with  the  enzyme’s  substrate  by  mimicking  
the   UDP  moiety.   Studies   elucidating   the   structures,   kinetic   parameters,   and   substrate  
specificity  of  Raetz  pathway  enzymes  may  facilitate  the  design  of  additional   inhibitory  
compounds  that  could  be  optimized  for  use  as  antibiotics.      
1.8 Conservation of Lipid A Biosynthesis 
1.8.1 Evolution of Raetz Pathway Enzymes 
While   the   lipid   A   pathway   of   E.   coli   is   often   used   as   a   standard   model   for  
production   of   the   saccharolipid,   recent   bioinformatic   studies   have   revealed   it   may  
represent   a   highly   evolved   form   of   synthesis   (81).   Comparison   of   bacterial   genomes  
representing   the   20   highly   divergent   phyla   of  Gram-­‐‑negative   organisms   revealed   that  
only  a  sub-­‐‑group  of  γ-­‐‑Proteobacteria  (termed  Group  II)  contains  the  nine  Lpx  enzymes  
seen  in  E.  coli.    These  bacteria  are  largely  enteric,  encountering  harsh  conditions  in  their  
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gastrointestinal  environment.     This   likely   increases   selective  pressure   for  an  optimized  
pathway  for  lipid  A  synthesis.      
The  similarity  of  the  lipid  A  pathway  in  different  organisms  appears  to  correlate  
with   bacterial   phylogeny,   as   movement   away   from   Group   II   γ-­‐‑Proteobacteria  
corresponds   with   loss   of   Lpx   orthologs   (81) (Fig. 7).      The   LpxM   ortholog   does   not  
emerge   outside   of   Group   II  Υ-­‐‑Proteobacteria.      The   enzyme   responsible   for   the   fourth  
step   of   the   E.   coli   pathway,   LpxH,   is   only   present   in   γ,	   β,	   and	   ε	   Proteobacteria;	   it	   is  
replaced  by  a  functional  analog,  LpxI,  in  α-­‐‑  and  ζ-­‐‑Proteobacteria  as  well  as  other  bacteria  
phyla  (Fig.  8).    Interestingly,  there  are  phyla  such  as  Chlamydiae  that  lack  orthologs  for  
LpxI   or  LpxH,   suggesting   the   existence  of   a   third  UDP-­‐‑DAGn  hydrolase.      Presence  of  
LpxK,  KdtA,  and  LpxL  seems  to  be  correlated,  as  most  bacteria  appear  to  contain  none  
or  all  of  these  enzymes.    Despite  the  variance  in  conservation  of  the  later  portion  of  the  
Raetz  pathway,   the  early  enzymes  LpxA,  LpxC,  LpxD,  and  LpxB  are  highly  preserved  
across  nearly  all  Gram-­‐‑negative  phyla.    Their  genes  are  often  found  in  a  lpxD-­‐‑lpxC-­‐‑fabZ-­‐‑
lpxA-­‐‑lpxB  operon,  with   fabZ   encoding  an  enzyme  of  phospholipid  biosynthesis.     These  
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Figure  7:  Conservation  of  Lipid  A  Biosynthetic  Enzymes  
The  presence  of   lipid  A  biosynthetic  enzymes   in  a  diverse   sample  of  Gram-­‐‑negative  bacteria   is  
depicted   through   use   of   block   key,   with   a   colored   square   denoting   the   presence   of   the  
corresponding   Lpx   enzyme.      Bacterial   species   are   organized   based   on   16S   rRNA   phylogeny,  
however   distance   is   not   to   scale.      Phylum   is   denoted   below   each   species.      The   block   key   is  
ordered  the  same  as  the  Raetz  pathway,  beginning  with  LpxA  on  the  left  and  ending  with  LpxM  
on  the  right.    Figure  was  created  based  on  data  presented  in  (81).      
  
1.8.2 Distribution of UDP-DAGn Hydrolase Orthologs 
Considering   the   prevalence   of   third   (LpxD)   and   fifth   (LpxB)   enzymes   of   the  
Raetz  pathway  across  Gram-­‐‑negative  bacteria,  it  is  intriguing  that  the  fourth  enzyme  is  
not  also  highly  conserved.    As  mentioned,  two  unrelated  enzymes  have  been  shown  to  
function  as  the  UDP-­‐‑DAGn  hydrolase  required  in  the  fourth  step  of  lipid  A  biosynthesis:  
LpxH   and   LpxI.         LpxH   orthologs   appear   to   be   confined   to   classes   of   Proteobacteria,  
however   an   LpxH   homolog  with   42%   similarity   does   exist   in   bacteria   outside   of   this  
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phylum   (40,81)   (Fig.   8).      Bioinformatic   studies   suggest   that   this   homolog,   designated  
LpxH2,  may  be  an  ancestor   to  LpxH,  with   the   former  undergoing  gene  duplication   to  
create  the  latter.    Such  an  event  is  not  rare  in  the  evolution  of  the  lipid  A  pathway.    The  
similarity   of   LpxA   and   LpxD   in   both   sequence   and   structure   suggest   they   originated  
through   gene   duplication.      Furthermore,   LpxL   shows   evidence   of   multiple   gene  
duplications,  including  one  that  resulted  in  evolution  of  LpxM.      
Both  LpxH  and  LpxH2  are  part  of  the  calcineurin-­‐‑like  phosphatase  (CLP)  family  
and   show   presence   of   the   conserved   DXHX~25GDXXDRX~25GNH(D/E)   motif   (40).      In  
LpxH  orthologs,  however,   the   last  histidine  of   the  motif   is   replaced  with  arginine;   this  
may   attribute   to   optimized   UDP-­‐‑DAGn   hydrolase   function.      Interestingly,   some  
Proteobacteria   like   Pseudomonas   aeruginosa   contain   both   LpxH   and   LpxH2   orthologs,  
indicating   lpxH2   was   retained   after   duplication.      Investigation   has   shown   that   P.  
aeruginosa   lpxH2   cannot   complement   lpxH   function   in  E.   coli   (82).  This   suggests   that   in  
the  case  of  dual-­‐‑existence  of  the  proteins,  LpxH2  may  have  evolved  a  different  function,  
allowing   LpxH   to   be   fully   responsible   for   UDP-­‐‑DAGn   hydrolysis.      Some   species  
containing   LpxI   also   display   LpxH2   orthologs,   as   is   seen   in   Sinorhizobium   meliloti.    
Curiously,  LpxH2  from  this  species  appears  to  play  the  role  of  a  phospholipase  C  (83).    
Overall,   this   implies   that   if  LpxH2  exists   in   the  presence  of  LpxH  or  LpxI,   it  does  not  
function  in   lipid  A  biosynthesis.      It  remains  to  be  determined  if  LpxH2  orthologs  from  
organisms  lacking  lpxH  and  lpxI  can  function  as  UDP-­‐‑DAGn  hydrolases  in  the  synthesis  
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of  lipid  A.    Nonetheless,  the  existence  of  LpxH2  in  phyla  lacking  LpxH  or  LpxI  presents  
possible  candidates  for  the  fourth  step  of  the  Raetz  pathway  in  these  organisms.      
The  other  known  UDP-­‐‑DAGn  hydrolase,  LpxI,  shares  no  homology  with  LpxH,  
indicating  that  they  evolved  separately  to  carry  out  their  enzymatic  functions  (41).      LpxI  
is  found  within  Proteobacteria  as  well  as  other  phyla,  but  never  in  the  same  organism  as  
LpxH   orthologs.      Overall,   bacteria   exhibiting   LpxI   orthologs   represent  more   ancestral  
species  of  bacteria  (Fig.  8).    The  gene  encoding  LpxI  is  found  to  cluster  between  lpxA  and  
lpxB   in   the   lpxC-­‐‑fabZ-­‐‑lpxA-­‐‑lpxB   operon.      Taken   together,   this   indicates   that   LpxI  may  
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Figure  8:  Distribution  of  UDP-­‐‑DAGn  Hydrolases  in  Gram-­‐‑Negative  Bacteria  
The   names   of   fifteen   Gram-­‐‑negative   bacterial   phyla   are   listed,   radiating   out   from   the  marked  
center  box.    Proteobacteria  is  further  subdivided  into  classes  to  better  illustrate  the  distribution  of  
UDP-­‐‑DAGn   hydrolases.      Likewise,   the   Spirochaetes   phylum   is   divided   into   families.  
Representative  bacterial  species  from  each  classification  were  used  to  determine  the  presence  of  
UDP-­‐‑DAGn  hydrolases  LpxI  and  LpxH,  or  the  related  protein  LpxH2.    Outcomes  are  denoted  by  
box  color  according  to  the  key.    Classifications  were  only  given  the  LpxH2  designation  if  neither  
LpxH  nor  LpxI  orthologs  were  present;  this  diagram  does  not  account  for  the  existence  of  LpxH2  
in  organisms  also  containing  LpxH  or  LpxI.     While  bioinformatic  analysis   suggests   that  LpxH2  
may  function  as  the  UDP-­‐‑DAGn  hydrolase  in  denoted  phyla,  no  biochemical  evidence  supports  
this  claim.     Box  color  was  additionally  utilized   to  denote   the  absence  of  LpxI,  LpxH,  or  LpxH2  
orthologs  despite   the  presence   of   other   lipid  A   enzymes   (blue).      The   lack   of   any  Lpx  genes   or  
evidence  of  lipid  A  production  is  also  marked  (gray).    Data  presented  in  (81)  and  (41)  was  used  to  
create  the  diagram      
  
1.8.3 Unanswered Questions and Recent Developments 
Organization  of  bacteria  by  conservation  of  Raetz  pathway  enzymes  aligns  well  
with   the   traditional  phylogeny  based  on  16S   rRNA  sequences,  however   exceptions  d
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exist   (81)   (Fig.   8).      In   the   Spirochaetes   phylum,   the   family   Spirochaetaceae   shows   no  
evidence   of   lipid   A   synthesis   genes,   however   sister-­‐‑families   Leptospiraceae   and  
Brachyspiraceae   display   strong   Lpx   orthologs.      Furthermore,   Leptospiraceae   contains  
LpxI  whereas  Brachyspiraceae  displays  no  evidence  of  LpxI,  LpxH,  LpxH2.      
The  absence  of  a  candidate  UDP-­‐‑DAGn  hydrolase  as  seen  in  Brachyspiraceae  is  
also   evident   in   other   phyla   (Fig. 8).      Cyanobacteria   and   Dictogolomi   have   LpxADCB  
orthologs   but   no   candidate   UDP-­‐‑DAGn   hydrolase.      In   Chlamydiae,   seven   of   the   Lpx  
enzymes  are  present,  but  there  is  no  evidence  for  LpxH,  LpxI,  or  LpxH2.    This  strongly  
suggests   the   presence   of   an   undiscovered   UDP-­‐‑DAGn   hydrolase   that   plays   a   role   in  
lipid  A  biosynthesis.      
Recently,  another  Lpx  enzyme  was  discovered  in  α,  δ,  ζ-­‐‑Proteobacteria  as  well  as  
Fusobacteria,   Chlamydiae,   Acidobacteria,   and   Spirochaetes   (84).      This   protein,   LpxJ,  
serves   the   same   function   as   LpxM   but   is   unrelated   in   sequence   and   distribution,   as  
LpxM   is   not   found   outside   of   Proteobacteria.      Such   a   relationship   is   similar   to   that  
between   LpxI   and   LpxH.      Discovery   of   LpxJ   further   supports   the   evolutionary  
divergence  of  the  Raetz  pathway.    
1.9 UDP-Diacylglucosamine Hydrolysis 
Discovery   that  UDP-­‐‑DAGn  hydrolysis  played  a   role   in   the   lipid  A  biosynthetic  
process  was  facilitated  through  the  discovery  of  lipid  X (Fig. 9).     While  searching  for  E.  
coli  mutants   defective   in   phospholipid   biosynthesis,   researchers   isolated   strain   MN7,  
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which  harbored   temperature   sensitive  mutations   in   the  phosphatidylglycerophosphate  
synthase   gene   pgsA   and   a   second   gene,   termed   pgsB   (85).   Characterization   of   MN7  
through   32P-­‐‑labeling   and   subsequent   2D-­‐‑TLC   revealed   temperature-­‐‑dependent  
accumulation  of   two  previously  unknown  phosphate-­‐‑containing   lipids,   termed   lipid  X  
and   lipid   Y   (86).      After   determination   of   the   structure   of   lipid   X   by   NMR,   it   was  
hypothesized   that   two   molecules   of   lipid   X   were   joined   together   to   yield   the  
diacyglucosamine  backbone  of  the  lipid  A  moiety  of  LPS  (87,88).    The  linkage  of  sugars  
is   often   facilitated   by   the   presence   of   a   nucleotide   moiety   that   serves   to   activate   the  
substrate.    Thus,  it  was  postulated  that  a  nucleotide-­‐‑derivative  of  lipid  X  may  be  a  lipid  
A   precursor   (89).      Indeed,   additional   32P   labeling   of   MN7   indicated   temperature-­‐‑
dependent  accumulation  of  a  modified  form  of  lipid  X  containing  a  UMP  moiety  on  the  
1-­‐‑phosphate,   corresponding   to   what   is   now   known   as   UDP-­‐‑DAGn.      Pulse-­‐‑labeling  
experiments   revealed   that   UPD-­‐‑DAGn   was   a   precursor   to   lipid   X,   yielding   the  
conclusion   that   some  sort  of  hydrolysis   reaction   served   to  generate   the   latter   from   the  
former.    Conversion  of  UDP-­‐‑DAGn  to  lipid  X  was  detectable  in  crude  extracts  of  E.  coli,  
supporting  the  existence  of  an  UDP-­‐‑DAGn  hydrolase  (90).    
The  discoveries  of  the  genes  that  are  known  to  encode  the  UDP-­‐‑DAGn  hydrolase  
activity  important  for  lipid  A  biosynthesis,  lpxH  and  lpxI,  are  discussed  below.  Another  
E.   coli   protein,   Cdh,   has   been   shown   to   have   UDP-­‐‑DAGn   hydrolase   activity   in   vitro,  
however  it  does  not  play  a  role  in  lipid  A  biosynthesis.    Cdh  is  a  promiscuous  hydrolase  
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first   characterized   to   act   on   CDP-­‐‑diacylglycerol,   an   intermediate   in   phospholipid  
biosynthesis   (91-­‐‑93).     While   it   can   produce   lipid   X   in   vitro,   it   is   not   necessary   for   cell  
viability,   indicating   it   is   not   involved   in   the   essential   lipid  A   pathway.      Furthermore,  
when  cdh  is  knocked  out,  UDP-­‐‑DAGn  hydrolase  activity  is  still  present  in  crude  lysates  
of  E.  coli.    Cdh  is  also  predicted  to  be  periplasmic  facing  (94),  and  as  lipid  A  biosynthesis  
has   been   demonstrated   to   take   place   in   the   cytoplasm   and   inner   leaflet   of   the   inner  
membrane   (95),   the   enzyme  would   not   have   proper   access   to  UDP-­‐‑DAGn   to   produce  




















































While   lpxI  has  been   suggested   to   evolve   earlier,   lpxH  was   the   first  UDP-­‐‑DAGn  
hydrolase  gene  to  be  discovered.    To  identify  the  gene  responsible  for  lipid  X  production  
in  E.  coli,  a  Kohara  phage  library  was  used  to  infect  a  Cdh  deletion  strain  and  resulting  
lysates  were  assayed  for  UDP-­‐‑DAGn  hydrolase  activity  (40).    One  clone,  corresponding  
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to   ybbf,   displayed   ~10-­‐‑fold   enhanced   activity   over   background.      This   candidate   gene,  
renamed   lpxH,   was   tested   independently   for   lipid   X   production   in   vitro   and   was  
confirmed   to   have   UDP-­‐‑DAGn   hydrolase   activity.      Over-­‐‑expression   of   LpxH  
corresponded   to   an   accumulation   of   lipid   X   in   cell-­‐‑free   extracts   over   vector   control.    
Deficiency   in   the   enzyme,   mediated   through   temperature-­‐‑controlled   expression,  
resulted   in   accumulation   of   UDP-­‐‑DAGn.      Complete   knockout   of   lpxH   without  
complementation  was   not   possible,   denoting   the   essentiality   of   the   gene’s   activity.      It  
was  thus  concluded  that  lpxH  encoded  the  enzyme  responsible  for  the  fourth  step  of  the  
Raetz  pathway  (40).      
1.9.1.2  Characterization  
Basic  characterization  of  LpxH  was  carried  out  using  a  crude  ~60%  homogenous  
sample   obtained   through   dye   affinity   chromatography   (40).      Its   mechanism   of  
hydrolysis  was  determined  through  31P  NMR  analysis  of  reaction  products  generated  in  
the  presence  of  H218O;  a  shift  in  the  UMP  spectrum  corresponded  to  the  presence  of  the  
heavy   oxygen   atom,   correlating   to   a   hydrolytic   attack   on   the   α   phosphate   of   UDP-­‐‑
DAGn.      Kinetic   studies   indicated   an   apparent   KM   of   60   μM   and   apparent   Vmax   of   10  μm/min/mg.      The   protein   displayed   a   pH   optimum   of   ~8.0   and   showed   sensitivity   to  
detergent   in  vitro,  with  activity  decreasing   in   the  presence  of  Triton  X-­‐‑100.     While   this  
characterization   of   LpxH  yielded   general   information   about   the   enzyme,   the   lack   of   a  
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homogenous   sample   prevented  definitive   conclusions   to   be  made   about   its   enzymatic  
properties.      
Bioinformatic   analysis   reveals   that   LpxH   contains   a   motif   signature   of   the  
calcineurin-­‐‑like   phosphoesterase   (CLP)   superfamily.      This   motif,  
DXHX~25GDXXDRX~25GNH(D/E),   is   found  in  enzymes  that  utilize  a  di-­‐‑metal  cluster  for  
catalysis.    While  addition  of  Mn2+  showed  stabilization  of  LpxH  during  purification  (40),  
metal  dependency  of   the  enzyme  was  not   reported   in   the   literature.     Furthermore,   the  
type   of   chemistry   performed   by   LpxH,   cleavage   of   a   pyrophosphate   bond   in   a  
nucleotide  moiety,  is  not  canonical  for  CLP  enzymes.    These  dilemmas  demand  further  
biochemical  characterization  of  LpxH.      
1.9.2 LpxI 
1.9.2.1  Discovery  
Upon  discovery  of  lpxH,  it  was  noted  that  orthologs  of  the  gene  were  not  found  
in   all   Gram-­‐‑negative   bacteria.      Specifically   lacking   were   α-­‐‑   and   δ-­‐‑Proteobacteria   and  
thermophiles  and  extremophiles  like  Aquifex,  all  of  which  contain  very  strong  homologs  
for   both   LpxD   and   LpxB   and   are   known   to   produce   lipid   A.      In   order   to   identify   a  
possible   UDP-­‐‑DAGn   hydrolase   in   these   organisms,   a   bioinformatic   approach   was  
employed   (41).      As   mentioned   above,   lpxDCAB   are   clustered   together   in   many  
organisms.     Sequence  analysis  revealed  a  gene  of  unknown  function  between   lpxA  and  
lpxB  in  several  bacteria  species  lacking  LpxH.    The  Caulobactor  crescentus  homolog  of  this  
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gene,  designated  lpxI,  was  cloned  and  expressed  in  E.  coli.    Presence  of  the  C.  crescentus  
protein   corresponded   to      >1000   fold   increase   in   UDP-­‐‑DAGn   hydrolysis   over   vector  
control.    This  hydrolase  activity  was  not  observed  in  the  presence  of  CDP-­‐‑diacylglycerol,  
indicating   specificity   of   LpxI   the   lipid   A   precursor.      Furthermore,   lpxI   was   able   to  
complement  an  lpxH  deletion  in  E.  coli.    Together,  this  provided  definitive  evidence  that  
lpxI  encoded  for  a  UDP-­‐‑DAGn  hydrolase  (41).      
1.9.2.2  Characterization  
With   use   of   affinity   chromatography,   LpxI  was   purified   to   >90%   homogeneity  
and  enzymologically  characterized   (41).      It  was  determined   to  have  an  apparent  KM  of  
105   μM   and   apparent   Vmax   of   69   μmol/min/mg.      Surface   dilution   kinetics   were   not  
detectable:   detergent   concentration   had   little   effect   on   lipid   X   production   in   vitro.    
Activity  was  shown  to  be  metal  dependent,  as  EDTA  addition  abrogated  activity  in  vitro.    
Mg2+   was   found   to   increase   LpxI-­‐‑mediated   hydrolysis   10-­‐‑fold,   while   Mn2+   and   Co2+  
stimulated   the   protein   6-­‐‑fold   over   no   metal   controls.      The   hydrolytic   mechanism   for  
LpxI   was   also   determined   with   use   of   H218O.      Mass   spectrometry   analysis   of   LpxI  
reaction  products  generated  in  the  presence  of  the  isotopically  labeled  water  indicated  a  
mass   shift   in   the   lipid  X   species   that   corresponded   to   18O   addition.      The  UMP   species  
showed   no   sign   of   such   shift,   suggesting   that   unlike   LpxH,   LpxI   employs   hydrolytic  
attack  at  the  β  phosphate  of  UDP-­‐‑DAGn  to  form  lipid  X.  
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1.9.2.3  Structure  
In  addition  to  LpxI’s  biochemical  properties,   the  structural  characteristics  of  the  
protein  have  also  been  reported  (96).      The  2.55  Å  structure  of  C.  crescentus  LpxI  reveals  a  
novel   fold,   with   two   distinct   domains   being   connected   by   a   flexible   linker (Fig. 10).    
Density   for   the   LpxI   product   lipid   X   is   clearly   seen   in   the   N-­‐‑terminal   domain   and  
existence   of   the  molecule   is   supported   by   the   observation   that   the   protein   co-­‐‑purifies  
with   stoichiometric   amounts   of   the   lipid.      This   N-­‐‑terminal   section   of   the   protein,  
designated  LXD  (lipid  X  binding  domain),   shows  presence  of  a   lipid-­‐‑binding  cleft   that  
encapsulates   the   acyl   chains   of   lipid   X.      Hydrophobic   residues   lining   the   cleft  
presumably  drive  the  association  of  the  product  with  the  LXD  as  the  diacyl  glucosamine  
head  group  of  lipid  X  is  solvent  exposed.      
The  C-­‐‑terminal  domain  of  LpxI  contains  11  absolutely  conserved  polar  residues,  
some  of  which  are  required  for  activity.    Thus,  this  domain  is  termed  ICD,  representing  
LpxI   catalytic   domain.      An   alanine   point   mutation   of   an   aspartate   residue   in   ICD  
(D225A)   abrogates   hydrolytic   activity,   and   its   over-­‐‑expression   corresponds   to   an  
accumulation  of  UDP-­‐‑DAGn  substrate.     Furthermore,   the  3.0  Å   crystal   structure  of   the  
D225A   variant   of   LpxI   reveals   the   presence   of   UDP-­‐‑DAGn   (Fig.   10),   indicating   co-­‐‑
purification  of  the  lipid  nucleotide  with  the  enzyme  (96).    Like  in  the  wild-­‐‑type  structure  
with   lipid   X,   the   LXD   of   the  mutant   structure   surrounds   the   acyl   chains   of   the   lipid  
nucleotide.  The  head  group  of  the  substrate  molecule,  however,  is  not  solvent  exposed,  
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but  shrouded  by  the  ICD.    This  results  in  a  “closed”  confirmation  of  LpxI  in  which  the  
LXD  and  ICD  are  positioned  70°	  closer	   together	   than	  seen	   in	   the	  wild	   type	  “open”	   form.	  	  
The  overall   structures  of   the   individual  domains   remain   the   same   in  both   forms,  with  
the  only  change  being  in  the  linker  region.    This  conformation  change  is  not  likely  to  be  
an  artifact  of  crystal  packing,  as  the  sedimentation  velocity  of  wild  type  LpxI  in  solution  
is  slower  than  that  of  the  mutant  form.  
CcLpxI WT CcLpxI D225A
Lipid X
UDP-DAGn
LCD LCDIXD IXD   
Figure  10:  Structures  of  LpxI  
The   2.55   Å   structure   of   wild-­‐‑type   LpxI   from   C.   crescentus   (CcLpxI   WT,   PDB   code   4GGM)   is  
depicted  on  the  left.     The  N-­‐‑terminal  lipid  X  binding  domain  (LXD,  blue)  is  connected  to  the  C-­‐‑
terminal   LpxI   catalytic   domain   (ICD,   cyan)   through   a   linker   region   (periwinkle).      The   LpxI  
reaction  product  lipid  X  (red)  was  also  present  in  the  structure.    The  3.0  Å  structure  of  the  D225A  
mutant  of  LpxI  from  C.  crescentus  (CcLpxI  D225A,  PDB  code  4J6E)  is  depicted  on  the  right.    UDP-­‐‑
DAGn  (red),  the  LpxI  reaction  substrate,  is  evident  in  the  mutant  structure.        
  
Capturing   the   enzyme   with   both   its   substrate   and   product   led   Metzger   and  
colleagues  to  propose  a  model  for  LpxI-­‐‑mediated  UPD-­‐‑DAGn  hydrolysis  (96)  (Fig.  11).    
Structural  and  biochemical  data  suggests  the  protein  likely  functions  a  dimer  through  its  
catalytic   cycle.      Since   lipid   X   is   bound   to   purified   LpxI   in   a   stoichiometric   ratio,   the  
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enzyme   likely   holds   onto   its   product   in   the   LXD   after   catalysis,   yielding   a   “resting”  
state.  Release  of   lipid  X  may  be   triggered  by  presence  of  UDP-­‐‑DAGn  that  binds   to   the  
ICD   through   interactions   with   the   lipid   head   group   of   the   substrate.      The   LXD   then  
discharges   the   lipid   X   so   it   can   accommodate   the   acyl   chains   of  UDP-­‐‑DAGn.      In   this  
resulting   closed   conformation,   cleavage   of   the   pyrophosphate   bond   occurs.      LpxI  
subsequently   extends   back   into   its   resting   state   form,   transferring   the   newly   formed  
lipid  X  to  the  LXD.    The  large  conformational  shift   in  this  model  may  be  driven  by  the  
energy  released  in  UDP-­‐‑DAGn  hydrolysis.      
The   present   LpxI   macromolecular   model   explains   in   vitro   catalysis,   however  
other   factors  may  play  a   role   in   lipid  X  production   in  vivo.     Specifically,   the   release  of  
lipid  X   could   be  mediated   through   the   presence   of   other   lipid  A   enzymes   (96).      Very  
little   information   is   known   about   how   proteins   in   the   Raetz   pathway   communicate  
throughout   the   metabolic   process.         It   is   possible   that   interaction   of   LpxI   with   the  










Figure  11:  Model  for  LpxI  Catalysis  
Schematic   representation   of   a   possible  method   for   production   of   lipid   X   by   LpxI,   as  modified  
from  Metzger,  et  al.  (96).    The  lipid  bilayer  (gray),  lipid  X  (purple  and  red)  and  UDP-­‐‑DAGn  (lipid  
X   with   green   representing   the   UMP   moiety)   are   shown.      LpxI   is   depicted   as   a   dimer   and   is  
colored  by  domain  as  in  Fig.  10.    (1)  The  cycle  begins  when  lipid  X-­‐‑bound  LpxI  encounters  UDP-­‐‑
DAGn  substrate.    (2)  The  ICD  binds  the  head  group  of  UDP-­‐‑DAGn.    (3)  Lipid  X  is  released  from  
the  LXD,  which  coincides  with  a  hinge-­‐‑like  conformational  shift.    (4)  The  closed  confirmation  of  
LpxI  is  achieved  when  the  LXD  encapsulates  the  acyl  chains  of  UDP-­‐‑DAGn.    (5)  Hydrolysis  of  the  
pyrophosphate  bond  occurs;   released  energy  drives   a   reverse   conformational   change.      (6)  LpxI  
reopens,  transferring  the  newly  formed  lipid  X  to  the  LXD.      
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1.9.3 Relationship between LpxH and LpxI 
As  previously  discussed,  LpxI  and  LpxH  are  never  found  in  the  same  organism.    
They  are  completely  unrelated  in  sequence,  with  LpxH  orthologs  belonging  to  the  CLP  
family   (discussed   below)   and   LpxI   orthologs   comprising   their   own   unique   class   of  
enzymes.     Furthermore,   these  proteins  use  different  hydrolytic  mechanisms  to  catalyze  
the  formation  of   lipid  X.        Despite  these  differences,  both  proteins  are  able  to  complete  
the  same  transformation  of  UDP-­‐‑DAGn  to   lipid  X,  with   lpxI  being  able   to  complement  
lpxH   in   vivo.     Thus,   these  UDP-­‐‑DAGn  hydrolases   represent   a   pair   of   transformational  
analogs,   as   they   generate   the   same   product   using   different   chemistry   (97).    
Transformational   analogs   commonly   represent   convergent   evolution,   a   phenomenon  
commonly  observed  with  hydrolases  (98,99).    Study  of  these  enzymes,  both  individually  
as  well  as   in   the  context  of   the   lipid  A  pathway,  may  provide   insight   into  why  nature  
has  evolved  to  use  extremely  different  enzymes  for  the  same  process.        
1.10 Calcineurin-Like Phophoesterases  
The  calcineurin-­‐‑like  phosphoesterase  (CLP)  superfamily  (Pfam00149)  represents  a  
group   of   metal-­‐‑dependent   phosphoesterases   that   contain   a   highly   conserved  
DXH(X)~25GDXXDR(X)~25GNHD/E   motif.      The   enzymes   of   this   family   hydrolyze   a  
variety   of   phosphate   substrates,   including   lipids   (sphingomyelin   phosphodiesterases  
(100)),  proteins  (serine/threonine  phosphatases  (101)),  and  nucleotide  phosphates  (DNA  
polymerases   (102),   5’-­‐‑nucleotidases,   3’-­‐‑5’   exonucleases   (103)).      Also   included   are   the  
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purple  acid  phosphatases  (PAPs)  (104);  their  function  is  unclear,  but  it  is  suspected  they  
serve   to   dephosphorylate   bone   matrix   in   mammals   and   mobilize   organic   phosphate  
esters   from   the   soil   in   plants   (103).      Proteins   of   this   family   often   adopt   a   β-­‐α-­‐β-­‐α-­‐β  
secondary  structure  (Fig.  12).    
CLP  enzymes  are  known  to  perform  catalysis  using  divalent  and/or  trivalent  metal  
cofactors  and  an  ordered  shell  of  water  molecules   (103,105).     The  metal  cofactors  often  
include  Fe2+,  Fe3+,  Zn2+,  Mn2+,  and/or  Mg2+  and  can  be   found   in  hetero-­‐‑  or  homonuclear  
pairs  (103).     CLP  proteins  have  been  shown  to  have  different  affinities  for  each  of  their  
cofactors   (33),   and   in   some   cases,   substrate   binding   is   required   for   the   binding   of   the  
lower-­‐‑affinity   metal   (103,106).      Structures   of   CLP   enzymes   reveal   that   metal   binding  
occurs  shallowly  beneath  the  surface  of  proteins,  permitting  solvent  accessibility  to  the  
active  site  (Fig.  11).     It  has  been  postulated  that  the  metal  ions  serve  to  bridge  an  oxide  
that   performs   a   nucleophilic   attack,   stabilize   the   formation   of   a   phosphorane  
intermediate,   or   coordinate   a   nucleophilic   hydroxyl   group   to   allow   for   deprotonation  
(105,106).      
A   distinct   feature   of   the   metal   ions   found   in   CLP   enzymes   is   their   close  
proximity   to   one   another  within   the   protein   (Fig.   12).      Such   clustering   of   cofactors   is  
beneficial  for  the  catalysis,  as  the  proximity  of  the  metal  ions  in  an  active  site  allows  for  a  
symmetric  delocalization  of  charge   that   is  not  possible  with  only  one  metal   (107).  This  
delocalized   distribution   over   two  metals   permits   them   to   act   like   a   unit   in   stabilizing  
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transition   states   of   concerted  mechanisms   that   facilitate   the   concurrent   anionic   ligand  
addition  and  anionic   ligand  dissociation.   In   the  case  of  hydrolases,   this  stabilization  of  
the   transition   state   lowers   the   activation   barrier   for   both   nucleophilic   attack   by   the  
activated  water  and  phosphoester  bond  cleavage.  Additionally,  it  has  been  reported  that  
having   two   close  Mn2+   ions   in   an   active   site   increases   the  Lewis   acidity   of   the  metals,  
allowing  them  to  have  a  higher  affinity  for  ligands  such  as  H2O  (107).  
The  residues  of  the  CLP  family  motif  play  an  important  role  in  enzyme  function.  
The   functional   groups   of   these   amino   acids   directly   serve   as   ligands   to   the   ions   and  
perform  secondary  coordination  of  waters  and  amino  acids   that   in   turn  coordinate   the  
metals,   as   observed   in   the   structure   of   bacteriophage   λ   protein   phosphatase   (Fig.   12).  
The  two  metal  cofactors  are  often  bridged  by  a  carboxylate  group;  such  an  orientation  is  





Figure  12:  Structures  of  Representative  CLP  Enzymes  
The  crystal   structures  of   (A)  Pyrococcus   furtosis  Mre11   (PDB  code  1II7),   (B)   sweet  potato  purple  
acid  phosphatase  (PDB  code  1XZW),  and  (C)  Bacteriophage  λ  Ser/Thr  protein  phosphatase  (PDB  
code  1G5B)  are  shown  as  representatives  of  the  CLP  superfamily.     Blue  spheres  represent  metal  
ions.    (D)  Active  site  of  Bacteriophage  λ  Ser/Thr  protein  phosphatase,  as  marked  in  (C)  by  dashed  
box.     The   residues  of   the   conserved  CLP  motif   (red)   serve   as   a   scaffold   for   the   two  metal   ions  
(blue).    Phosphate  substrate  analog  is  shown  in  gray.    
  
1.11 Chlamydia trachomatis 
Many well-known Gram-negative pathogens, such as E. coli, Salmonella, Yersinia 
pestis, Vibrio cholerae, and Helicobactor pylori are part of the Proteobacteria phylum.  
However, the phylum Chlamydiae also encompasses several bacterial species that are 
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threats to human health, specifically Chlamydia trachomatis.  This obligate intracellular 
pathogen is the world’s leading cause of infectious blindness and sexually transmitted 
bacterial infection (108).  Ocular infections of C. trachomatis are responsible for 
conjuctival disease, which can develop into trachoma (blindness).  Colonization of the 
bacteria in the genital   tract   can   induce   inflammation,   edema,   and  mucosal   discharge;  
neglect   of   treatment   may   lead   to   salpingitis,   pelvic   inflammatory   disease,   ectopic  
pregnancies,   infertility,   and   increased   susceptibility   to   infection   with   other   sexually  
transmitted  pathogens  like  HIV  (109).      
1.11.1 Life Cycle 
Like   other  members   of  Chlamydiae,  C.   trachomatis  exhibits   a   biphasic   life   cycle  
comprised   of   two   morphological   forms:   the   elementary   body   (EB)   state   and   the  
reticulate  body  (RB)  state  (Fig.  13)  (109).    Infection  begins  when  bacteria  in  the  EB  form  
attach   and   invade  host   epithelial   cells.     Once   inside   the  phagocytic   compartment,   EBs  
produce   proteins   that   mediate   the   formation   of   an   inclusion.      This   inclusion   quickly  
dissociates  from  the  endolysosomal  pathway,  avoiding  degradation  by  the  lysosome.    
  After   inclusion  formation,  EBs  begin  to  differentiate   into  the  RB  form,  which  is  
the  metabolically  active  and  replicative  state  of  C.  trachomatis.     This  transition  does  not  
occur   simultaneously   in   all   EBs   within   the   inclusion.      Once   in   the   RB   morphology,  
bacteria   begin   to   divide   via   binary   fission,   expanding   the   inclusion.      At   this   halfway  
point  of   the   infection,   some  of   the  RBs  begin   to   convert  back   into   the  EB   state.     These  
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newly  formed  EBs  are  released  through  the  mutually  exclusive  processes  of  cell  lysis  or  
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Blocked as result of 
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Figure  13:  The  Bi-­‐‑Phasic  Life  Cyle  of  Chlamydia  trachomatis  
Infection   begins   when   C.   trachomatis   in   the   EB   form   (dark   blue)   invade   host   epithelial   cells  
(purple).     After  endocytosis,  EBs  hijack  the  endosomal  pathway  to  generate  a  membrane-­‐‑bound  
inclusion  (denoted).    At  this  time,  EBs  begin  to  differentiate  into  the  RB  form  (peach).    Subsequent  
replication  of  RBs  increases  the  size  of  the  inclusion.     RBs  then  initiate  transition  back  to  the  EB  
form.      This   process   is   blocked   in   the   presence   of   inhibitors   targets   at   the   lipid  A   biosynthetic  
enzyme,  LpxC.      In  the  final  stage  of   infection,  newly  formed  EBs  leave  the  cell   through  lysis  or  
extrusion,  restarting   the   infection  cycle.     Time  scale  of  events   is  denoted  below  each  step.     This  




Being a Gram-negative species, Chlamydia trachomatis has a dual-membrane cell 
envelope.  Recent labeling experiments have demonstrated that the bacteria contain a 
sparse peptidoglycan (108).  The proteins of the outer membrane of C. trachomatis EBs 
are highly cross-linked, providing structural integrity necessary for successful infection 
of host cells (110,111).  Also in the outer membrane is lipooligosaccharide (LOS), an LPS-
like species that displays a short, branching core but lacks additional outer core or O-
antigen.  C. trachomatis lipid A is penta-acylated, missing a 3’ secondary hydrocarbon 
chain compared to the corresponding E. coli molecule; it also displays longer acyl chains 
at the 2, 2’, and 2’-3-OH positions and lacks 3-hydroxyl moieties on the 3 and 3’chain  
(Fig.   14)   (12).  The branched core of C. trachomatis LOS is comprised of three Kdo 
































































































Figure  14:  Structural  Comparison  of  E.  coli  and  C.  trachomatis  Lipid  A  
Shown   are   the   lipid  A  moieties   of  E.   coli  LPS   (left)   and   C.   trachomatis  LOS   (right).      The  E.   coli  
molecule   represents   the   canonical   Kdo2   lipid   A   species   that   is   the   end   product   of   the   Raetz  
pathway.    The  lipid  A  moiety  of  C.  trachomatis  LOS  is  pentacylated,  exhibits  longer  hydrocarbon  
chains  than  E.  coli,  and  contains  an  third  Kdo  residue.  While  additional  outer  core  and  O-­‐‑antigen  
regions  are  attached  to  Kdo2  lipid  A  in  the  mature  form  of  E.  coli  LPS,  no  further  addition  is  made  
to  C.  trachomatis  LOS.      
  
1.11.2.1  Function  
The   role   of   LOS   in   C.   trachomatis   has   been   partially   elucidated   through  
determining   the   effects   of   inhibiting   its   synthesis   (20).      Small   molecules   known   to  
abrogate   LpxC,   the   third   enzyme   of   the   LOS   biosynthesis,  were   employed   to   treat  C.  
trachomatis   infection   in  HeLa   cells.      It  was  observed   that   the  bacteria  were   still   able   to  
replicate  normally  inside  of  HeLa  cells,  forming  inclusions  of  standard  morphology  that  
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were   filled  with  RBs.      This  was   in   contrast   to   the   antibacterial   effect   seen   in   a   similar  
intercellular  Salmonella  entercia  serovar  Typhimurium infection.    The  RBs  from  inhibitor-­‐‑
treated   C.   trachomatis   lacked   detectable   LOS   (as   determined   through   use   of   an   LOS-­‐‑
specific   antibody),   indicating   that   blockage   of   LpxC   activity   was   in   fact   preventing  
synthesis  of  the  molecule.    Thus,  it  was  concluded  LOS  is  not  required  for  C.  trachomatis  
survival  during  beginning  infection  stages  that  involve  intracellular  replication  (20).      
While  inhibitor-­‐‑treated  C.  trachomatis  infections  formed  normal  inclusions  in  size  
and  integrity,  the  population  of  each  inclusion  displayed  a  much  higher  RB  to  EB  ratio  
compared   to   that   seen   in  untreated   infections.     This   translated   to   inclusions  composed  
primarily   of   RBs,   with   the   occasional   EB   appearing   misshapen.      Furthermore,   C.  
trachomatis   harvested   from   inhibitor-­‐‑treated   cultures   showed   a   dramatic   decrease   in  
their  ability  to  establish  secondary  infections,  corresponding  to  the  reduced  level  of  EBs.    
Overall,  this  suggested  that  while  LOS  is  not  necessary  for  the  transition  of  C.  trachomatis  
from  EB  to  RB  or  for  replication  of  RBs,  it  is  required  for  morphological  conversion  of  RB  
form  to  EB  form  (20).      
  
The   importance   of   LOS   in   C.   trachomatis’   development   to   an   infectious   form  
might   be   due   to   the   molecule’s   relationship   with   outer   membrane   proteins.      As  
previously   mentioned,   the   proteins   in   the   outer   membrane   of   C.   trachomatis   EBs   are  
highly   cross-­‐‑linked,   creating   a   sheath   that   gives   the   cell   structure   and   protection  
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(110,111).      The   protein   OmcB   forms   part   of   this   formidable   barrier   (112);   it   is  
developmentally   regulated   for   the   late   stages  of   the  bacteria’s   life   cycle   for   expression  
during  the  transition  of  the  osmotically  fragile  RB  to  a  rigid  EB  (113).    C.  trachomatis  that  
were  blocked  for  LOS  synthesis  displayed  a  decrease  in  OmcB  despite  presence  of  other  
constitutive   outer  membrane  proteins   (20).   This  decrease  was  not  ubiquitous,   as   other  
developmentally   regulated   proteins   that   are   involved   in   nucleoid   condensation   were  
evident   at   normal   levels.      Thus,   it   is   possible   that   presence   of   LOS   is   important   for  
proper  expression  or  stability  of  OmcB  (20).    As  the  protein  is  important  for  maintaining  
the  integrity  of  the  EB,  the  inability  of  OmcB  to  function  due  to  absence  of  LOS  arrests  C.  
trachomatis  in  the  RB  state.    
As  LOS   inhibition  correlates   to   inability  of  C.   trachomatis   to   transition   to   the  EB  
state,   it  may  be  employed   for  use  as  a   therapeutic   tool.      It   is   already  been   shown   that  
small  molecules  abrogating  the  activity  of  LpxC  are  effective  in  restricting  the  amount  of  
infectious  bacterial  progeny  in  culture  (20);   inhibitors  to  other  Raetz  pathway  enzymes  
would  likely  have  the  same  effect.    Such  molecules  could  translate  into  treatments  for  C.  
trachomatis   infections.     Halting   the  bacteria   in   the  RB  state  would  not  only  prevent   the  
spread  of  the  pathogen  to  other  cells,  but  it  would  also  allow  more  time  for  infected  cells  
to   mount   an   immune   response.      This   could   assist   in   acquisition   of   cell-­‐‑mediated  
immunity,  which  may  be  helpful  to  the  host  in  the  instance  of  subsequent  C.  trachomatis  
infection.      
  50  
1.11.2.2  Conservation  of  Raetz  Pathway    
The   similarity   in   the   overall   structures   of   lipid   A   from   both   E.   coli   and   C.  
trachomatis   corresponds   with   the   conservation   of   Raetz   pathway   enzymes   in   these  
organisms  (Fig.  15).    The  primary  difference  between  the  two  molecules  is  the  secondary  
acyl   chain   at   the   3’   position   (Fig.   15).      In  E.   coli,  LpxM   catalyzes   the   addition   of   this  
moiety;  C.  trachomatis  lacks  such  an  ortholog,  accounting  for  the  nonappearance  of  the  3’  
secondary   acyl   chain.      This   is   not   rare,   as   LpxM   is   only   conserved   within   some   γ  
proteobacteria.    The  presence  of  other  acyl  chains  in  the  lipid  A  molecules  is  reflected  in  
the  conservation  of  LpxA,  LpxD,  and  LpxL  in  both  bacteria.     Likewise,  existence  of  the  
disaccharide   backbone   and   4’   phosphate   group   can   be   rationalized   by   occurrence   of  
LpxB   and   LpxK,   respectively.      The   Kdo   residues   attached   to   the   backbone   can   be  
attributed   to   their   respective   KdtA   orthologs.         Furthermore,   LpxC   is   present   in   both  
Gram-­‐‑negatives.    Thus,  the  only  difference  between  the  Raetz  pathway  of  E.  coli  and  C.  
trachomatis  (albeit  LpxM,  as  discussed  above)  appears  to  be  in  LpxH.      
Considering   the   presence   of   other   Lpx   enzymes   in   C.   trachomatis   and   the  
structure   of   the   final   lipid   A   product,   the   absence   of   LpxH   does   not   indicate   lack   of  
UDP-­‐‑DAGn   hydrolase   activity   in   the   bacteria.      Rather,   it   suggests   that   an   alternative  
enzyme   is   serving   to   function   in  place  of  LpxH   in   the  Raetz  pathway.     Other  bacteria  
lacking  LpxH  employ  its  functional  analog,  LpxI,  to  serve  as  the  fourth  enzyme  of  lipid  
A  biosynthesis.    However,  C.  trachomatis  does  not  display  an  ortholog  for  LpxI,  implying  
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that   the   bacterial   species   contains   an   unidentified   protein   capable   of   UDP-­‐‑DAGn  









































E. coli C. trachomatis   
Figure  15:  Genetic  Comparison  of  E.  coli  and  C.  trachomatis  Lipid  A  Biosynthesis  
Key  block   showing   the  presence  of  Lpx  orthologs  encoding   lipid  A  biosynthetic  activities   in  E.  
coli  and  C.  trachomatis.    Absence  of  color  correlates  with  absence  of  protein  within  the  genome  of  
the  respective  bacteria.      
  
1.11.3 Genetics 
C.   trachomatis  as   a   relatively   small   genome,   being   ~   1  Mb   in   size.     Comparison  
with  other  bacterial  genomes   reveals   the  absence  of  key  biosynthetic  pathways;   this   is  
likely  due  to  the  ability  to  C.  trachomatis  to  obtain  a  variety  of  metabolites  from  its  host  
(114).    Some  of  the  existing  C.  trachomatis  pathways  are  missing  canonical  enzymes  and  
utilize   unique  proteins   in   their   place   (115,116).     Despite   the   small   size   of   the   genome,  
there  are  many  C.  trachomatis  open  reading  frames  that  have  unknown  functions.      
Functional   characterization   of   the  C.   trachomatis   genome   is   difficult   due   to   the  
lack   of   genetic   tools   available   for   the   bacteria   (109).      The   obligate   intracellular   nature,  
unique   life  cycle,  and  incomplete  understanding  of  host   interaction  make   it   impossible  
to  use  common  molecular  biology  techniques  for  study  of  C.  trachomatis.    However,  it  is  
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known   that   the   bacteria   can   undergo   DNA   exchange   with   one   another   in   laboratory  
culture  (117,118).    Furthermore,  chimeric  C.  trachomatis  plasmids  can  be  transformed  into  
EBs   and   show   evidence   of   recombinant   gene   expression   (119).      Very   recently,   this  
technique   was   optimized   for   controllable   expression   with   use   of   the   Tetracyline  
repressor  and  anhydrotetracycline  (120).  
In   the   absence   of   precise,   direct   genetic   methods,   other   techniques   for   the  
functional   assessment   of   C.   trachomatis   genes   have   been   developed   (109).      Gain-­‐‑of-­‐‑
function   approaches   involve   expressing  C.   trachomatis  genes   in   a   heterologous   system  
and  subsequently  monitoring  of  any  changes   in  host   function  (121,122).     Alternatively,  
for   loss-­‐‑of-­‐‑function   approaches,   C.   trachomatis   are   randomly   mutagenized   and   then  
screened   for   desired   genotype   or   phenotype.      As   random   mutagenesis   often   causes  
multiple  genomic  lesions  in  a  single  strain,  any  unwanted  mutations  in  isolated  bacteria  
can  be  removed  through  genetic  exchange  with  other  C.   trachomatis  strains   (123).     This  
allows   isolation   of  C.   trachomatis  with   single   mutations   that   can   be   utilized   to   assess  
corresponding  gene  functions.      
1.12 Contributions of This Work to the Field 
The   work   presented   in   the   subsequent   chapters   serves   to   further   elucidate  
enzymological  and  genetic  aspects  of  UDP-­‐‑DAGn  hydrolysis  in  lipid  A  biosynthesis.    As  
mentioned   above,   initial   characterization   of   LpxH  was   hampered   by   sample   impurity  
and  a  lack  of  a  robust  UDP-­‐‑DAGn  hydrolase  assay,  making  it  difficult  to  draw  definitive  
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conclusions   about   the   enzyme’s   properties.      Chapter   2   addresses   this   issue   with   the  
purification   of   the  H.   influenzae   ortholog   of   LpxH   (HiLpxH)   and   development   of   an  
optimized   in   vitro   assay   for  LpxH  activity.     With  use  of   an  ~90%  homogenous  protein  
sample   and   new   dynamic   method   for   hydrolytic   assessment,   we   report   a   significant  
increase  in  apparent  Vmax.      Additionally,  we  show  a  more  dramatic  pH  profile  of  LpxH  
and   present   evidence   that   it   does   not   obey   surface   dilution   kinetics   as   previously  
reported.        
While   initial   studies   of   LpxH  bioinformatically   identified   the   protein   as   a  CLP  
metalloenzyme,  there  was  a  dearth  of  supporting  biochemical  evidence.      Armed  with  a  
homogenous   sample   of   LpxH   and   a   robust   in   vitro   assay,   we   report   the   metal  
dependency   of  HiLpxH   in   Chapter   3.      The   enzyme   shows   ~600   fold   activation   in   the  
presence  of  Mn2+.     Furthermore,   through  EPR  spectroscopy,  we  show  evidence  of  a  di-­‐‑
Mn2+  cluster  in  the  enzyme.     Mutagenesis  additionally  suggests  that  the  residues  of  the  
CLP   motif   in   HiLpxH   play   an   important   role   in   activity.         Overall,   this   analysis  
definitively  indicates  that  LpxH  does  function  as  a  CLP  enzyme.      
The   hydrolysis   of   UDP-­‐‑DAGn   is   likely   ubiquitous   in   lipid   A   biosynthesis,  
however   some   Gram-­‐‑negative   bacteria,   such   Chlamydia   trachomatis,   have   neither   an  
LpxH  nor  LpxI  ortholog   to   facilitate   this  process.      In  Chapter  4,  we  discuss   the  design  
and  implementation  of  a  screen  aimed  to   identify  the  unknown  UDP-­‐‑DAGn  hydrolase  
in  C.   trachomatis.     The   strategy  employs  an  E.   coli  strain  with  a   temperature-­‐‑controlled  
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expression   of   lpxH   to   screen   a   C.   trachomatis   open   reading   frame   (ORF)   library   for  
functional   complementarity.         Successful   completion   of   the   method   identified   a  
candidate   ORF,   Ct461,   that   is   capable   of   lipid   X   production   in   vivo   and   in   vitro.     We  
conclude  that  Ct461  encodes  for  LpxG,  a  unique  UDP-­‐‑DAGn  hydrolase.    This  portion  of  
work  not  only  elucidates   the  genetic  nature  of  UDP-­‐‑DAGn  hydrolysis   in  C.   trachomatis  
but  also  serves  as  a  model  for  the  implementing  functional  analysis  of  unknown  genes  in  
genetically  intractable  bacteria.  
In  Chapter  5,  we  present  the  initial  characterization  of  the  newly  identified  UDP-­‐‑
DAGn  hydrolase  LpxG.    With  use  of  a  purified  protein  sample  and  mass  spectrometry,  
we  demonstrate   that  LpxG   facilitates  hydrolysis   through  attack  on   the  α-­‐‑phosphate  of  
UDP-­‐‑DAGn.      Based   its   homology   to   CLP  metalloenzymes,   we   investigated   the  metal  
dependence   of   CtLpxG   and   found   Mn2+   stimulates   enzyme   activity   35-­‐‑fold.    
Additionally,  we  provide  initial  evidence  that  CtLpxG  behaves  like  as  CLP  enzyme,  as  a  
point   mutation   in   the   conserved   metallophosphoesterase   motif   abrogates   activity.    
Finally,   we   compare   the   ability   of   LpxG,   LpxH,   and   LpxI   to   perform   UDP-­‐‑DAGn  
hydrolysis   in   vivo  using  heterologous   expression   in  E.   coli;  LpxG  seems   to  be   the   least  
efficient  functional  ortholog,  which  may  reflect  an  ancestral  or  adaptive  evolution  of  the  
C.  trachomatis  lipid  A  pathway.    The  work  in  this  chapter  provides  a  foundation  for  more  
detailed   enzymatic   characterization   of   LpxG   and   allows   for   initial   biochemical   and  
bioinformatic  comparison  of  the  new  hydrolase  to  its  known  functional  orthologs.      
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2. Optimized Purification and Enzymological 
Characterization of the UDP-2,3-diacylglucosamine 
Hydrolase LpxH 
2.1 Introduction 
In  E.  coli,  the  pathway  for  lipid  A  biosynthesis  consists  of  nine  enzymes,  each  of  
which   catalyzes   a   separate   step   (7).   Nearly   all   of   these   nine   enzymes   are   highly  
conserved   throughout   Gram-­‐‑negative   bacteria   (81).   However,   an   exception   to   the  
universal  nature  of  the  pathway  is  the  fourth  step  that  involves  the  hydrolysis  of  UDP-­‐‑
2,3-­‐‑diacylglucosamine   (UDP-­‐‑DAGn)   to   yield   UMP   and   2,   3-­‐‑diacylglucosamine   1-­‐‑
phosphate  (more  commonly  known  as  lipid  X)  (Fig.  9).  This  reaction,  thought  to  be  the  
first   membrane-­‐‑associating   step   of   the   pathway,   can   be   carried   out   by   either   LpxH  
(40,82)  or  LpxI  (41).  These  two  enzymes  share  no  sequence  similarity,  are  never  found  in  
the   same   organism,   and   attack   different   phosphates   in   their   catalysis   of   UDP-­‐‑DAGn  
hydrolysis   (41).  Despite   these  differences,   lpxI   can  complement  an   lpxH  knockout   in  E.  
coli  (41),  indicating  that  LpxI  and  LpxH  have  the  same  function  within  the  context  of  the  
lipid  A  pathway.  
In   early   efforts   to   characterize   LpxH,   the   E.   coli   ortholog   (EcLpxH)   was   over-­‐‑
expressed   and   purified.      It   was   noted   that   the   enzyme   behaved   like   a   peripheral  
membrane   protein,   partitioning   to   both   the   membrane   and   the   cytosol   during   cell-­‐‑
extract   fractionation.      A  Green-­‐‑19   dye   affinity   column  was   employed   to   extract   over-­‐‑
expressed   EcLpxH   from   cell   lysate.      While   this   method   did   result   in   a   13-­‐‑fold  
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enhancement   in  UDP-­‐‑DAGn  specific  activity,   it  produced  an  EcLpxH  sample   that  was  
only   60%   homogenous.      It   was   noted   that   incubating   the   sample   with   MnCl2   after  
elution   from   the  Green-­‐‑19   column   coincided  with   an   increase   in   activity.      Subsequent  
purification  steps  were  attempted,  however   the  protein  proved  to  be  unstable  and   lost  
activity  during  later  isolation  efforts.      
Activity  assessment  during  initial  purification  of  LpxH  was  carried  out  through  
use   of   an   in   vitro   autoradiographic   thin-­‐‑layer-­‐‑chromatography   (TLC)-­‐‑based   assay.    
Specifically,  the  enzyme  sample  was  incubated  with  buffer  and  substrate  doped  with  [β-­‐‑
32P]-­‐‑UDP-­‐‑DAGn,   then   samples   of   the   reaction   were   spotted   on   a   silica   TLC   plate   at  
various  time  intervals.    The  β  position  of  the  substrate’s  radiolabel  permits  the  retention  
of   the   32P-­‐‑marker   after   the  molecule   is   hydrolyzed   to   lipid   X.      Thus,   it   is   possible   to  
quantify  the  percentage  of  substrate  conversion  using  autoradiography.    
In   addition   to   tracking  UDP-­‐‑DAGn  hydrolase   activity  during   the   identification  
and   purification   of   LpxH,   the   autoradiographic   assay   was   also   used   for   enzymatic  
characterization.    The  catalytic  activity  of  partially  purified  EcLpxH  was  assessed  for  pH  
dependence;   activation   was   observed   at   pH   8.0,   however   the   dynamic   range   of   the  
results  was  too  low  to  make  any  definitive  conclusions  about  enzyme  behavior.  As  the  
enzyme  works  on  a  lipid  substrate  and  showed  the  properties  of  a  peripheral  membrane  
protein,   LpxH   hydrolysis   was   also   tested   over   a   range   of   detergent   concentrations.    
Activity  seemed  to  decrease  as   the   level  of  detergent   in  the  assay   increased,   leading  to  
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the  conclusion   that  LpxH  obeyed  surface  dilution  kinetics.     Finally,   the  KM  and  Vmax  of  
LpxH  were  determined  to  be  61.7  µμM  and  17.2  µμmol  min-­‐‑1mg-­‐‑1,  respectively.    
While  the  initial  purification  and  characterization  of  EcLpxH  provided  important  
information  about  the  function  and  basic  properties  of  the  UDP-­‐‑DAGn  hydrolase,  a  lack  
of   sample   purity   and   low   protein   activity   prevented  more   detailed   insight   about   the  
protein.   To   circumvent   these   problems,   a   more   stable   ortholog,   better   purification  
scheme,   and   more   robust   assay   were   necessary.      Here   we   report   the   cloning   and  
purification  the  Haemophilus  influenzae  ortholog  of  LpxH  (HiLpxH)  to  near  homogeneity  
and   the   identification  of  optimized  UDP-­‐‑DAGn  hydrolase  assay  conditions.     With   this  
sample  of  enhanced  purity  and  a  more  dynamic  method  of  in  vitro  catalytic  assessment,  
we  are   able   to   re-­‐‑evaluate   the   enzymatic  properties  of  LpxH.     We  observe   a   1000-­‐‑fold  
increase   in   observed   activity   under   our   optimized   conditions,   corresponding   to   an  
significant   increase   in   the   observed  Vmax.     Additionally,  we   report   a   strong   reliance   of  
activity   on   basic   assay   conditions.      Finally,   we   show   that   HiLpxH   does   not   display  
surface  dilution  kinetics,   as  previously   reported.     Overall,   our  development  of   a  more  
efficient   purification   scheme   paired   with   our   new   understanding   of   the   fundamental  
properties   of   LpxH   set   the   scene   for   further   enzymatic   characterization   and   structural  
studies,  which  could  both  be  important  in  the  development  of  inhibitors.  
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2.2 Materials and Methods  
2.2.1 Chemicals and Reagents 
Reagents   for   bacterial   growth   included   yeast   extract,   tryptone,   and  Bacto  agar,  
and   were   purchased   from   Difco   (Detroit,   MI).   The   4-­‐‑(2-­‐‑hydroxyethyl)-­‐‑1  
piperazineethanesulfonic   acid   (HEPES),   phosphate-­‐‑buffered   saline   (PBS)   components,  
HCl,  salts,  ampicillin,  isopropyl-­‐‑β-­‐‑D-­‐‑thiogalactoside  (IPTG),  fatty  acid-­‐‑free  bovine  serum  
albumin   (BSA),  ethylenediaminetetraacetic  acid   (EDTA),  and  dithiothreitol   (DTT)  were  
purchased   from   Sigma-­‐‑Aldrich   (St.   Louis,   MO).   Methanol,   chloroform,   pyridine,   and  
acetic   acid  were   obtained   from   EMD   Science   (Gibbstown,  NJ).   Radioactive   γ-­‐‑32Pi  was  
purchased   from   PerkinElmer   (Waltham,   MA).   The   plasmids   used   in   this   study   were  
purified   using   Qiagen   Mini-­‐‑Prep   kits   (Qiagen,   Valencia,   CA)   according   to   the  
manufacturer’s   protocol.   DNA   fragments   were   purified   using   QIAquick   Spin   kits.  
Sequencing  was  carried  out  by  Eton  Bioscience,  Inc  (Research  Triangle  Park,  NC).  Unless  
otherwise   noted,   protein   concentration   was   determined   either   by   BCA   Assay   or  
Bradford   Assay   (Thermo   Scientific,   Waltham,   Massachusetts)   depending   on  
compatibility   with   buffer   components.   Both   of   these   methods   were   carried   out   as  
described  by  the  manufacturer.  
2.2.2 Cloning of H. influenzae lpxH 
Amplification   of   lpxH   (HI0375)   from   H.   influenzae   genomic   DNA   (ATCC,  
Rockville,  MD)  was  accomplished  using  polymerase  chain  reaction  (PCR)  with  primers  
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Hih_F  and  Hih_R  that  were  50  base  pairs  upstream  and  downstream  of   lpxH.  (Table  1)  
To   facilitate   eventual   ligation   of   the   gene   product   into   an   expression   vector,  we   used  
primers   (Integrated   DNA   Technologies,   Coralville,   IA)   that   allowed   for   the  
incorporation   of  Nde1   and  XhoI   restriction   sites   to   the   5’   and   3’   ends   of   lpxH   and   the  
elimination  of  the  stop  codon  at  the  end  of  the  gene.  The  PCR  reaction  was  carried  out  
using  a  Mastercycler  Gradient  Thermocycler  (Eppendorf,  Hamburg,  Germany)  with  the  
reagents   and   protocol   of   the   KOD   Hot   Start   Kit   (EMD   Chemicals,   Gibbstown,   NJ),  
however  the  reaction  was  additionally  supplemented  with  3%  (w/v)  dimethyl  sulfoxide.  
Sequencing   of   the   resulting   product   using   the   original   primers   was   used   to   ensure  
proper  amplification.    
To  generate  an  expression  vector  with  a  C-­‐‑terminal  His10  tag  that  was  cleavable  
by  Tobacco  Etch  Virus  (TEV)  protease,  33  additional  nucleotides  were  added  to  pET21b  
(Novagen/EMD   Chemicals)   to   encode   for   the   7   amino   acids   of   the   protease   site  
(ENLYFQG)  (124)  and  the  4  additional  histidine  residues  needed  to  elongate  the  affinity  
tag.   This  was   accomplished  using  QuikChange   (Stratagene,   La   Jolla,  CA)  mutagenesis  
with  21TEV_F  and  21TEV_R  primers  (Integrated  DNA  Technologies)  that  were  designed  
to  insert  the  additional  nucleotides  3’  to  the  XhoI  restriction  site  in  pET21b.  The  reaction  
was  carried  out  using  the  manufacturer’s  protocol  with  an  additional  supplement  of  3%  
(w/v)  dimethyl  sulfoxide  and  1  M  betaine.  Following  nucleotide  insertion,  the  resulting  
plasmid,  p21t10,  was  confirmed  by  sequencing  with  T7_Forward  and  T7_Reverse  (Table  
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1)   and   transformed   into   chemically   competent   DH5α   cells   (Invitrogen).   Additionally,  
p21t10  was  transformed  into  chemically  competent  E.  coli  C41(DE3)  to  create  the  vector  
control  expression  strain  VC_T10.  
Insertion   of   amplified   H.   influenza   lpxH   into   p21t10   was   accomplished   by  
digestion  of  both   the  PCR  fragment  and  the  vector  with  Nde1  and  XhoI   (New  England  
Biolabs)  under  conditions  described  by  the  manufacturer.  After  treatment  of  p21t10  with  
antarctic   phosphatase   (New   England   Biolabs)   under   conditions   described   by   the  
manufacturer,  digested  lpxH  was  inserted  into  the  plasmid  with  T4  ligase  (Invitrogen)  as  
directed   by   the   manufacturer.   The   ligation   product,   pHiHt10,   was   transformed   into  
chemically   competent   C41(DE3)   E.   coli   to   generate   the   expression   strain   HiH_t10.  
Sequencing  with  T7  forward  and  reverse  primers  confirmed  the  appropriate  insertion  of  
H.  influenzae  lpxH  into  p21t10.  
  61  
  
Table  1:  Primers  Used  in  the  Characterization  of  HiLpxH  
Name Purpose Primer sequence (5'-3' orientation) 
21TEV_F 
To add a TEV cleavage site 






To add a TEV cleavage site 









To amplify H. influenzae 
lpxH, eliminates stop codon 




To sequence segments of 




To sequence segments of 




Table  2:  Plasmids  Used  in  the  Characterization  of  HiLpxH  
Plasmid Description Source 
pET21b high-copy expression vector containing a T7 promoter, AmpR Novagen 
p21t10 modified pET21b vector encoding C-terminal TEV-protease cleavage site followed by a His10 tag, AmpR 
this work 
pHiHt10 p21t10 containing H. influenzae lpxH, AmpR this work 
pKJB2 pET21a+ plasmid containing E. coli lpxH, AmpR (40) 
pHiHt10 p21t10 containing H. influenzae lpxH, AmpR this work 
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Table  3:  E.  coli  Strains  Used  in  Characterization  of  HiLpxH  
Strain Description Source 
DH5α F
− Δ(argF-lacZYA)U169 deoR phoA supE44 Φ80 
Δ(lacZ)M15 gyrA96 relA1 endA1 thi-1 hsdR17 recA1λ− Invitrogen 
C41(DE3) F- ompT hsdSB (rB- mB-) gal dcm (DE3) (125) 
VC_t10 C41(DE3) harboring p21t10, AmpR this work 
HiH_t10 C41(DE3) harboring pHiHt10, AmpR this work 
 
2.2.3 Protein Localization 
Two   samples   of   cell-­‐‑free   extract   from   HiH_t10   (obtained   as   described   below)  
corresponding   to   6  mg   of   total   protein  were      brought   to   a   volume   of   1  mL  with   the  
appropriate   stock   solutions   to   yield   final   solution   concentrations   of   200  mM  NaCl,   20  
mM  HEPES   pH   8.0,   and   either   0%   or   1.5%  w/v   of   TX-­‐‑100.      These   samples  were   then  
incubated  for  1  h  at  4  °C,  then  subjected  to  ultracentrifugation  at  100,000  ×  g  for  45  min.    
Resulting   supernatants   were   collected   as   cytosolic   fractions   and   pellets   were  
resuspended  in  200  mM  NaCl  and  20  mM  HEPES  pH  8.0  to  obtain  membrane  fractions.    
The   fractions  were   analyzed   for   the   presence   of  HiLpxH   by   both   SDS-­‐‑PAGE   and   the  
optimized  UDP-­‐‑DAGn  hydrolase  activity  assay,  as  described  below.      
2.2.4 Protein Expression and Purification 
A   typical   prep   of   HiLpxH   began   with   inoculating   an   overnight   culture   of   LB  
with   a   single   colony   of   HiH_t10.   This   overnight   culture   was   subsequently   used   to  
inoculate  3  L  of  LB  (10  g  tryptone,  5  g  yeast  extract,  10  g  NaCl  per  liter)  supplemented  
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with  100  µμg/mL  of  ampicillin  to  an  OD600  of  0.02.  Cultures  were  incubated  at  30  °C  with  
aeration  at  220  rpm  until   they  reached  OD600  of  0.7-­‐‑0.8,   then  induced  for  expression  by  
the   addition   of   1  mM   IPTG   and   grown   for   an   additional   4   to   5   hours   until   the  OD600  
reached  ~4.  Cells  from  the  growths  were  pelleted  by  centrifugation  at  5,000  ×  g,  washed  
with   140   mL   of   cold   PBS,   and   then   stored   at   -­‐‑80   °C.   For   lysis,   the   frozen   pellet   was  
thawed,   resuspended   in   80   mL   of   ice   cold   20   mM  HEPES   pH   8.0,   and   passed   twice  
through   a   French   pressure   cell   (SIM-­‐‑AMINCO;   Spectronic   Instruments)   at   18,000   psi.  
The  debris  from  the  resulting  lysate  was  removed  by  centrifugation  at  10,000  ×  g  and  the  
subsequent  supernatant  was  collected  as  cell-­‐‑free  extract  and  stored  at  -­‐‑80  °C.    
Cell-­‐‑free  extract  was  thawed  and  diluted  to  5  mg/mL  with  20  mM  HEPES  pH  8.0.  
A   stock   solution  of   10%   (w/v)  Triton  X-­‐‑100   (Thermo  Scientific),  was  used   to  bring   the  
cell-­‐‑free   extract   to   a   final   detergent   concentration   of   1.5%   (w/v).   All   subsequent   steps  
were  carried  out  at  4  °C.  The  resulting  solution  was  then  mixed  by  inversion  for  1  h  and  
then   subjected   to   ultracentrifugation   at   100,000   ×   g   for   45   min.   The   supernatant   was  
removed   and   diluted   with   the   appropriate   stocks   to   make   a   450   mL   solution   of   ~3  
mg/mL   protein,   20   mM   HEPES   pH   8.0,   200   mM   NaCl,   20   mM   imidazole,   and   0.5%  
Triton  X-­‐‑100.  This  solution  was  then  loaded  by  gravity  onto  a  packed  column  of  20  mL  
of  Ni-­‐‑NTA  resin  (Qiagen)  that  had  been  pre-­‐‑equilibrated  in  20  column  volumes  of  load  
buffer   (20   mM   HEPES   pH   8.0,   200   mM   NaCl,   20   mM   imidazole,   0.1%   TX-­‐‑100).   The  
loaded  column  was  next  washed  with  an  additional  10  column  volumes  of   load  buffer  
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followed   by   a   15   column   volume   wash   with   load   buffer   supplemented   with   30   mM  
imidazole  (final  imidazole  concentration  50  mM).  To  exchange  HiLpxH  out  of  detergent,  
the  column  was  subjected  to  a  50  column  volume  wash  with  a  solution  of  20  mM  HEPES  
pH  8.0,  200  mM  NaCl.  Elution  of  the  protein  was  accomplished  by  a  7  column  volume  
wash  with  a  solution  of  20  mM  HEPES  pH  8.0,  200  mM  NaCl,  and  400  mM  imidazole.  
Samples  from  each  wash  of  the  column  were  analyzed  by  SDS-­‐‑PAGE  to  ensure  proper  
fractionation.    
After   elution,   a   TEV-­‐‑protease   reaction  was   used   to   cleave   the  C-­‐‑terminal  His10  
tag.  The  eluted  protein  was  diluted   to  a  volume  of  200  mL  with   the  appropriate   stock  
solutions  to  yield  a  sample  with  final  concentrations  of  2  mM  DTT,  2  mM  EDTA,  20  mM  
HEPES   pH   8.0,   200   mM   NaCl,   300   mM   imidazole,   and   ~0.015   mg/mL   (~1/50   of   the  
HiLpxH  concentration)  of  TEV  protease.  The  protease  used  was  prepared  as  described  
in   the   literature   (124)   and   cleavage  was  monitored   using   SDS-­‐‑PAGE.   After   overnight  
incubation,   the   reaction   was   concentrated   to   a   final   volume   of   50   mL   using   15   mL  
Amicon  Ultra  10K  molecular  weight  cutoff  centrifuge  concentrators  (Millipore,  Billerica,  
MA)   and   then   dialyzed   overnight   against   8   L   of   20  mM  HEPES   pH   8.0   and   200  mM  
NaCl.   Remaining   TEV   protease   and   any   uncleaved   HiLpxH   was   removed   from   the  
sample   by   passage   over   a   5   mL   Ni-­‐‑NTA   column   pre-­‐‑equilibrated   with   20   column  
volumes   of   a   solution   containing   20  mM  HEPES   pH   8.0,   200  mM  NaCl,   and   20  mM  
imidazole.   The   flow-­‐‑through   was   collected   and   then   concentrated   using   Millipore  
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conical   spin   concentrations   to   a   final   concentration   of   ~8   mg/mL.   The   final   protein  
sample,  which  contained  HiLpxH  followed  by  the  residual  TEV  cleavage  site  residues  of  
ENLYFQ,  was  analyzed  by  SDS-­‐‑PAGE  to  confirm  purity  and  stored  at   -­‐‑80  °C  in  15  µμL  
aliquots.  
2.2.5 Synthesis of Radioactive Substrate 
32P-­‐‑labeled   UDP-­‐‑2,3-­‐‑diacylglucosamine   (UDP-­‐‑DAGn)   was   prepared   as  
previously  described  (41)  with  some  modifications.  Firstly,  the  50  µμL  0.2  M  1-­‐‑H-­‐‑tetrazole  
in   acetonitrile   in   the   morpholidate   reaction   was   replaced   with   20   µμL   0.1   M  
dicyanoimdiazole   in   acetonitrile   (Sigma   Aldrich).   Secondly,   after   the   product   of   the  
morpholidate  reaction  was  dried  under  N2,   it  was  extracted  with  a  single  phase  Bligh-­‐‑
Dyer  (126)  with  volumes  of  0.5  mL  methanol,  0.25  mL  chloroform,  and  0.2  mL  PBS.  The  
mixture  was  centrifuged  to  pellet  debris  and  the  supernatant  was  transferred  to  a  2  mL  
polypropylene   tube   and   dried   under   N2.   The   radioactive   substrate   was   then  
resuspended  in  100-­‐‑170  µμL  of  20  mM  HEPES  pH  8.0  containing  0.02%  Triton  X-­‐‑100  and  
sonicated   for   2   min.   One   final   centrifugation   step   was   used   to   pellet   any   insoluble  
material.  The   supernatant   containing   the   final   [β-­‐‑32P]  UDP-­‐‑DAGn  was   transferred   to  a  
new   tube   and   stored   at   -­‐‑20   °C.   These   extra   extraction   steps   removed   contaminating  
impurities  that  interfered  with  the  linearity  of  our  assays.    
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2.2.6 Optimized In Vitro Assay for UDP-DAGn Hydrolase Activity 
General   autoradiographic   assays   for   hydrolase   activity   were   similar   to   that  
previously  described  (40)  with  optimized  modifications.  Reactions  mixtures  were  a  final  
volume  of  15  µμL  in  0.6  mL  polypropylene   tubes  and  contained  20  mM  HEPES  pH  8.0,  
0.5%  (w/v)  BSA,  0.05%  (w/v)  Triton  X-­‐‑100,  1  mM  MnCl2,  100  µμM  UDP-­‐‑DAGn  (prepared  
as  previously  described  (127),  1,000  cpm/µμL  [β-­‐‑32P]  UDP-­‐‑DAGn,  and  enzyme.  Previous  
studies  of  E.   coli  LpxH   reported  a   small   enhancement   in   enzyme   stability   and  activity  
when  the  protein  was  purified  with  MnCl2  (40);  therefore,  MnCl2  was  incorporated  into  
the  assay.  All  reaction  components  besides  the  enzyme  were  mixed  to  a  volume  of  12  µμL  
and  equilibrated  at  30  °C  for  10  min,  after  which  3  µμL  of  enzyme  was  added  to  start  the  
reaction.  Unless  otherwise  noted,  enzyme  samples  were  diluted  in  a  buffer   identical   to  
the  assay  mixture  but  lacking  any  lipid  substrate.  Aliquots  of  1.5  µμL  were  taken  from  the  
reactions  at  various  time  intervals  and  spotted  onto  20  cm  ×  20  cm  glass-­‐‑backed  silica  gel  
thin  layer  chromatography  (TLC)  plates  (EMD  Chemicals,  Darmstadt,  Germany).  These  
plates   were   developed   in   a   25:15:4:2   chloroform:   methanol:   water:   acetic   acid   tank  
system,   dried,   exposed   to   phosphoscreens,   scanned,   and   quantified   as   previously  
described  (40).  
2.2.7 Comparison of In Vitro Assays 
Comparison  of  In  Vitro  Assays.  To  assess  the  effectiveness  of  the  optimized  in  vitro  
assay,   E.   coli   LpxH   (EcLpxH)   cell-­‐‑free   extract,   HiLpxH   cell-­‐‑free   extract,   and   purified  
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HiLpxH   were   analyzed   for   activity   under   both   the   original   and   the   improved   assay  
conditions.   To  prepare   the  EcLpxH   cell-­‐‑free   extract,  E.   coli  C41(DE3)  was   transformed  
with   pKJB2   (40),   a   pET21a+   plasmid   containing   E.   coli   lpxH.  A   250  mL   culture   of   the  
resulting  strain  was  grown  at  30  °C  in  LB  media  and  induced  for  expression  with  IPTG  
at  mid-­‐‑log  phase.  After  5  h  cells  were  harvested  and   lysed   to  generate  cell-­‐‑free  extract  
using  the  method  described  above.  The  same  procedure  was  carried  out  in  parallel  with  
strain  HiH_t10  to  prepare  the  HiLpxH  cell-­‐‑free  extract.  Purified  HiLpxH  was  isolated  by  
the   aforementioned   technique.   Activity   assessment   under   original   conditions   was  
conducted  as  previously  reported  with  the  final  protein  concentrations  in  the  assay  for  
EcLpxH   cell-­‐‑free   extract,  HiLpxH   cell-­‐‑free   extract,   and  HiLpxH  being   1.8,   4.5,   and   8.5  
µμg/mL   respectively.   Samples  were   also   tested   under   the   optimized   in   vitro   conditions  
with  protein   concentrations   of   45  ng/mL  EcLpxH   cell-­‐‑free   extract,   110  ng/mL  HiLpxH  
cell-­‐‑free  extract,  and  1.7  ng/mL  HiLpxH.  
2.2.8 Kinetic Parameters, pH Optimum, and Detergent Dependence of 
HiLpxH 
To  determine   the  KM  and  Vmax  of  HiLpxH  with   respect   to  UDP-­‐‑DAGn,  purified  
HiLpxH  was  assayed  under  standard  conditions  except  the  concentration  of  UDP-­‐‑DAGn  
was  varied  from  20  to  400  µμM.  The  velocities  from  each  of  these  reactions  were  plotted  
against   substrate   concentration   and,   using   KalediaGraph   (Synergy   Software,   Reading  
PA),  the  resulting  curve  was  fit  to  the  Michaelis-­‐‑Menten  equation.  In  order  to  maintain  
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linear   conversion   at   various   substrate   concentrations,   the   HiLpxH   in   the   assay   was  
varied  from  6  to  63  pM.  
To   assess   the   effect   of   pH   on   HiLpxH   activity,   purified   protein   was   assayed  
under   standard   conditions   except   20   mM   HEPES   pH   8.0   was   replaced   with   a   triple  
buffer  system  containing  100  mM  sodium  actetate,  50  mM  bis(2-­‐‑hydroxyethyl)iminotris-­‐‑
(hydroxymethyl)hexane,   and   50  mM  TRIS   at   a   pH   from   4.0   to   9.0.  KalediaGraph  was  
used   to   fit   a   single-­‐‑limb   pKa   curve   (Eq.   1)   to   the   resulting   data.   The   enzyme  
concentration  of  HiLpxH  needed  to  see  linear  activity  in  the  assay  at  different  pH  values  
ranged  from  30  pM  to  372  nM.  
v = C1+[H ] /Ka
  
Equation  1:    pKa  Determination  
To  monitor  the  detergent  dependence  of  HiLpxH,  the  Triton  X-­‐‑100  concentration  
in   the   standard  assay  was  varied   from  0   to   18  mM  (1.2  %  w/v).  Purified  HiLpxH  was  
diluted  in  the  standard  buffer  lacking  Triton  X-­‐‑100,  added  to  the  reactions  covering  the  
mentioned   range   of   detergent   concentrations,   and   assayed   for   activity.   Reported   total  
detergent   concentrations   accounted   for   the   small   amount   of   detergent   (0.01   mM,  
0.0007%   w/v)   present   in   both   the   [β-­‐‑32P]   UDP-­‐‑DAGn   and   the   non-­‐‑radioactive   UDP-­‐‑




2.2.1 Expression and Purification of HiLpxH 
  Previous  studies  of  LpxH  were  performed  using  the  E.  coli  ortholog.    However,  
purification   attempts   with   this   version   of   the   protein   proved   cantankerous,   as   the  
enzyme   did   not   maintain   activity   over   time,   suggesting   it   may   be   unstable   upon  
isolation.      In  an  effort   to  circumvent  this   issue,  we  turned  to  an  UDP-­‐‑DAGn  hydrolase  
ortholog   from   another   species:   Haemophilus   influenzae.      Additionally,   as   dye   affinity  
chromatography   did   not   yield   protein   of   high   purity,   we   sought   to   employ   a   more  
efficient  method  of  purification  using  Ni-­‐‑NTA  chromatography.      
With  the  aforementioned  motivations  in  mind,  the  gene  encoding  LpxH  from  H.  
influenzae   was   amplified   from   genomic   DNA   and   cloned   into   a   modified   pET21b  
expression  vector  designed  to  yield  a  protein  product  that  was  tagged  at  the  C-­‐‑terminus  
with   an   8-­‐‑residue   TEV   protease   cleavage   site   followed   by   10   histidine   residues.      (It  
should  be  noted  that  there  is  a  high  frequency  of  conserved  residues  at  the  N-­‐‑terminus  
of   LpxH   orthologs,   thus   a   C-­‐‑terminal   tag   was   chosen   to   prevent   any   inadvertent  
alterations  to  the  integrity  of  the  N-­‐‑terminal  region).  Transformation  of  this  plasmid  into  
E.  coli  C41  resulted  in  strain  HiH_t10.  When  HiH_t10  was  grown  at  30  °C  in  the  presence  
of   IPTG,   the  over-­‐‑expression  of   a  27  kD  protein  matching   the  molecular  weight  of   the  
predicted   protein   product   was   evident   when   compared   to   a   vector   control   strain  
VC_T10  via  SDS-­‐‑PAGE  (Fig.  16A).  
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When  over-­‐‑expressed   in  E.  coli  C41,  HiLpxH  partitioned   to  both   the  membrane  
and  the  cytosolic  fractions,  as  indicated  by  SDS-­‐‑PAGE  and  activity  assay  (Fig.  16B).    This  
membrane  association  of  the  protein  is  similar  to  the  behavior  reported  for  EcLpxH  (40).    
To   increase  the  yield  of  protein  for  purification,   the  cell-­‐‑free  extract   from  HiH_t10  was  
incubated  with  Triton  X-­‐‑100  to  solubilize  any  HiLpxH  that  may  be  associated  with  the  
membrane,   resulting   in   recovery  of  nearly  all   the  LpxH  activity   to   the   soluble   fraction  
(Fig.  2B).    This  additional  isolation  step  was  not  explored  in  the  purification  of  EcLpxH.  
Following  detergent  treatment,  Ni-­‐‑NTA  chromatography  was  used  to  isolate  the  
His10-­‐‑tagged  HiLpxH.    Any  remaining  detergent  from  the  initial  solubilization  step  was  
removed  with   an   extensive  wash  with   buffer   lacking   detergent   or   imidazole   after   the  
protein  was  loaded  onto  the  Ni-­‐‑NTA  column.  The  initial  Ni-­‐‑NTA  step  resulted  in  a  10-­‐‑
fold   increase   in   specific   activity   (Table   4)   and   yielded   protein   that  was   ~90%  pure   by  
SDS-­‐‑PAGE  (Fig.  16C).  Following  dialysis  to  remove  imidazole,  cleavage  of  the  His-­‐‑tag,  
and   subsequent   clean-­‐‑up   with   another   Ni-­‐‑NTA   column,   the   final   protein   sample  
showed  marginal  increase  in  purity  by  gel,  but  a  6-­‐‑fold  enhancement  in  specific  activity.  
This  corresponded  to  a  dramatic  increase  in  total  active  units  (480%,  Table  4),  suggesting  
that  although  the  inclusion  of  an  affinity  tag  facilitated  protein  purification,  its  presence  
inadvertently   impaired   the   enzyme   activity.   Overall,   we   were   able   to   consistently  
recover   ~30  mg  of  HiLpxH  per   1   L   of  HiH_t10   culture.   This   final   protein   sample  was  
~95%  pure  (Fig.  2C)  and  exhibited  a  60-­‐‑fold  increase  in  specific  activity  (Table  4).      
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Figure  16:    SDS-­‐‑PAGE  Analysis  of  Over-­‐‑expression  and  Purification  of  HiLpxH  
(A)   Cell-­‐‑free   extract   (CFE)   of   VC_t10   and   HiH_t10   prepared   as   described   in   Experimental  
Procedures.   The   27   kD   band   that   is   present   in   the   HiH_t10   lane   and   not   in   the   VC_t10   lane  
corresponds   to   over-­‐‑expressed   HiLpxH.   (B)   Analysis   of   fractions   from   HiLpxH   purification  
outlined   in   Materials   and   Methods.   Fractions   from   the   Ni-­‐‑NTA   purification   include   the   load  
denoting   the   solubilized   cell-­‐‑free   extract   from   HiH10_t   that   was   loaded   onto   the   column,   FT  
representing  the  flow  through  from  the  column,  W1  signifying  the  50  mM  imidazole  wash,  and  
Elute   indicating   the   tagged  HiLpxH  obtained   from   the  400  mM   imidazole  wash.  The  CU  elute  
lane  shows  protein  that  flowed  through  the  second  clean-­‐‑up  Ni-­‐‑NTA  column  after  TEV-­‐‑protease  
digestion.   The   purified  HiLpxH   fractions   depict   the   final   sample   of   purified  HiLpxH   that  was  
used  in  radiographic  assays  and  EPR  experiments.  The  labels  5  µμg  and  10  µμg  indicate  how  much  
protein  was  loaded  in  each  lane.  
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Table  4:  Purification  of  HiLpxH  from  HiH_t10  






(mmol min-1 mg-1) 
Fold 
Purification 
NiNTA Load 1400 400 182 0.13 1 
NiNTA Elute 210 140 273 1.3 10 
Final Sample 112 16 874 7.8 60 
  
2.2.2 HiLpxH Activity in Optimized Autoradio-graphic Assay.  
As  discussed  above,  LpxH  activity  can  be  monitored  with  a  TLC-­‐‑based  assay  that  
utilizes   [β-­‐‑32P]-­‐‑UDP-­‐‑DAGn.      Previously   published   assay   conditions   contained   25   mM  
HEPES  pH  8.0,  100  µμM  UDP-­‐‑DAGn,  and  1,000  cmp/µμL  [β-­‐‑32P]  UDP-­‐‑DAGn  (40).  Based  
on  the  observations  of  increased  stability  of  the  E.  coli  ortholog  in  the  presence  of  MnCl2  
and  slight  activation  of  the  enzyme  upon  pre-­‐‑incubation  with  the  metal  (40),  we  added  1  
mM   MnCl2   to   the   assay   dilution   buffer   as   well   as   to   the   reaction.   Additionally,   we  
supplemented   the   reaction   with   0.05   mg/mL   BSA   and   0.05%   Triton   X-­‐‑100   to   aid   in  
protein  stability  and  substrate  solubility.    
Our   new   assay   conditions   proved   to   enhance   the   in   vitro   catalysis   of   LpxH.    
When   purified  HiLpxH  was   assayed  with   these  modifications,   we  were   able   to   track  
conversion  of  [β-­‐‑32P]-­‐‑UDP-­‐‑DAGn  to  [32P]-­‐‑lipid  X  (Fig.  17A)  and  calculate  an  activity  that  
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was  1000-­‐‑fold  higher  than  that  calculated  when  HiLpxH  was  assayed  under  previously  
reported  conditions  (Fig.  17B).  This  increase  in  activity  under  optimized  conditions  was  
also  observed  when   the   cell-­‐‑free  extract  of   strains  over-­‐‑expressing  HiLpxH   (HiH  CFE)  
and  EcLpxH   (EcH  CFE)  were   tested   for   lipid  X   formation.  The  LpxH  expression   from  
both  of   these  cell-­‐‑free  extract   samples  appeared  equal  by  SDS-­‐‑PAGE   (data  not   shown)  
and   corresponded   to   similar   levels   of   activity   under   both   conditions,   indicating   the  
activation  was   not   ortholog-­‐‑specific.   Furthermore,   activity   in   the   optimized   system   is  














Figure  17:  Assay  for  LpxH  Activity    
(A)  Scan  of  phosphoscreen  exposed  to  silca  TLC  plate  from  a  representative  HiLpxH  assay  using  
10   pM   enzyme.   Product   conversion   is   calculated   by   quantifying   intensity   of   lipid   X   as   a  
percentage   of   the   total   intensity   of   each   lane   and   then   subtracting   the   background   conversion  
calculated  from  the  no  enzyme  (no  rxn)  control.   (B)  Specific  activity  of  various  protein  samples  
under   original   assay   conditions   compared   to   optimized   assay   conditions.   Cell-­‐‑free   extract   of  
samples  over-­‐‑producing  EcLpxH  (EcH  CFE)  and  HiLpxH  (HiH  CFE)  were  prepared   in  parallel  
and  exhibit  similar  levels  of  protein  expression.  (C)  Percent  of  100  µμM  UDP-­‐‑DAGn  converted  to  
lipid  X  at  specific  time  points  under  standard  assay  conditions  with  10  pM  HiLpxH.  Data  was  fit  
to   a   linear   curve  using  KaleidaGraph  and   showed  an  R2  value  of   0.998.   (D)  Percent  of   100  µμM  
UDP-­‐‑DAGn  converted  to  lipid  X  at  various  HiLpxH  concentrations  after  10  min  under  standard  
reaction   conditions.  KaleidaGraph  was  once  again  used   to   fit  data   to  a   linear   curve  with  an  R2  
value  of  0.995.  Plots  generated  in  (C)  and  (D)  are  the  result  of  the  average  of  three  independent  
data  sets.  
  75  
2.2.3 Apparent Kinetic Parameters, pH Rate Profile, and Detergent 
Dependence of HiLpxH.  
While   the   enzymatic   properties   of   EcLpxH   had   been   reported   previously   (40),  
these   observations   were   obscured   by   sample   impurity,   less-­‐‑than-­‐‑optimal   assay  
conditions,   and   low   enzymatic   activity.   Therefore,   it   is   critical   to   revisit   the  
characterization   of   LpxH   using   a   highly   purified   protein   sample   and   our   newly  
optimized  assay  conditions.  The  specific  activity  of  purified  HiLpxH  was  determined  at  
varied   concentrations   of   UDP-­‐‑DAGn   to   calculate   the   basic   kinetic   parameters   of   the  
enzyme   (Fig.   18A).   When   this   information   was   fit   to   a   Michaelis-­‐‑Menten   model,   it  
resulted  in  an  apparent  KM  of  79.4  ±  11.0  µμM  for  the  lipid  substrate  and  an  apparent  Vmax  
of  18.1  ±  0.9  mmol  min-­‐‑1mg-­‐‑1,  
The   high   specific   activity   of   HiLpxH   also   enabled   us   to   determine   the   pH  
dependence  of  LpxH  catalysis.  LpxH   is  most   active  at   slightly  alkaline  pH  values  and  
exhibits  a  sharp  decrease   in   its  catalytic  activity  at   low  pH.  It   is   important   to  note   that  
such   drop   in   LpxH   activity   at   acidic   pH   is   not   due   to   enzyme   instability   as   pre-­‐‑
incubation   of   HiLpxH   at   low   pH   does   not   alter   the   apparent   enzyme   activity   at   the  
standard  condition  of  pH  8.0  (data  not  shown).  These  data  were  fit  to  a  single  lobed  pH  
curve  described  by  Eq.  1  with  a  pKa=6.6  ±  0.4  (Fig.  18B).  
Finally,   in   order   to   gain   insight   into   how   LpxH   interacts   with   a   hydrophobic  
surface,   the  activity  of  HiLpxH  was  assessed  at  a   range  of  Triton  X-­‐‑100  concentrations  
from  0   to   18  mM.     As   shown   in  Fig.   18C,   the   enzyme   is   active  without  detergent   and  
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demonstrates  stimulation  in  hydrolysis  as  the  detergent  concentration  nears  the  critical  
micelle   concentration   (0.19   mM).   At   detergent   amounts   above   the   critical   micelle  
concentration,   the   protein   initially   shows   a   decrease   in   hydrolytic   ability,   after  which  
activity   appears   to   be   unaffected   by   the   detergent   concentration   in   the   assay.   Such  
behavior  is  not  indicative  of  surface  dilution  kinetics,  suggesting  that  while  the  enzyme  
likely   associates   with   the   surface   of   the   detergent-­‐‑substrate   micelles   in   vitro   during  





Figure  18:  Kinetic  Enzymatic Analysis of HiLpxH 
(A)  HiLpxH   activity   under   standard   conditions   is   dependent   upon  UDP-­‐‑DAGn   concentration.  
The  apparent  KM  was  79.4  ±  11.0  µμM  and  the  apparent  Vmax  was  18.1  ±  0.9  mmol  min-­‐‑1  mg-­‐‑1,  both  
calculated   by   fitting   the   data   to  KaleidaGraph.   (B)   Changes   in   pH   alter   the   in   vitro   activity   of  
HiLpxH.   The   enzyme   shows   exhibits   a   dramatic   increase   in   activity   as   the   pH   of   the   reaction  
reaches  7,  but  very  little  change  upon  progressively  more  alkaline  conditions.  Data  was  fit  to  Eq.  
1   using   KaleidaGraph,   yielding   a   pKa   of   6.6   ±   0.4.   (C)   Effect   of   Triton   X-­‐‑100   concentration   on  
HiLpxH   specific   activity   at   100   µμM  UDP-­‐‑DAGn.   Surface   dilution   kinetics   are   not   apparent   as  
activity   does   not   appear   to   have   a   strong   correlation  with   detergent   amount   and   the   enzyme  
displays  detectable  activity  even  at  very  low  Triton  X-­‐‑100  concentrations.  All  plots  shown  were  
each  generated  from  the  average  of  three  separate  experiments  
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2.3 Discussion 
The  conversion  of  UDP-­‐‑DAGn  to  lipid  X  by  LpxH  is  an  important  step  in  lipid  A  
biosynthesis   (40,82).   Previous   studies   of   E.   coli   LpxH   identified   it   as   a   peripheral  
membrane  protein,  but  limited  conclusions  could  be  drawn  from  further  studies  due  to  
sample  purity  (60%)  and  low  enzymatic  activity  under  assay  conditions  (40).    The  lack  of  
an   efficient   purification   scheme   or   robust   method   for   in   vitro   assessment   prevented  
further  study  of   the  protein,   leaving   the  enzyme  kinetic  properties  of  LpxH  catalysis  a  
mystery.  
In  order  to  reveal  the  true  characteristics  of  LpxH,  we  first  sought  to  improve  the  
purification  method  of  the  hydrolase.    We  cloned  and  purified  H.  influenzae  ortholog  of  
LpxH   to   near   homogeneity.      This   ortholog   also   behaves   as   a   peripheral   membrane  
protein  and  thus  we  incorporated  a  detergent  solubilization  step  to  increase  the  protein  
yield.   Interestingly,   a   dramatic   increase   in   total   active   units   (480%,   Table   1)   was  
observed   in   the   final   sample   after   removing   the  His-­‐‑tag,   suggesting   that   although   the  
inclusion  of  a  metal  affinity  tag  facilitated  protein  purification,  its  presence  inadvertently  
impaired  the  enzyme  activity.    
Second,   we   aimed   to   optimize   LpxH   assay   conditions   based   on   previously  
reported   observations   about   the   positive   effect   Mn2+   had   on   the   behavior   EcLpxH.  
Incorporation  of  MnCl2  into  the  standard  reaction  conditions  along  with  the  addition  of  
BSA  and  Triton  X-­‐‑100  yielded  a  1000-­‐‑fold  enhancement  of  activity  of  purified  HiLpxH  
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compared  to  that  observed  under  original  assay  conditions.  The  enhancement  was  also  
seen  in  samples  of  cell-­‐‑free  extracts  over-­‐‑expressing  HiLpxH  and  EcLpxH;  moreover,  the  
activities   of   these   samples   were   similar   to   each   other   under   each   respective   assay  
condition.   These   observations   indicate   enhanced   activity   under   optimized   assay  
conditions   is   not   an   ortholog-­‐‑specific   phenomenon.   Later   experiments   including   BSA  
and   Triton   X-­‐‑100   but  without  MnCl2   (see   Chapter   3;   “No  metal”   sample   described   in  
metal  dependence  assays)  only  stimulated  activity  2-­‐‑fold,   implying  the  presence  of   the  
metal  was  the  main  contributor  to  the  improved  condition.  
Armed  with  a  more  homogenous  protein  sample  and  a  more  dynamic  method  of  
catalytic  evaluation,  we  elected  to  re-­‐‑examine  the  kinetic  parameters  of  LpxH.  We  found  
that  HiLpxH  has  an  apparent  KM  of  79.4  µμM,  similar  to  that  reported  for  E.  coli  ortholog,  
61.7  µμM  (40).  Remarkably,  the  apparent  Vmax  of  HiLpxH,  18.1  mmol  min-­‐‑1  mg-­‐‑1,  is  ~1000-­‐‑
fold  greater  than  that  reported  for  EcLpxH  (40),  which  was  determined  in  the  absence  of  
BSA,   Triton   X-­‐‑100,   and  MnCl2.      It   is   likely   that   the   presence   of  MnCl2   is   the   primary  
reason   for   this  drastic  change   in  Vmax   (see  above  discussion),  alluding   to   the   important  
role  of   the  metal   ion   in  hydrolysis.      In  contrast,   the  comparable  values  of   the  apparent  
KM   determined   both   in   the   absence   and   presence   of   metal   suggest   the  Mn2+   has   little  
effect  on  the  binding  of  the  UDP-­‐‑DAGn  substrate.      
The   low   enzymatic   activity   of   the   previous   EcLpxH   assay   also   affected   the  
interpretation   of   the   pH-­‐‑rate   profile,   which   showed   only   small   variation   of   EcLpxH  
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activities  within  the  same  order  of  magnitude  over  the  entire  range  of  tested  pH  values  
(40).   In   contrast,   the  pH-­‐‑rate  profile  of  HiLpxH  reveals  a  1000-­‐‑fold   increase   in  activity  
over   three   pH  units   (from   5   to   7),   and   this   level   of   activity   is  maintained  under   basic  
conditions.   The   mono-­‐‑limbic   shape   of   the   pH-­‐‑rate   profile   HiLpxH   is   similar   to   that  
reported  for  LpxI,  a  functional  ortholog  of  LpxH  which  also  hydrolyzes  UDP-­‐‑DAGn  to  
lipid   X   (41).   The   ability   of  HiLpxH   to   recover   activity   after   pre-­‐‑incubation   at   low   pH  
values  indicates  the  reduction  in  LpxH  hydrolytic  ability   is  not  due  to  a   loss   in  overall  
enzyme  stability  and  implies  that  a  deprotonation  event  is  necessary  for  catalysis.  
Perhaps   the   most   notable   difference   between   EcLpxH   and   HiLpH   was   their  
activity   in   the   presence   of   detergent.   Although   it   was   reported   that   EcLpxH  
demonstrated   surface   dilution   kinetics,  with   the   enzyme   showing   inactivation   at   high  
levels   of   detergent   (40),  HiLpxH   retains   a   relatively   consistent   level   of   activity   over   a  
wide  range  of  detergent  concentrations  well  beyond  the  critical  micelle  concentration  of  
detergent.  Such  a  discrepancy  most  likely  does  not  reflect  an  ortholog  difference,  as  the  
sequence  of  HiLpxH  and  EcLpxH  are  highly  similar.  Rather,  it  is  more  probable  that  the  
low  purity  of  the  EcLpxH  protein  and  unsatisfactory  assay  conditions  falsely  led  to  the  
observation  of  reduced  enzymatic  activity  in  a  micellar  system.  Since  HiLpxH  does  not  
obey   surface   dilution   kinetics,   it   is   likely   this   enzyme   is   free   roaming   in   solution   and  
scavenges   its   lipid-­‐‑like   substrate   in  a  micellar   environment   to  perform  catalysis,  much  
like  the  model  suggested  for  LpxI  (41)  (Fig.  11).  This  similarity  in  membrane  association  
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is  consistent  with  the   idea  that  LpxI  and  LpxH  are  functionally   interchangeable  within  
the  lipid  A  pathway.  
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3. LpxH Utilizes a Mn2+ Cluster in for Lipid X Production 
3.1 Introduction 
In   the   proceeding   chapter,   we   present   in   detail   the   purification   and   basic  
characterization  of  an  ortholog  of  LpxH  from  H.  influenzae.    This  work  heavily  relied  on  
the  use  of  an  optimized  in  vitro  assay  that  utilized  Mn2+.    The  incorporation  of  the  cation  
into   the   assay   conditions   was   based   on   a   previous   report   that   pre-­‐‑incubation   of   a  
partially  purified  sample  of  the  E.  coli  ortholog  of  LpxH  with  MnCl2  enhanced  activity  3  
fold  (40).    Additionally,  it  was  observed  that  the  presence  of  MnCl2  enriched  UDP-­‐‑DAGn  
hydrolase   activity   in   the   membrane   fraction   of   cell-­‐‑free   extracts   over-­‐‑expressing  
EcLpxH.    Investigators  hypothesized  that  Mn2+  may  play  a  role  in  maintaining  enzyme  
structure,   facilitating   membrane   association,   or   contributing   to   the   formation   of   the  
active  site  of  EcLpxH  (40),  however  no  definitive  metal  dependence  of  the  protein  was  
ever  reported.    
Along  with  elementary  in  vitro  observations,  bioinformatic  analysis  also  provides  
evidence   to   support   the  hypothesis   that  LpxH  uses  metal   ions   for   catalysis.      Sequence  
alignment  of  LpxH  orthologs  reveal  a  DXH(X)~25GDXXDR(X)~25GNHD/E  (where  X  is  any  
residue;  the  final  histidine  is  replaced  with  an  arginine  in  LpxH  orthologs)  motif  that  is  
found   in   the   calcineurin-­‐‑like   phosphoesterase   (CLP)   superfamily   (Pfam00149).   Besides  
calcineurin,   enzymes   of   the   CLP   superfamily   also   include   protein   serine/threonine  
phosphatases   (101),   purple   acid   phosphatases   (104),   nucleotidases,   sphingomyelin  
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phosphodiesterases  (100),  exonucleases,  and  cyclic  nucleotide  phosphodiesterases  (103).    
These   enzymes   perform   catalysis   using   an   ordered   shell   of   water  molecules   and   two  
divalent   or   trivalent   metal   cofactors   coordinated   by   conserved   residues   of   the  
metallophosphoesterase  motif   (103,105)   (Fig.   12).   The   two  metals   have   been   shown   to  
form  a  cluster,  separated  by  only  a  few  angstroms.    It  has  been  postulated  that  the  metal  
ions   serve   to   bridge   an   oxide   that   performs   a   nucleophilic   attack,   to   stabilize   the  
formation   of   a   phosphorane   intermediate,   and   to   coordinate   a   nucleophilic   hydroxyl  
group  to  allow  for  deprotonation  (105,106).  
Despite   this  homology  to  a   family  of  CLP  enzymes,   it  was  still  unclear   if  LpxH  
utilized  a  metal  cluster  for  hydrolysis.    Compared  to  other  enzymes  of  this  family,  LpxH  
hydrolyzes  a  unique  substrate  containing  both  lipid  and  nucleotide  moieties  and  does  so  
by  breaking  a  pyrophosphate  bond,  a  type  of  chemistry  that  to  our  knowledge  has  not  
been   previously   reported   for   CLP   enzymes   (103).   In   fact,   the   hydrolase   reaction  
catalyzed   by   LpxH   is   more   commonly   carried   out   by   enzymes   in   the   Nudix   family,  
which   cleave   the   pyrophosphate   bond   of   nucleoside   diphosphates   linked   to   another  
moiety  (128).    Also,  the  lack  of  biochemical  analyses  pertaining  to  the  metal-­‐‑dependence  
of   LpxH   further   added   to   the   mystery   of   whether   the   enzyme   functions   like   other  
members  of  the  CLP  family.  
In  order   to  clarify   the  mechanism  of  LpxH  hydrolysis,  we  used   in  vitro   activity  
assessment  and  electron  paramagnetic  resonance  (EPR)  spectroscopy  to  study  the  metal  
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dependence  of  HiLpxH.     We  show  that  HiLpxH  activity  is  stimulated  over  600-­‐‑fold  by  
Mn2+,  a  vast  enhancement  compared  to  any  other  metals  tested.    Our  EPR  studies  reveal  
the  presence  of   a  Mn2+   cluster   comprised   to   two  binding   sites  with  differing   affinities.    
As  these  findings  support  the  similarity  of  LpxH  to  other  CLP  enzymes,  we  proceeded  
with   mutagenesis   studies   to   assess   the   functional   importance   of   the   predicted   Mn2+-­‐‑
binding   residues   in   the   conserved  metallophosphoesterase  motif.      Overall,   these   new  
observations  highlight  a  strong  mechanistic  similarity  of  LpxH  to  members  of   the  CLP  
family  and  allow  for  a  prediction  of  LpxH’s  active  site  structure.    
3.2 Materials and Methods 
3.2.1 Chemicals and Reagents 
  Reagents   for  bacterial  growth   included  yeast  extract,   tryptone,  and  Bacto  agar,  
and   were   purchased   from   Difco   (Detroit,   MI).   The   4-­‐‑(2-­‐‑hydroxyethyl)-­‐‑1  
piperazineethanesulfonic   acid   (HEPES),   phosphate-­‐‑buffered   saline   (PBS)   components,  
HCl,  salts,  ampicillin,  isopropyl-­‐‑β-­‐‑D-­‐‑thiogalactoside  (IPTG),  fatty  acid-­‐‑free  bovine  serum  
albumin   (BSA),  ethylenediaminetetraacetic  acid   (EDTA),  and  dithiothreitol   (DTT)  were  
purchased   from   Sigma-­‐‑Aldrich   (St.   Louis,   MO).   Methanol,   chloroform,   pyridine,   and  
acetic   acid  were   obtained   from   EMD   Science   (Gibbstown,  NJ).   Radioactive   γ-­‐‑32Pi  was  
purchased   from   PerkinElmer   (Waltham,   MA).   The   plasmids   used   in   this   study   were  
purified   using   Qiagen   Mini-­‐‑Prep   kits   (Qiagen,   Valencia,   CA)   according   to   the  
manufacturer’s   protocol.   DNA   fragments   were   purified   using   QIAquick   Spin   kits.  
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Sequencing  was  carried  out  by  Eton  Bioscience,  Inc  (Research  Triangle  Park,  NC).  Unless  
otherwise   noted,   protein   concentration   was   determined   either   by   BCA   Assay   or  
Bradford   Assay   (Thermo   Scientific,   Waltham,   Massachusetts)   depending   on  
compatibility   with   buffer   components.   Both   of   these   methods   were   carried   out   as  
described  by  the  manufacturer.  
3.2.2 Generation and Purification of Point Mutants  
QuikChange  (Stratagene)  mutagenesis  was  used  to  make  alanine  point  mutants  
of  conserved  residues  within  HiLpxH.  The  method  was  carried  out  as  described  by  the  
manufacturer,   with   pHiHt10   (Table   2)   serving   as   template   DNA.   Specific   primers  
(Integrated   DNA   Technologies)   (Table   5)   were   created   for   each   desired   alanine  
substitution,  and  sequencing  with  T7  forward  and  reverse  primers  was  used  to  confirm  
the  mutations.  The  mutated  pHiHt10  vectors  (Table  6)  were  transformed  into  chemically  
competent   E.   coli   C41(DE3)   to   create   respective   expression   strains   (Table   7).   These  
strains,   along   with   wild-­‐‑type   HiH_t10,   were   grown   under   conditions   described   for  
HiLpxH  purification  in  Chapter  2  except  that  the  culture  volume  was  250  mL.  Cells  from  
each   of   the   growths  were   centrifuged   at   5,000   ×   g,   and   collected   pellets  were  washed  
with  30  mL  of  cold  PBS  and  then  stored  at  -­‐‑80  °C.  For  lysis,  the  frozen  pellet  from  each  
mutant  strain  and  the  wild-­‐‑type  strain  was  thawed,  resuspended  in  8  mL  of  ice-­‐‑cold  20  
mM  HEPES  pH   8.0,   and  passed   twice   through   a   French  pressure   cell   (SIM-­‐‑AMINCO;  
Spectronic  Instruments)  at  18,000  psi.  The  debris  from  the  resulting  lysate  was  removed  
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by  centrifugation  at  10,000  ×  g  and  the  subsequent  supernatant  was  collected  as  cell-­‐‑free  
extract  and  stored  at  -­‐‑80  °C.    
Purification   of   the   protein   from   these   growths   was   the   same   as   HiLpxH,   but  
adjusted   to   account   for   the   smaller   culture   size.   The   cell-­‐‑free   extract   was   thawed,  
diluted,  and  solubilized  as  described  for  HiLpxH.  Following  the  centrifugation  step  after  
detergent   incubation,   the   supernatant  was   removed   and   diluted  with   the   appropriate  
stocks  to  make  a  20  mL  solution  of  ~3  mg/mL  protein,  20  mM  HEPES  pH  8.0,  200  mM  
NaCl,  20  mM  imidazole,  and  0.5%  Triton  X-­‐‑100.  This  solution  from  each  strain  was  then  
loaded  by  gravity  onto  separate  columns  of  1  mL  Ni-­‐‑NTA  resin  (Qiagen)  that  had  been  
pre-­‐‑equilibrated   in   20   column   volumes   of   the   load   buffer   described   above.  Washing,  
detergent  exchange,  and  elution  were  carried  out  as  outlined  for  HiLpxH.  Samples  from  
each  wash  of   the  column  were  analyzed  by  SDS-­‐‑PAGE   to  ensure  proper   fractionation.  
Following   elution,   the   samples   were   each   concentrated   to   3   mL   using   5   mL   Amicon  
Ultra   10K   molecular   weight   cutoff   centrifuge   concentrators   (Millipore)   and   then  
dialyzed   overnight   against   1   L   of   20   mM   HEPES   pH   8.0,   200   mM   NaCl.   Resulting  
protein  solutions  from  each  mutant  and  the  wild-­‐‑type  sample  were  further  concentrated  
to  500  µμL  and  stored  in  -­‐‑80  °C.  
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Table  5:  Primers  Used  for  Creation  of  HiLpxH  Point  Mutants  
Name Purpose Primer sequence (5'-3' orientation) 
H11A_F To mutate HiLpxH H11 to alanine 
TGAAACATAGCTATTTTATTTCTGATTTGG
CTTTAAGCGAAACTCAGCCAGAATT 
H11A_R To mutate HiLpxH H11 to alanine 
AATTCTGGCTGAGTTTCGCTTAAAGCCAAA
TCAGAAATAAAATAGCTATGTTTCA 
D42A_F To mutate HiLpxH D42 to alanine 
GAACGGCTTTACATTTTGGGTGCTCTTTTTG
ATTTTTGGATTGGTG 
D42A_R To mutate HiLpxH D42 to alanine 
CACCAATCCAAAAATCAAAAAGAGCACCC
AAAATGTAAAGCCGTTC 
R81A_F To mutate HiLpxH R81 to alanine 
GTTATTTTCAGCACGGCAACGCTGATTTCT
TGATTGGTGAAC 
R81A_R To mutate HiLpxH R81 to alanine 
GTTCACCAATCAAGAAATCAGCGTTGCCGT
GCTGAAAATAAC 
H115A_F To mutate HiLpxH H115 to alanine 
CAATTGATTACACTTTATGATAAAAAAATC
TTACTTTGTGCTGGCGATACGCTTTGTATT 




D117A_F To mutate HiLpxH D117 to alanine 
AAAATCTTACTTTGTCATGGCGCTACGCTT
TGTATTGATGATGAG 
D117A_R To mutate HiLpxH D117 to alanine 
CTCATCATCAATACAAAGCGTAGCGCCATG
ACAAAGTAAGATTTT 
D123A_F To mutate HiLpxH D123 to alanine 
CGATACGCTTTGTATTGATGCTGAGGCTTA
CCAACAATTTC 
D123A_R To mutate HiLpxH D123 to alanine 
GAAATTGTTGGTAAGCCTCAGCATCAATAC
AAAGCGTATCG 
H196A_F To mutate HiLpxH H196 to alanine 
GTAAATTTATTAATTCACGGAGCCACACAC
CGTGAGGCGATTCA 






Table  6:  Plasmids  Harboring  HiLpxH  Point  Mutants  
Plasmid Description Source 
pET21b high-copy expression vector containing a T7 promoter, AmpR Novagen 
p21t10 modified pET21b vector encoding C-terminal TEV-protease cleavage site followed by a His10 tag, AmpR this work 
pHiHt10 p21t10 containing H. influenzae lpxH, AmpR this work 
pKJB2 pET21a+ plasmid containing E. coli lpxH, AmpR (40) 
pHiHt10 p21t10 containing H. influenzae lpxH, AmpR this work 
pD9At10 p21t10 containing mutatued H. influenzae lpxH encoding for a D9A mutation, AmpR this work 
pH11At10 p21t10 containing mutatued H. influenzae lpxH encoding for a H11A mutation, AmpR this work 
pD42At10 p21t10 containing mutatued H. influenzae lpxH encoding for a D42A mutation, AmpR this work 
pR81At10 p21t10 containing mutatued H. influenzae lpxH encoding for a R81A mutation, AmpR this work 
pH115At10 p21t10 containing mutatued H. influenzae lpxH encoding for a H115A mutation, AmpR this work 
pD117At10 p21t10 containing mutatued H. influenzae lpxH encoding for a D117A mutation, AmpR this work 
pD123At10 p21t10 containing mutatued H. influenzae lpxH encoding for a D123A mutation, AmpR this work 




Table  7:  E.  coli  Strains  Used  for  Expression  of  HiLpxH  Point  Mutants  
Strain Description Source 
DH5α F
− Δ(argF-lacZYA)U169 deoR phoA supE44 Φ80 
Δ(lacZ)M15 gyrA96 relA1 endA1 thi-1 hsdR17 recA1λ− Invitrogen 
C41(DE3) F- ompT hsdSB (rB- mB-) gal dcm (DE3) (125) 
VC_t10 C41(DE3) harboring p21t10, AmpR this work 
HiH_t10 C41(DE3) harboring pHiHt10, AmpR this work 
D9A_t10 C41(DE3) harboring pD9At10, AmpR this work 
H11A_t10 C41(DE3) harboring pH11At10, AmpR this work 
D42A_t10 C41(DE3) harboring pD42At10, AmpR this work 
R81A_t10 C41(DE3) harboring pR81At10, AmpR this work 
H115A_t10 C41(DE3) harboring pH115At10, AmpR this work 
D117A_t10 C41(DE3) harboring pD117At10, AmpR this work 
D123A_t10 C41(DE3) harboring pD123A10, AmpR this work 
H196_t10 C41(DE3) harboring pH196At10, AmpR this work 
 
3.2.3 Metal Dependence of HiLpxH  
To   analyze   the   metal   dependence   of   HiLpxH,   a   modified   procedure   for   the  
optimized  autoradiographic   assay  described   in  Chapter   2  was   employed.  First,   a  pure  
HiLpxH  sample  (obtained  as  outlined  in  Chapter  2)  was  diluted  with  standard  reaction  
buffer   that  replaced  1  mM  MnCl2  with  2  mM  EDTA,   incubated  on   ice   for  20  min,   then  
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diluted  again  into  standard  reaction  buffer  with  no  MnCl2,  and  incubated  on  ice  for  an  
additional   10  min.  This  EDTA-­‐‑treated  enzyme  was  next  added   to   reaction  mixtures   in  
which  1  mM  MnCl2  was  replaced  by  no  di-­‐‑  or  trivalent  metal  ion,  2  mM  NaCl,  or  each  of  
the  following  chloride  salts  at  1  mM:  Ca2+,  Co2+,  Cu2+,  Fe3+,  Mg2+,  Mn2+,  Ni2+,  and  Zn2+.  To  
ensure   linear  activity  under  each  condition,   the  concentration  of  HiLpxH  in   the  assays  
were  varied  from  35  to  178  nM.    
Another   form   of   the   modified   autoradiographic   assay   was   used   to   assess  
HiLpxH  dependence   on  MnCl2   in  which   the   protein  was   diluted   in   standard   reaction  
buffer   containing   no   MnCl2   and   then   diluted   into   reactions   in   which   the   MnCl2  
concentration  ranged   from  0   to  5  mM.  Protein  concentration  was  980  pM  in   the  0  mM  
assay  condition  and  10  pM  in  all  others.    
3.2.4 EPR Spectroscopy  
X-­‐‑band  EPR  spectra  were  recorded  using  Bruker  Biospin  (Billerica,  MA)  Bruker  
E-­‐‑500   spectrometer   equipped   with   super   high   Q   cavity   providing   a   conventional  
perpendicular  EPR  mode  (i.e.,  microwave  magnetic  field  B1  is  perpendicular  to  the  static  
magnetic   field   B0).   All   room   temperature   spectra   were   recorded   at   the   same  
experimental   conditions:   10   G   modulation   amplitude   at   100   kHz,   2   mW   incident  
microwave   power   at   9.86   GHz   frequency.   For   EPR   measurements   at   cryogenic  
temperatures   the   spectrometer   was   outfitted   with   ESR   910   cryostat   and   ITC-­‐‑4  
temperature  controller  (Oxford  Instruments,  Concord,  MA).  Temperature  at  the  sample  
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cavity  was  calibrated  using  a  CernoxTM  thin   film  sensor   (Lake  Shore  Cryotronics   Inc .,  
Westerville,  OH).  Incident  microwave  power  was  kept  at  levels  to  avoid  saturation  and  
modulation   amplitude  was   set   to   about   1/3   to   1/4   of   the   narrowest   peak-­‐‑to-­‐‑peak   line  
width.  
3.2.5 Manganese Titration with EPR Detection at Room Temperature 
To   assess   binding   of  Mn2+   to   HiLpxH,   80   µμL   of   a   solution   containing   100   µμM  
purified  HiLpxH  (Chapter  2),  20  mM  HEPES  pH  8.0,  and  200  mM  NaCl  was  titrated  in  
successive  additions  with  1  µμL  of  1.645  mM  MnCl2  stock  containing  the  same  buffer  as  
the  protein  solution.  After  each  addition  of  manganese  stock,  the  sample  was  mixed  and  
incubated   for   >5  min   at   room   temperature.   Subsequently,   approximately   20  µμL   of   the  
titrated  solution  was  drawn  into  a  quartz  capillary  with  0.70  mm  i.d.  and  0.87  mm  o.d.  
(VitroCom,  Mountain   Lakes,  NJ).  One   end   of   the   capillary  was   sealed  with  Critoseal®  
(McCormick   Scientific,   St.   Louis,  MO)   and   inserted   into   a   3  mm   i.d.   quartz   EPR   tube  
(Wilmad-­‐‑LabGlass,  Vineland,  NJ).  The  tube  was  then  fixed  inside  the  EPR  resonator  so  
that  the  section  of  the  capillary  containing  the  aqueous  sample  was  covering  the  entire  
sensitivity   region   of   the   EPR   resonator  while   the  Critoseal®   plug  was   located   outside.  
After   taking   an   EPR   spectrum,   the   protein   solution   was   recovered   into   the   vial  
containing   the   rest   of   the   sample   and   a   new   portion   of  MnCl2   was   added.   The   same  
quartz  tube  was  used  for  all  the  protein  containing  samples.  When  changing  the  sample,  
solution  was  drawn  in  and  out  of  the  capillary  twice  to  ensure  complete  replacement  of  
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the   previous   sample.   For   a   control   calibration   of   EPR   signal   intensity   vs.   Mn2+  
concentration,  the  same  procedure  was  used  except  that  a  buffer-­‐‑only  solution  was  used.  
After  collection  of  spectra,  the  concentration  of  free  Mn2+  ion  present  in  solutions  
was   evaluated  by   either   least-­‐‑squares   fitting   of   the  high   field  hyperfine   component   of  
the  six-­‐‑line  Mn2+  EPR  spectrum  using  EWVoigt  program  (129)  or  by  measuring  peak-­‐‑to-­‐‑
peak   intensity   of   that   component   as   the   peak   line   width   did   not   change.   Both  
measurements   yielded   identical   results.   The   determined   free  Mn2+   concentration  were  
analyzed  based  a  two-­‐‑site  binding  model  (Eq.  2):  
P +M Ka1! →! P1M
P +M Ka2! →! P2M
P1 +M Ka2! →! PMM
P2 +M Ka1! →! PMM
 
Equation  2:  Two-­‐‑Site  Ligand  Binding  
P   is   the  protein  with   only   the   first   (P1M),   and   the   second   (P2M),   or   both  metal  
binding  sites  occupied  by  metal  ion  M,  and  Ka1  and  Ka2  are  the  corresponding  association  
constants.  All  experimental   spectra  were  corrected   for  a  small  background  signal   from  
the   resonator   that   was   recorded   using   a   capillary   containing   only   protein   solution   in  
buffer.   Least-­‐‑squares   fitting   of   experimental   data   was   accomplished   using   the  
Levenberg-­‐‑Marquardt   optimization   and   parameter   uncertainties   were   determined   by  
standard  covariance  matrix  method  using  SigmaPlot  (Systat  Software,  San  Jose,  CA).  
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3.2.6 Manganese Titration with EPR Detection at Cryogenic 
Temperatures  
Low  temperature  EPR  experiments  were  employed  for  further  assessment  of  the  
Mn2+-­‐‑protein   interaction  and   for   the  existence  of  a  Mn2+  cluster.  For   these  experiments,  
samples  containing  20  mM  HEPES  pH  8.0,  200  mM  NaCl,  10%  (v/v)  glycerol  and  234  µμM  
of  HiLpxH  were  incubated  with  molar  equivalents  of  MnCl2  ranging  from  0  to  2.0.  After  
assembly,   these   samples   were   stored   at   -­‐‑80   °C.   Just   before   an   EPR   measurement,   a  
sample   was   thawed   and   drawn   into   3  mm   i.d.   precision   quartz   EPR   tubes   (Wilmad-­‐‑
LabGlass)  and  then  frozen  again  by  immersing  the  tube  into  liquid  nitrogen  before  being  
placed  in  a  pre-­‐‑cooled  EPR  cryostat.  
 
3.3 Results 
3.3.2 Metal Dependence of HiLpxH  
While  it  had  been  previously  suggested  that  Mn2+  plays  a  role  in  the  structure  or  
catalysis   of   EcLpxH   (40),   the   exact   function   of   metal   ions   in   LpxH   remained   to   be  
elucidated.   In   order   to   determine   how   metal   ions   altered   the   capability   of   LpxH   to  
hydrolyze  UDP-­‐‑DAGn,  we  used  an  autoradiographic  TLC-­‐‑based  assay  to  monitor  the  in  
vitro  activity  of  the  enzyme  in  the  presence  of  various  metal  salts.    First,  highly  purified  
HiLpxH  was   incubated   in   standard   reaction   buffer   in  which   the  MnCl2   was   replaced  
with  2  mM  EDTA  to  remove  any  co-­‐‑purifying  metal  ions.    The  protein  was  then  diluted  
into   standard   assay   conditions   containing   1  mM   of   the   following   chloride   salts:   Ca2+,  
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Co2+,  Cu2+,   Fe3+,  Mg2+,  Mn2+,  Ni2+,   and  Zn2+.  Assay   conditions  where   the  di-­‐‑   or   trivalent  
metal   salt   was   replaced   by   2   mM   NaCl   or   no   metal   additive   were   also   included   as  
controls.     Activity  was  monitored  over   time  and   the  specific  activity  was  calculated  as  
previously  outlined  in  Chapter  2.     Results  were  compared  to  the  activity  of  HiLpxH  in  
the  presence  of  no  metal  (Fig.  19A).  The  Mn2+  assay  condition  showed  activity  that  was  
670-­‐‑fold  greater  than  the  condition  with  no  metal.  The  Ni2+,  Co2+,  and  Fe3+  conditions  also  
enhanced  activity;  however,   the   increase   (10-­‐‑50   fold)  was  substantially   lower   than   that  
seen   when   Mn2+   was   present.   The   activity   of   the   enzyme   was   negligible   in   NaCl,  
indicating  that  the  ionic  strength  of  the  reaction  was  not  responsible  for  any  stimulation  
observed.   The   enzyme   did   show   residual   activity   in   the   absence   of  metal,   albeit   only  
visible  at  enzyme  concentrations  1000-­‐‑fold  greater  than  that  usually  used  in  the  assay.    
To   further   investigate   Mn2+-­‐‑dependent   stimulation,   HiLpxH   activity   was  
determined  using  the  autoradiographic  assay  containing  a  range  of  Mn2+  concentrations  
(Fig.  19B).  Enzyme  activity  increased  with  Mn2+  concentrations  up  to  2.5  mM,  a  ~108-­‐‑fold  
molar  excess  compared  to  the  HiLpxH  concentration  in  the  assay.  After  this  point,  there  
seemed  to  be  no  further  stimulation  in  product  hydrolysis.  This  pattern  was   indicative  
of  Michaelis-­‐‑Menten  saturation  kinetics,  suggesting  the  metal  acts  as  a  pseudo-­‐‑substrate  
for  HiLpxH.  Consequently  the  data  was  fit  to  determine  an  apparent  KM  of  487  ±  113  µμM  
for  Mn2+.  This  term  was  designated  the  KMetal  for  the  enzyme.    
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Figure  19:  Metal  Dependency  of  HiLpxH  
(A)   HiLpxH   treated   with   EDTA   was   assayed   under   standard   conditions   supplemented   with  
either  metal,  NaCl,  or  no  metal.  Resulting  specific  activity  was  calculated  and  compared   to   the  
specific  activity  of   the  no  metal  control.  Data  shown  is   the  mean  of   three  separate  experiments.  
(B)   UDP-­‐‑DAGn   hydrolysis   activity   of   HiLpxH   was   determined   as   a   function   of   MnCl2  
concentration  in  the  assay.  This  data  was  fit  to  a  Michaelis  Menten  model  with  KaleidaGraph  to  
obtain  a  KM  of  487  ±  113  µμM  for  Mn2+.    
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3.3.2 Evidence for Two Mn2+ Binding Sites in HiLpxH  
While  in  vitro  assays  showed  stimulation  of  hydrolase  activity  in  the  presence  of  
Mn2+,  we  wished   to   further   probe   the   interaction   of  Mn2+  with  HiLpxH.   To  do   so,  we  
generated  a  Mn2+  titration  curve  using  EPR  spectroscopy,  a  technique  that  has  been  used  
to   characterize   the  Mn2+   binding   site   in   another   CLP   family   enzyme,   bacteriophage   λ  
protein  phosphatase  (130).  This  approach  relies  on  the  fact  that  a  Mn2+  ion  coordinated  to  
a  protein  binding  site  exhibits  very  broad  EPR  lines  caused  by  large  zero-­‐‑field  splitting  
effects,  making  it  undetectable  at  room  temperature,  whereas  free  Mn2+  yields  a  distinct  
EPR  signal  under  the  same  condition.    
Representative  room  temperature  EPR  spectra  from  the  titration  of  HiLpxH  with  
manganese  are  shown   in  Fig.  6A.  For  samples  with  Mn2+-­‐‑to-­‐‑protein  ratio  above  1:1,  an  
EPR  spectrum  revealed  a  six-­‐‑line  hyperfine  pattern  (nuclear  spin  I=5/2)  with  a  splitting  
of  approximately  95  G  positioned  at  g≈2.0   that   is  characteristic  of   free  (hexaaqua)  Mn2+  
ion.  The  intensity  of  the  spectrum  varied,  increasing  concomitantly  with  the  manganese-­‐‑
to-­‐‑protein  ratio  (Fig.  6A).  Spectra  obtained  from  samples  with  Mn2+-­‐‑to-­‐‑protein  ratio  of  ≤1  
demonstrated   no   detectable   six-­‐‑line   component   characteristic   of   the   free   Mn2+   ion,  
indicating  that  the  free  metal  concentration  was  below  the  EPR  detection  limit  (<1  µμM)  
and  that  nearly  all  the  Mn2+  ions  in  these  samples  are  bound  to  the  protein.  
The  spectra  were  further  analyzed  to  assess  the  binding  of  the  metal  ion  to  LpxH.  
As   the   intensity   of   the   six-­‐‑line   hyperfine   component   correlates   to   the   amount   of   free  
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Mn2+   in   the   sample   tube,   the   concentration   of   unassociated   ion   could   be   determined.  
This  was  accomplished  by  a  double  integration  of  the  high  field  hyperfine  component  of  
the  HiLpxH-­‐‑MnCl2  titration  spectra  and  a  calibration  of  the  double-­‐‑integrated  intensity  
from   a   control   titration   containing   only   MnCl2.   Fig.   20B   shows   the   intensity   of   EPR  
spectra   of   free   hexaaqua  Mn2+   ion   as   a   function   of   total   [Mn2+]   for   samples   containing  
either  MnCl2  in  buffer  (squares)  or  MnCl2  and  HiLpxH  (circles).  In  all  protein-­‐‑containing  
samples,  the  intensity  of  Mn2+  EPR  signal  is  less  than  that  in  the  control  samples  without  
the  protein.  Above  ~200  µμM  Mn2+,  which  represents  [Mn2+]/[HiLpxH]  ratios  above  2,  the  
slopes   of   both   plots   are   approximately   the   same,   indicating   that   concentration   of  
protein-­‐‑bound  Mn2+  species  plateaus  and  that  each  HiLpxH  binds  two  Mn2+  ions.    
Based  on   this   observation,   the   titration   curve   in  Fig.   6B  was   fit  with   a   two-­‐‑site  
binding   model   (Eq.   2).   While   the   least-­‐‑squares   fit   was   of   exceptionally   high   quality  
(Rsqr=0.998)  for  Ka2,  yielding  a  value  of  5.8±0.6×105  M-­‐‑1  (or  Kd2=1.7  µM),  it  was  found  to  be  
insensitive   to  Ka1  as   long  as  Ka1>50  x  106  M-­‐‑1   (or  Kd1  <  20  nM).   Indeed,  no  free  Mn2+  was  
detectable  in  EPR  spectra  when  the  metal-­‐‑to-­‐‑protein  ratio  is  below  1,  consistent  with  the  
notion  that  the  binding  affinity  for  the  first  metal  is  very  tight,  well  below  the  detection  
limit  of  the  EPR  instrument  (~  1  µM).  
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Figure  20:  Room  Temperature  EPR  Analysis  of  Mn2+  binding  
(A)  Representative  room  temperature  CW  X-­‐‑band  EPR  spectra  from  samples  containing  100  µμM  
of   HiLpxH   and   the   appropriate   concentration   of   MnCl2   to   yield:   1   equivalent   of   Mn2+,   1.4  
equivalents   of  Mn2+,   and   2.0   equivalents   of  Mn2+.   For   a   comparison,   an   EPR   spectrum   from   a  
control   sample   containing   only   buffer   and   MnCl2   at   the   same   concentration   as   0.6   Mn2+  
equivalents.   (B)  Double   integrated  intensity  of  free  (hexaaqua)  Mn2+  EPR  signal  as  a  function  of  
Mn2+  concentration  for  the  room  temperature  titration  experiment  (circles)  and  a  control  titration  
experiment  without   the  protein  present   (squares).  Line  represents   least-­‐‑squares   fit  using  a   two-­‐‑
site  binding  model.  
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3.3.3 Indication of Di-Mn2+ Cluster Formation in HiLpxH.  
Observing  that  two  metal  ions  seem  to  associate  with  HiLpxH  and  knowing  that  
other   members   of   the   CLP   family   have   been   identified   to   contain   metal   centers,   the  
possibility  of   such  cluster   formation   in  HiLpxH  was   investigated  using  cryogenic  EPR  
spectroscopy.  Fig.  21A  shows  representative  experimental  CW  EPR  spectra  measured  at  
28   K   from   a   buffered   protein   solution   in   absence   of   MnCl2   (top)   and   from   protein  
samples  with  varying  Mn2+-­‐‑to-­‐‑protein  ratios.  This  temperature  was  chosen  to  achieve  a  
measurable  thermal  population  of  several  different  spin  states  to  yield  a  large  number  of  
potentially   detectable   transitions,   some   of   which   are   expected   to   yield   characteristic  
features   to   identify   formation  of  an  exchange-­‐‑coupled  Mn2+   cluster   (131-­‐‑135).   It   should  
be  noted  that  the  EPR  spectrum  of  HiLpxH  in  absence  of  Mn2+  revealed  small  but  easily  
observable  feature  at  g=4.3  (Fig.  7A,  marked  by  a  dashed  line)  that  was  assigned  to  a  low  
symmetry   Fe3+   ion   non-­‐‑specifically   bound   to   protein.   The  g=4.3   signal  was   used   as   an  
internal   EPR   intensity   marker,   as   the   protein   concentration   was   kept   constant   in   all  
samples.  
The   cryogenic   experiments   reveal   that   an   increase   in   [Mn2+]/[HiLpxH]   ratio  
resulted   in   systematic   changes   in   EPR   spectra   at   this   temperature   indicated   by   the  
progressive  appearance  of  new  features  upon  further  addition  of  MnCl2  to  the  samples.  
Some   of   these   features   are   attributed   to  Mn2+   ions   bound   to   the   protein   while   others  
likely  arise  from  non-­‐‑associated  hexaaqua  Mn2+,  as  such  features  are  also  obtained  from  
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a  control  experiment  using  a  MnCl2  solution  supplemented  with  10%  (v/v)  glycerol  (Fig.  
21A,  “Mn  only”  spectrum).  The  control  spectrum  is  easily  identified  by  a  sharp  six-­‐‑line  
hyperfine  pattern  at  g=2.04   (Fig.  21A,  marked  with  arrow)  arising   from  electronic   spin  
S=±1/2   transition   that   is   split   into   six   lines  with   a   splitting   of   about   95  G   by   the  Mn2+  
nuclear  spin  I=5/2.  
For  a  symmetric  exchange-­‐‑coupled  pair  of  Mn2+  ions  in  an  isotropic  case,  eleven  
hyperfine  lines  are  expected  by  EPR,  with  hyperfine  coupling  constant  of  approximately  
half  of   that   for  a  single  Mn2+   ion   (136).  Such  patterns  are  evident   in   the  cryogenic  EPR  
spectra   of   HiLpH   and   MnCl2.   Specifically,   at   g≈7.7   we   observed   a   component   with  
multiline  pattern  characterized  by  an  effective  hyperfine  splitting  of  approximately  40.2  
G.  Such  a  pattern  appears  first  in  the  spectrum  from  the  HiLpxH  sample  containing  1.25  
equivalents  of  Mn2+.  The  intensity  of  this  pattern  increased  with  greater  metal-­‐‑to-­‐‑protein  
ratios  (Fig.  21B).  The  hyperfine  splitting  constants  for  binuclear  Mn2+  complexes  reported  
in  the  literature  range  from  40  to  47  G  (133-­‐‑135,137-­‐‑143).  Thus,  the  splitting  of  40.2  G  we  
observed   for   the   HiLpxH/Mn2+   sample   is   consistent   with   the   existence   of   binuclear  
manganese  center  in  the  protein.    
In  support  of  the  spectral  feature  at  g≈7.7,  other  spectral  features  similar  to  those  
detected   for   a   binuclear   Mn2[(OPPh2)2N]4   complex   (144)   were   observed   at   g≈14   in  
HiLpxH  samples  with  more  than  one  Mn2+  equivalent  (Fig.  7B).  The  signals  at  g≈3.1  and  
2.48   (Fig.   21B)   also   can   be   attributed   to   a   binuclear   cluster   (131),   although   they  might  
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exhibit  a  substantial  overlap  with  the  signal  originating  from  a  singly-­‐‑occupied  HiLpxH  
Mn2+  site  as  well  as  the  free  Mn2+  signal.  While  none  of  these  components  show  resolved  
hyperfine  patterns  with  splitting  characteristic  of  the  binuclear  Mn2+  center,  such  a  loss  in  
resolution  is  not  uncommon  for  many  binuclear  Mn2+  complexes  (131-­‐‑135).  
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Figure  21:  Cryogenic  EPR  Spectra  of  HiLpxH  
(Caption  continued  on  next  page)  
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Figure  21:  (A)  Representative  CW  X-­‐‑band  EPR  spectra  measured  at  28  K.  From  top  to  bottom  are  
background  signal  from  an  EPR  resonator  outfitted  with  a  low  temperature  quartz  insert;  signal  
from   samples   containing   a   range   of   [Mn2+]   /[HiLpxH]   ratios;   and   signal   from   a   Mn2+   only  
solution.  Position  of  the  g=4.3  marker  originating  from  a  low  symmetry  Fe3+  ion  non-­‐‑specifically  
bound  to  the  protein  is  shown  by  a  dashed  line.  The  areas  of  the  spectra  indicating  the  presence  
of   a   di-­‐‑   Mn2+   cluster.   g=14,   7.7,   3.1,   and   2.48,   are   denoted   by   arrows.   (B)   Spectra   from   (A)  
enhanced   in   the   range  500   to  2500  G   to  highlight   the   increase   in  hyperfine   splitting   in  g=7.7  at  
greater  [Mn2+]  /[HiLpxH]  ratios.  
  
3.3.4 Point Mutagenesis of Conserved Residues  
After   establishing   that   LpxH   possesses   a   binuclear   Mn2+   metal   cluster,   we  
proceeded   to   examine   the   functional   role   of   conserved   residues   in   catalysis.   Sequence  
alignment   of   LpxH   orthologs   reveals   three   areas   of   amino   acid   conservation   (Fig.   22)  
that  show  homology  to  the  motifs  characteristic  of  the  CLP  family.  The  most  conserved  
CLP  family  motif,  DXH(X)~25GDXXDR(X)~25GNHD/E  where  X  indicates  any  amino  acid  
(the   italicized  histidine   is  not  completely  conserved   in  LpxH  orthologs  and   is   replaced  
by   an   arginine),   is   clustered   at   the   N-­‐‑terminal   region   of   LpxH   (Motif   1,   green).   The  
middle  region  of  the  protein  contains  a  motif  of  a  highly  conserved  histidine  followed  by  
an   aspartate   (Motif   2,   cyan)   that   is   less   ubiquitous   in   the  CLP   family   and   not   always  
detectable   from  sequence  alignment   (106).  Lastly,  at   the  C-­‐‑terminus  of  LpxH  there   is  a  
UUXGHXH   motif   (Motif   3,   orange),   with   U   representing   any   hydrophobic   residue,  
which  was  first  characterized  in  a  sub-­‐‑class  of  CLP  enzymes  that  are  involved  in  DNA  
repair  and  polymerization  (102,145).    
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To  assess  the  importance  of  these  areas  of  conservation,  we  made  the  following  
alanine  point  mutants  of  amino  acids  (Fig.  22,  underlined)  from  the  motif  in  each  region:  
D9A,  H11A,  D42A,  R81A   in  Motif  1;  H115A  and  D117A   in   the  Motif  2;   and  H196A   in  
Motif  3.  These  point  mutants,  along  with  a  wild-­‐‑type  HiLpxH  control,  were  expressed  in  
E.   coli  with   a   C-­‐‑terminal  His10   tag   and   purified   using  Ni-­‐‑NTA   chromatography.      The  
mutant  proteins  over-­‐‑expressed  at   levels  comparable   to   that  of  wild-­‐‑type  and   the   final  
purities  of  all  protein  forms  were  similar  (data  not  shown).  The  isolated  protein  samples  
were  analyzed  for  UDP-­‐‑DAGn  hydrolase  activity  using  the  radioactive  assay  and  their  
resulting  activities  were  compared   to   that  of   the  wild-­‐‑type  control   (Table  8).  All  of   the  
point  mutants  showed  a  decrease  in  specific  activity,  however  the  residues  of  the  motif  
in   the   N-­‐‑terminal   region   displayed   the   most   significant   change.   The   D9A   mutant  
exhibited  a  20,000-­‐‑fold   inhibition  of  hydrolysis,   10-­‐‑fold  over  any  of   the  other  mutants.  
The   other   mutants   of   the   N-­‐‑terminal   region,   as   well   as   the   H115A   mutation   in   the  
middle  region  and  the  H196A  mutation  in  the  C-­‐‑terminal  region  showed  similar  levels  
of   hydrolysis   inactivation.   This   is   in   contrast   to   the   D117A   mutant   from   the   middle  
region  that  was  only  slightly  impaired  compared  to  wild-­‐‑type.    
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Figure  22:  Sequence  Alignment  of  LpxH  Orthologs    
  Motifs   characteristic   of   the   calcineurin-­‐‑like   phosphatases   are   boxed   in   color:   green   represents  
Motif   1,   the   most   conserved   residues   across   the   family   (DXHX~25GDXXDRX~25GNHD/E);   cyan  
denotes   a   lesser   conserved   motif,   Motif   2,   not   always   clearly   detectable   through   sequence  
alignment   (usually   a   highly   conserved   His   followed   by   Asp);   and   orange   depicts  Motif   3,   an  
additional   motif   first   identified   in   a   subset   of   enzymes   that   are   involved   in   DNA   repair  
(UUXGHXH  where  U  is  a  hydrophobic  amino  acid).  Residues  that  were  mutated  to  alanine  are  
italicized  and  underlined.  Alignment  was  generated  using  the  ClustalW2  tool  on  the  EBI  website  
(http://www.ebi.ac.uk/Tools/msa/clustalw2/).   LpxH   orthologs   listed   include   those   from   H.  
influenzae   (HiLpxH),  E.  coli   (EcLpxH),  Neisseria  meningitidis   (NmLpxH),  Yersina  pestis   (YpLpxH),  












 Wt 6900 ± 700 1 
      
Motif 1 
 
D9A 0.03 ± 0.004 200000 
H11A 0.41 ± 0.02 20000 
D42A 0.09 ± 0.01 80000 
R81A 0.93 ± 0.04 7000 
      
Motif 2 H115A 0.57 ± 0.008 12000 D117A 3020 ± 90 2 
      
Motif 3 H196A 1.4 ± 1 5000 
 
3.4 Discussion 
LpxH   catalyzes   the   fourth   step   of   the   lipid   A   biosynthetic   pathway,   which  
involves  the  hydrolysis  of  UDP-­‐‑DAGn  to  lipid  X.    Previous  biochemical  understandings  
of  LpxH  were  based  on  studies  with  the  ortholog  from  E.  coli.    This  work  suggested  that  
a  metal  cofactor,  specifically  Mn2+,  might  be  important  for  protein  stability  or  membrane  
association.     Furthermore,  LpxH   is   classified  by  sequence   to  belong   to   the  calcineurin-­‐‑
like  phosphoesterase   (CLP)   family   that  employs   two  clustered  metal   ions   for  catalysis.    
Despite   these   initial   biochemical   and   bioinformatic   hints   that   LpxH  utilizes   a  metallic  
cofactor,  its  metal  dependency  was  never  reported.      
  One  reason  for  the  deficiency  of  information  about  the  metal  cofactors  in  LpxH  
was  the  inability  to  obtain  a  pure  sample  of  the  protein.    We  developed  of  a  new  scheme  
of  LpxH  purification,  employing  the  ortholog  from  H.  influenzae  (HiLpxH)  as  described  
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in  Chapter  2.    This  method  results  in  a  95%  homogenous  sample  of  the  hydrolase,  thus  
allowing  use  to  carry  out  detailed  analysis  of  the  role  of  metal  ions  in  LpxH  function.    
3.4.1 Mn2+ Facilitates LpxH-Mediated Hydrolysis of UDP-DAGn 
Since  the  identity  of  the  active  site  metals  can  vary  greatly  across  the  CLP  family  
(103),  we  assayed  HiLpxH  for  UDP-­‐‑DAGn  hydrolysis  in  the  presence  of  different  metal  
ions  to  determine  which  metal  might  be  the  most  physiologically  relevant.  We  noted  a  
significant  increase  in  HiLpxH  activity  in  the  presence  of  Mn2+  that  was  >10-­‐‑fold  higher  
than  the  activation  displayed  by  any  other  metal,  making  Mn2+  the  most  likely  candidate  
for  HiLpxH’s  cofactor.  The  calculated  KMetal  of  the  enzyme  for  Mn2+  was  487  µμM.  While  
CLPs   have   been   shown   to   contain   two   different  metals   in   their   binuclear   active   sites,  
those  containing  Mn2+  usually  have  this  ion  occupying  both  sites  (103).    
3.4.2 LpxH Contains a Mn2+ Cluster for Catalysis 
We  took  advantage  of  the  paramagnetic  properties  of  Mn2+  to  probe  the  binding  
of   the  metal   to  the  HiLpxH.  Using  EPR  at  room  temperature,  we  were  able  to  monitor  
the  change  in  signal  intensity  of  the  canonical  six-­‐‑line  Mn2+  signature  when  HiLpxH  was  
present  with  the  ion  in  solution.  Comparing  this  data  to  a  standard  curve  of  Mn2+  alone  
in  solution,  it  is  evident  that  two  tight-­‐‑binding  Mn2+  ions  are  interacting  with  the  protein,  
as  the  free  Mn2+  signal  generated  from  HiLpxH  samples  containing  greater  than  2  molar  
equivalents  of  Mn2+  increases  at  a  similar  slope  as  the  standard  curve.  Fitting  the  titration  
data  with   a   two-­‐‑site   binding  model   revealed   two  binding   sites:   the   first   site   binds   the  
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metal  ion  very  tightly,  having  an  extremely  low  Kd  (<  20  nM),  while  the  second  site  has  a  
tight,   but  detectable  Kd   value   of   1.7  µμM.  Varying   affinity   for  metal   ions   at   each   site   is  
common  for  CLP  enzymes,  as  binding  at  one  site  can  be  as  much  as  100-­‐‑times  stronger  
than  that  at  the  second  site  (103,106).  
Cryogenic  EPR   experiments   allowed   for   further  dissection   of   the   interaction   of  
Mn2+   with   HiLpxH.   The   data   from   spectra   of   HiLpxH   incubated   with   varying   molar  
equivalents  of  Mn2+  show  evidence  of  strong  spin  exchange  coupling.  Such  coupling  of  
the   Mn2+   electronic   spins   has   also   been   seen   in   a   di-­‐‑manganese   cluster   bridged   by  
oxygen  atoms,  as  studied  by  Hayden  and  Hendrich  (142),  making  it  likely  that  the  two  
metal   binding   sites   in   HiLpxH   are   in   close   proximity   and   form   a   cluster.   Similar  
conclusions   about   the   existence   of   a   di-­‐‑nuclear   cluster   based   on   observations   of   spin  
coupling  have  been  made  in  other  CLP  enzymes  (103,130).    
Cluster   formation   is  beneficial   for   the  catalysis  of   reactions,  as   the  proximity  of  
the  metal  ions  in  an  active  site  allows  for  a  symmetric  delocalization  of  charge  that  is  not  
possible   with   only   one   metal   (107).   This   delocalized   distribution   over   two   metals  
permits   them  to  act   like  a  unit   in  stabilizing   transition  states  of  concerted  mechanisms  
that  facilitate  the  concurrent  anionic  ligand  addition  and  anionic  ligand  dissociation.  In  
the   case   of   hydrolases,   this   stabilization   of   the   transition   state   lowers   the   activation  
barrier   for   both   nucleophilic   attack   by   the   activated   water   and   phosphoester   bond  
cleavage.  Additionally,  it  has  been  reported  that  having  two  close  Mn2+  ions  in  an  active  
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site   decreases   the   strength   of   bridging-­‐‑ligand   field   and   potential   increases   the   Lewis  
acidity  of   the  metals,  allowing   them  to  have  a  higher  affinity   for   ligands   like  H2O  and  
facilitating  the  formation  of  a  hydroxide  anion  that  performs  the  nucleophilic  attack  in  a  
hydrolysis  reaction  (107).  
Intriguingly,   while   both   our   enzymatic   assay   and   the   EPR   measurements  
establish  LpxH  as  a  metalloenzyme,  the  two  techniques  yielded  very  different  affinities  
for  Mn2+   binding.   Fitting   of  metal-­‐‑dependent   enzymatic   stimulation   yield   an   apparent  
KMetal   of   ~0.5   mM,   whereas   the   EPR   measurements   reveals   two   binding   sites   with  
binding  affinities   in   the   low  nM  and  µM  ranges  respectively.  This  discrepancy  may  be  
due  to  the  presence  of  UDP-­‐‑DAGn  in  the  enzymatic  assay,  as  divalent  ions  such  as  Mn2+  
have  been  shown  to  coordinate   the  phosphate  group  of  nucleotides.  Since  UDP-­‐‑DAGn  
contains  such  a  moiety,  it   is  possible  that  Mn2+-­‐‑UDP-­‐‑DAGn  interaction  promotes  LpxH  
catalytic   activity,   thus   generating   a   high   KMetal.   In   some   CLP   enzymes,   such   an  
interaction   of  metal   ions  with   substrates   has   been  proposed   to   be  part   of   the   catalytic  
sequence   in   that   a   low-­‐‑affinity   metal   ion   binds   to   the   enzyme   complexed   with   the  
phosphoryl  group  of  the  substrate  (106).    
An  alternative,   and  perhaps  more   likely,   explanation   for   the  disparity   in  metal  
affinity  calculations  described  above  may  be  the  existence  of  three  Mn2+  binding  site   in  
LpxH:  two  sites  in  the  binuclear  cluster  revealed  in  the  EPR  studies  with  affinities  in  the  
low  nM  and  µM  ranges,  and  another  weak-­‐‑binding  Mn2+  that  facilitates  the  catalysis,  but  
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only  binds  LpxH  in  the  presence  of  the  substrate  UDP-­‐‑DAGn,  yielding  an  apparent  KMetal  
in   the   high   µM   to   sub-­‐‑mM   range.   Supporting   this   notion,   members   of   the   protein  
phosphate   M   (PPM)   family   have   been   shown   to   contain   a   third   Mn2+   cofactor   in  
proximity  of   the  di-­‐‑metal   cluster   found   in   their   active   sites   (146).  This   third  metal  has  
been  shown  to  have  significantly  weaker  affinity  (high  µM  to  sub-­‐‑mM)  than  the  ions  in  
metal  cluster  (146)  and  has  been  suggested  to  directly  take  part  in  catalysis  (147)  or  have  
a  regulatory  role  important  in  substrate  recognition  (148).    
3.4.3 Functional Importance of Conserved Residues Define LpxH as a 
CLP 
The   presence   of   a   Mn2+-­‐‑cluster   is   a   feature   LpxH   shares   with   the   CLP   family,  
however   the   type   of   chemistry   performed   by   the   lipid   A   biosynthetic   enzyme   is   not  
canonically   displayed   by   this   group   of   proteins.      Rather,   the   hydrolase   reaction  
catalyzed   by   LpxH   is   more   commonly   carried   out   by   enzymes   in   the   Nudix   family,  
which   cleave   the   pyrophosphate   bond   of   nucleoside   diphosphates   linked   to   another  
moiety   (128).  While   these   enzymes   also   use   metals   and   activated   water   molecules   in  
catalysis,   they   have   a   characteristic   sequence   motif   (“Nudix   box”)   of  
GX5EX7REUXEEXGU,  with   glutamate   residues   in   the   conserved  motif   positioning   the  
cofactors.    The  metal  cofactors  in  Nudix  enzymes  are  almost  always  Mg2+  (128),  making  
them  much  less  diverse  that  those  of  the  CLP  family.    
In  the  CLP  family,  metal  chelation  is  achieved  by  use  of  the  residues  in  the  Asp-­‐‑
rich   metallophosphoesterase   motif,   highlighted   in   Fig.   23A   (103,106).   The   functional  
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groups  of  these  amino  acids  directly  serve  as  ligands  to  the  ions  and  perform  secondary  
coordination  of  waters  and  amino  acids  that  in  turn  coordinate  the  metals,  as  observed  
in   the   structure   of   bacteriophage   λ   protein   phosphatase   (Fig.   23B).   The   two   metal  
cofactors   are   often   bridged  by   a   carboxylate   group-­‐‑containing   residue   (D49,   Fig.   23B);  
such  a  configuration  is  a  common  structural  motif  in  binuclear  enzymes  (103,107).    
The   investigated   alanine   point   mutants   of   conserved   residues   in   the   HiLxpH  
metallophosphoesterase  motifs  showed  a  significant  decrease  in  activity,  supporting  the  
similarity   of   the   protein   to   the   CLP   family   despite   the   unique   substrate   it   prefers.   In  
particular,   mutants   D9A,   H11A,   and   D42A   showed   the   largest   decrease   in   activity.  
These   residues   in   HiLpxH   are   likely   to   participate   in   metal   coordination,   similar   to  
corresponding  residues  in  other  CLP  enzymes  (149-­‐‑151)  (seen  with  the  positions  of  D20,  
H22,  and  D49  in  the  structure  of  bacteriophage  λ  protein  phosphatase  in  Fig.  23B),  and  
their  mutations  impair  hydrolysis  by  abrogating  metal  binding.  The  diminished  activity  
of  H115A  and  H196A  can  also  be  explained  by  a  cofactor-­‐‑coordination  function,  as  the  
counterparts  of  these  residues  in  other  CLP  enzymes  serve  as  ligands  to  the  metal  ions  
(H139  and  H186  Fig.  23B)  (106,150,152).  The  D117A  mutation  only  had  a  slight  effect  on  
HiLpxH   activity   suggesting   it   has   a   negligible   role   in   catalysis.   Support   for   this  
hypothesis   comes   in   the   position   of   D117’s   corresponding   residue   in   bacteriophage   λ  
protein  phosphatase,  which  lies  distant  from  the  enzyme’s  binuclear  site.    
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Taken   together,   the   mutagenesis   data   from   HiLpxH   support   an   active   site  
structure  similar  to  that  found  in  other  CLP  enzymes,  with  the  residues  of  the  conserved  
CLP  motif   in  HiLpxH   coordinating   a   high   affinity   binuclear  Mn2+   site   (Fig.   23C).   This  
strongly   suggests   that   despite   the   fact   LpxH   cleaves   the   pyrophosphate   bond   of   a  
substrate   containing  a  nucleoside  di-­‐‑phosphate   linked   to   a   lipid  moiety,   it   is   a  unique  
member  of  the  CLP  family  rather  than  the  Nudix  family  (103).    
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Figure  23:  Proposed  Structure  of  HiLpxH  Active  Site    
A)  Alignment  of  conserved  CLP  motifs  in  various  family  members.  The  most  conserved  portion  
of   the   motif   is   labeled   Motif   1.   Motif   2   and   3   indicate   portions   of   the   motif   less   ubiquitous  
throughout  the  family.  (B)  Active  site  of  bacteriophage  λ  protein  phosphatase  modified  from  PDB  
1G5B   (150).   Residues  marked   in   green,   cyan,   and   orange   correspond   to   those   that   are   part   of  
Motif  1,  2,  and  3  respectively  and  their   location   in   the  motifs  are  denoted  by  *   in   (A).  Residues  
marked  in  gray  are  not  part  of  the  CLP  motif  but  have  roles  in  active  site  coordination.  Mn2+  ions  
are  represented  by  purple  spheres,  water  molecules  are  indicated  by  dark  gray  spheres,  and  the  
SO4   substrate   mimic   is   shown   in   yellow.   Black   dashed   lines   indicate   possible   modes   of  
coordination   as   suggested   by   intramolecular   distances.   (C)   Proposed   Mn2+   coordination   of  
HiLpxH  based  on  similarity  to  the  enzymes  of  the  CLP  family.  
.
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4. Identification of LpxG, the UDP-2,3-diacylglucosamine 
Hydrolase in Chlamydia trachomatis  
4.1 Introduction 
Thus  far,   lipid  A  biosynthesis  has  been  discussed  from  the  focal  point  of  LpxH,  
the  enzyme  that  catalyzes   the  conversion  of  UDP-­‐‑DAGn  to   lipid  X   through  hydrolysis  
(40,82).     While  there  is  clear  biochemical  and  genetic  evidence  that  LpxH  is  responsible  
for  this  step  of  lipid  A  biosynthesis,  it  is  not  conserved  in  all  Gram-­‐‑negative  bacteria  (81);  
LpxH   orthologs   are   primarily   found   in   β,   γ,   and   ε   proteobacteria,   but   missing   from  
many  other  organisms   that  make   lipid  A.     This   lack  of   conservation   is  not   seen   in   the  
other  early  steps  of  lipid  A  biosynthesis,  as  orthologs  for  LpxA,  LpxC,  LpxD,  LpxB,  and  
LpxK  are  highly  conserved  (81).    
The  conservation  of   the  enzymes  both  proceeding  and  following  LpxH,  as  well  
as   the   similar   backbone   structure   of   the   final   lipid  A  molecule,   led   to   the   assumption  
that   the   enzymatic   process   of   hydrolyzing   UDP-­‐‑DAGn   to   lipid   X   still   occurs   in   in  
bacteria   lacking   LpxH,   but   it   is   carried   out   by   a   different   protein   (41).      Bioinformatic  
analysis   of   several   Gram-­‐‑negative   bacteria   lacking   LpxH,   specifically   those   of   the   α-­‐‑
proteobacteria  family,  revealed  a  gene  of  unknown  function  that  seemed  to  cluster  with  
other  lipid  A  biosynthetic  enzymes.    An  ortholog  of  this  gene  from  Caulibactor  crescentus  
termed  lpxI,  was  shown  to  encode  for  a  hydrolase  that  was  capable  of  converting  UDP-­‐‑
DAGn  into  lipid  X.     Furthermore,  expression  of   lpxI  complemented  a  deletion  of  E.  coli  
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lpxH.    It  was  thus  concluded  that  LpxI  was  responsible  for  the  fourth  step  of  the  lipid  A  
pathway  in  bacteria  containing  corresponding  orthologs  (41).      
While  the  discovery  of  LpxI  completed  part  of  the  puzzle  of  proteins  responsible  
for  UDP-­‐‑DAGn  hydrolysis,  missing  pieces  still  remain.     Nearly  all  proteobacteria  seem  
to   contain   either   LpxH   or   LpxI,   however   the   Chlamydiae   phylum   lacks   orthologs   of  
either  protein  (41,81).    Of  specific  interest  is  one  of  the  most  characterized  pathogens  of  
this  phylum,  C.   trachomatis.     These  bacteria  display  a   fairly  similar   lipid  A  structure   to  
that   of   E.   coli:   Both   lipid   A   species   have   a   disaccharide   backbone   composed   of   two  
diacylglucosamine  molecules   joined  by  a   linked  β  1’-­‐‑6   linkage   (153)   (Fig.  14).     There   is  
slight  difference  in  the  acylation  pattern  compared  to  E.  coli,  with  C.  trachomatis  lipid  A  
lacking  a   sixth   acyl   chain   as  well   as  hydroxylated   fatty   acids   at   the   3   and  3’  positions  
(153).     Despite   this   small  variance,   and   the   lack  of   a  known  UDP-­‐‑DAGn  hydrolase,  C.  
trachomatis  contains  homologs   for  seven  of   the   first  eight   lipid  A  biosynthetic  enzymes  
found  in  E.  coli.     This  strongly  suggests  the  biosynthetic  pathway  proceeds  through  the  
same   set   of   intermediates   as   found   in   E.   coli   and   that   an   unidentified   protein   is  
performing  the  function  of  UPD-­‐‑DAGn  hydrolysis.  
To   investigate   the   existence   of   a   UDP-­‐‑DAGn   hydrolase   in   C.   trachomatis,   we  
pursued   biochemical   and   genetic   studies   of   the   bacteria.     C.   trachomatis   is   an   obligate  
intracellular   pathogen   that   is   the   leading   cause   of   infectious   blindness   and   sexually  
transmitted  bacterial  infections  worldwide.    It,  along  with  the  rest  of  Chlamydiae,  has  a  
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biphasic  life-­‐‑cycle  that  consists  of  an  reticulate  body  (RB)  and  elementary  body  (EB)  state  
(Fig.   12)   (109).      In   the   beginning   stages   of   infection,   C.   trachomatis   in   metabolically  
inactive  EB  state  attaches   to   the  host  epithelial   cell.     The  bacteria  are   then   internalized  
into  the  host  and  differentiate  into  the  RB  state.    At  this  stage,  the  RBs  form  a  membrane-­‐‑
bound   inclusion  and   replicate.     Midway   through   the   infectious   cycle,   some  of   the  RBs  
begin  to  change  back  into  EBs.    These  newly  formed  EBs  are  released  through  extrusion  
or  cell  lysis,  allowing  them  to  initiate  a  new  round  of  infection.    
The  bi-­‐‑phasic,   intracellular   life  cycle  of  C.   trachomatis  presents  challenges   to   the  
identification   of   gene   functions   in   the   bacteria   (109).      Specifically,   studies   identifying  
LpxH   in  E.   coli   employed   the  Kohara   library,  which   allowed   for   screening   of   infected  
strains   for   enhanced   UDP-­‐‑DAGn   hydrolase   activity   (40).      Such   a   strategy   is   not  
conducive  in  C.  trachomatis,  as  it  is  not  susceptible  to  phage  infection.  Furthermore,  any  
strategy   of   functional   identification   involving   a   read-­‐‑out   of   increase   in   UDP-­‐‑DAGn  
hydrolase   activity   would   be   cantankerous-­‐‑-­‐‑C.   trachomatis   must   be   cultured  
intracellularly,   thus   bacterial   lysate   activity   would   be   diluted   in   the   presence   of   the  
host’s   cellular   milieu.      While   separation   of   C.   trachomatis   and   host   cell   is   possible,   it  
would  not  be  efficient  in  the  context  of  a  whole  genome  functional  screen.    A  method  for  
controlled  gene  expression  in  C.  trachomatis  has  been  recently  described  (120),  however  
as  accumulation  of  lipid  X  is  not  predicted  have  an  easily  discernable  phenotype  for  C.  
trachomatis,   this   strategy   would   not   be   efficient.      Other   strategies   involving   targeted  
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genetic  manipulation   including  gene  deletions   are  not  possible,   as   this   technology  has  
not  been  developed  in  C.  trachomatis  (109).      
The   lack   of   tools   available   for   the   genetic   and   biochemical  manipulation   of  C.  
trachomatis  makes  it  advantageous  to  use  heterologous  expression  systems  to  screen  for  
gene  functionality.    Thus,  we  developed  genetic  complementation  screen  for  identifying  
the   unknown   UDP-­‐‑DAGn   hydrolase   in   C.   trachomatis.      By   utilizing   an   E.   coli   strain  
engineered  to  have  temperature-­‐‑controlled  expression  of  lpxH,  we  were  able  to  assess  a  
C.  trachomatis  open  reading  frame  (ORF)  library  for  functional  complements  of  lpxH.    As  
lpxH   is   essential,   positive   hits   were   easily   detected   by   viability   at   high   temperatures.    
Our   screen   identifies   a   candidate   ORF,   Ct461,   that   is   conserved   in   other   Chlamydia  
species   and   exhibits   UDP-­‐‑DAGn   hydrolase   activity   both   in   vivo   and   in   vitro   (further  
discussed   in   Chapter   5).     We   conclude   that   Ct461   encodes   for   LpxG,   a   unique   UDP-­‐‑
DAGn   hydrolase.      Overall,   this   study   reveals   yet   another   enzyme   capable   of   the  
production  of   lipid  X,   helping   to   complete   the   landscape  of   the   fourth   step  of   lipid  A  
biosynthesis.      Additionally,   it   serves   as   a   model   for   functional   analysis   of   unknown  
genes  in  C.  trachomatis.      
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4.2 Materials and Methods 
4.2.1 Chemicals and Reagents  
The   4-­‐‑(2-­‐‑hydroxyethyl)-­‐‑1   piperazineethanesulfonic   acid   (HEPES),   phosphate-­‐‑
buffered  saline   (PBS)  components,  HCl,   salts,  ampicillin,   isopropyl-­‐‑β-­‐‑D-­‐‑thiogalactoside  
(IPTG),   fatty   acid-­‐‑free   bovine   serum   albumin   (BSA),   Triton   X-­‐‑100   (TX-­‐‑100)  
ethylenediaminetetraacetic  acid  (EDTA),  and  dithiothreitol  (DTT)  were  purchased  from  
Sigma-­‐‑Aldrich   (St.   Louis,   MO).   Methanol,   chloroform,   pyridine,   and   acetic   acid   were  
obtained   from   EMD   Science   (Gibbstown,   NJ).   Radioactive   γ-­‐‑32Pi   was   purchased   from  
PerkinElmer   (Waltham,   MA).      Unless   otherwise   noted,   protein   concentration   was  
determined   either   by   BCA   Assay   or   Bradford   Assay   (Thermo   Scientific,   Waltham,  
Massachusetts)   depending   on   compatibility   with   buffer   components.   Both   of   these  
methods  were  carried  out  as  described  by  the  manufacturer.  
4.2.2 Bacterial Strains and Growth Conditions  
The   bacterial   strains   used   in   this   study   are   listed   in   Table   9.      Chemically  
competent   cells   were   prepared   using   an   established   protocol.      All   P1   vir   lysate  
preparation   and   infections   were   carried   out   according   to   the   procedure   outlined   in  
Current   Protocols   in  Molecular   Biology   (154)   and   any   alterations   have   been   denoted.    
Growth  medium  for  liquid  culture  was  Luria  broth  (LB),  containing  5  g/L  yeast  extract,  
10  g/L  tryptone,  and  10  g/L  NaCl.    LB  supplemented  with  7.5  g/L  of  bacto  agar  was  used  
for  solid  phase  growth.    All  media  components  were  purchased  from  Difco  (Detroit,  MI).    
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Antibiotics  were  used  at   the  following  concentrations:  100  µμg/mL  ampicillin  (Amp),  50  
µμg/mL  kanamycin  (Kan),  25  µμg/mL  chloramphenicol  (Cam).      
Table  9:  Strains  Used  in  the  Discovery  of  LpxG  
Strain Description Source or Reference 
DH5α E. coli, F
− Δ(argF-lacZYA)U169 deoR phoA supE44 Φ80 
Δ(lacZ)M15 gyrA96 relA1 endA1 thi-1 hsdR17 recA1λ− Invitrogen 
C41 E. coli, F− ompThsdsB(rB−mB−) gal dcm (DE3) Δ(srl-recA)306::Tn10 (125) 
C41_CtLib C41, pDEST_Ctlib This work 
C41Ec C41, pKJB2 This work 
C41ΔHCtG C41  ΔlpxH::kan, pKJB2 This work 
BL21(DE3) E. coli, F
– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) Invitrogen 
HY0 BL21(DE3),  pKJB5 This work 
HY1 BL21(DE3) ΔlpxH::kan, pKJB5 This work 
HY1_Lib BL21(DE3) ΔlpxH::kan, pKJB5,  pDEST17_CtLib This work 
HY1_EcH BL21(DE3) ΔlpxH::kan, pKJB5, pKJB2 This work 
HY1_VC BL21(DE3) ΔlpxH::kan, pKJB5, pHSC This work 
HY1_461Lib BL21(DE3) ΔlpxH::kan, pKJB5, pDEST_461 This work 
HY1_461 BL21(DE3) ΔlpxH::kan, pKJB5, p461 This work 
HY1_733Lib BL21(DE3) ΔlpxH::kan, pKJB5, pDEST_733 This work 
HY1_733 BL21(DE3) ΔlpxH::kan, pKJB5, p733 This work 
HY2_VC BL21(DE3) ΔlpxH::kan, pMAK705, pKJB2 This work 
CtG_t10 C41 harboring p461T This work 
VC_t10 C41 harboring pET21t10 This work 
D125A_t10 C41 harboring pD125AT This work 
W3110A E. coli, F- aroA::Tn10 msbA+ , TetR (155) 
W3110AΔHEc W3110A lpxH::kan harboring pBAD33Ec (41) 
W3110AΔHCc W3110A lpxH::kan harboring pBAD33Cc (41) 
W3110ACtG W3110A, pBAD33461 This work 
W3110A733 W3110A, pBAD33733 This work 
W3110AΔHCtG W3110A lpxH::kan harboring pBAD33461 This work 
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4.2.3 DNA Amplification and Analysis  
All  primers  used  in  this  study,  listed  in  Table  10,  were  synthesized  by  Integrated  
DNA  Technologies   (Coralville,   IA).      PCR   reactions   employing   the  KOD  method  were  
carried   out   using   a   Mastercycler   Gradient   Thermocycler   (Eppendorf,   Hamburg,  
Germany)  with   the   reagents   and  protocol   of   the  KOD  Hot   Start  Kit   (EMD  Chemicals,  
Gibbstown,   NJ),   however   reactions   were   additionally   supplemented   with   3%   (w/v)  
dimethyl  sulfoxide  and  1  M  betaine  unless  otherwise  noted.    PCR  reactions  utilizing  the  
TAQ  method  also  used  the  Mastercycler  Gradient  Thermocycler  (Eppendorf,  Hamburg,  
Germany),   but   for   these   samples,   reactions   were   performed   with   the   reagents   and  
protocol  of  Apex  2.0X  Taq  RED  Master  Mix  kit  (Genesee  Scientific,  San  Diego,  CA).    PCR  
products  were  visually  analyzed  using  1%  (w/v)  agarose  gels  ran  at  85  V  in  TAE  buffer  
with  HyperLadder  1  kb   (Bioline,  Taunton,  MA)  as  a  sizing  reference.     DNA  fragments  
were   purified   either   from   agarose   gel   or   directly   from   reactions   using  QIAquick   Spin  
kits.   The   plasmids   used   in   this   study,   listed   in   Table   11,   were   purified   using   Qiagen  
Mini-­‐‑Prep  kits  (Qiagen,  Valencia,  CA)  according  to  the  manufacturer’s  protocol.  
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Table  10:  Primers  Used  in  the  Discovery  of  LpxG  
Name Purpose Primer sequence (5'-3') 
T7_For To sequence segments of DNA cloned into T7 vectors TAATACGACTCACTATAGGG 
T7_Rev To sequence segments of DNA cloned into T7 vectors CTAGTTATTGCTCAGCGGTG 
5002_For 
To amplify the region of the E. coli 
genome surrounding lpxH; 
complementary to DNA 500 bp 
upstream of lpxH  
GCCAGTAACGCCGCGTTT 
5002_Rev 
To amplify the region of the E. coli 
genome surrounding lpxH; 
complementary to DNA 500 bp 
donstream of lpxH  
CACCAATCAAACGGAACAGGATGC 
p21 To amplify the kan cassette CCAGGATCTTGCCATCCTATGGA 
Ct461_For 
To amplify Ct461 from C. trachomatis 
ORFeome library; incorporates truncated 
codons from N-terminal region; confers 





CT461_Rev To amplify Ct461 from C. trachomatis ORFeome library; confers 5' SalI site 
CGC GCG GTCGAC CTA AGG TTC ATA 
GAG GCA CCT CAT TAA AC 
CT461thru_
Rev 
To amplify Ct461 from C. trachomatis 
ORFeome library; eliminates stop 




To amplify Ct733 from C. trachomatis 
ORFeome library; incorporates truncated 
codons from N-terminal region; confers 





Ct733_Rev To amplify Ct733 from C. trachomatis ORFeome library; confers 5' SalI site 
GCGCGCGTCGACCTATAAATGGATAC
TAACGGTTCCATTTAAGTGA  
D59A_For To mutate CtLpxG D59 to alanine  CGCATTGTACAGATTTCGGCTTTACACCTAAACCACTCG 
D59A_Rev To mutate CtLpxG D59 to alanine  CGAGTGGTTTAGGTGTAAAGCCGAAATCTGTACAATGCG 
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Table  11:  Plasmids  Used  in  the  Discovery  of  LpxG  
Plasmid Description Source or Reference 
pMAK705 Temperature sensitive replicon; CamR (156) 
pKJB5 pMAK705 E. coli lpxH; CamR (82) 
pDONR221 Gateway® entry vector; KanR Invitrogen 
pDONR_CtLib pDONR221 harboring Ct ORFeome library; KanR This work 
pDONR_461 pDONR221 harboring Ct461 lacking the codons for the N-terminal transmembrane region of the protein product; KanR This work 
pDONR_733 pDONR221 harboring Ct733 lacking the codons for the N-terminal transmembrane region of the protein product; KanR This work 
pDEST17 
Gateway® destination vector compatible with T7 expression; 
encodes for N-terminal HIs6 fusion; contains ribosome 
binding site and ATG start codon upstream His-tag; AmpR 
Invitrogen 
pDEST_CtLib pDEST17 containing C. trachomatis ORFeome library; AmpR This work 
pDEST_461 pDEST17 containing Ct461 lacking the codons for the N-terminal transmembrane region of the protein product; AmpR This work 
pDEST_733 pDEST17 containing Ct733 lacking the codons for the N-terminal transmembrane region of the protein product; AmpR This work 
pET21a, b High-copy expression vector containing a T7 promoter; AmpR Invitrogen 
pET21t10 Modified pET21b with TEV-protease cleavage and His10 tag 3' of XhoI site; AmpR (157) 
pHSC Modified pET21b with TEV-protease cleavage site and His10 tag 3' of HindII siteI; AmpR 
Dr. Hak Suk 
Chung 
p461 pHSC harboring C. trachomatis ORF 461; AmpR This work 
p733 pHSC harboring C. trachomatis ORF 733; AmpR This work 
pKJB2 pET21a+ plasmid containing E. coli lpxH; AmpR (40) 
pBAD33  Arabinose inducible vector; CamR Invitrogen 
pBAD33Ec pBAD33 harboring E. coli lpxH; CamR (41) 
pBAD33Cc pBAD33 harboring C. crescentus lpxI; CamR (41) 
pBAD33461 pBAD33 harboring C. trachomatis ORF 461; CamR This work 
pBAD33733 pBAD33 harboring C. trachomatis ORF 733; CamR This work 
p461T 
pHSC harboring C. trachomatis ORF 461 lacking stop codon 
to generate C-terminal His10 tag cleavable by TEV-protease; 
AmpR 
This work 
pGD59AT p461T with D125A mutation; AmpR This work 
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4.2.4 C. trachomatis Cell Culture  
C.  trachomatis  (serovar  LGV  biovar  L2  434/Bu)  was  grown  in  HeLa  cells  (CCL-­‐‑2;  
ATCC),  cultivated  in  a  T175  flask  at  37°C.     The  infected  culture  was  incubated  for  30  h  
and  inclusion  and  EB  formation  was  confirmed  via  microscope.     For  harvesting,  media  
was  removed  from  the  culture  and  cells  were  washed  twice  with  5  mL  of  PBS.    Next,  a  5  
mL  aliquot  of  PBS  was  added  to  the  culture  and  a  cell  scraper  was  used  to  disrupt  the  
adhered  cells.     This  sample  was  collected  in  a  falcon  tube  and  centrifuged  at  3,500  ×  g.    
After   removal   of   the   supernatant,   the   pelleted   cells  were   resuspended   in   750   µμL   of   a  
buffer  containing  20  mM  HEPES  pH  8.0  and  1.0  %  w/v  Triton  X-­‐‑100  (TX-­‐‑100)  and  then  
lysed  by  sonication.     Remaining  debris  was  removed  with  centrifugation  at  10,000  ×  g.    
The  resulting  supernatant,  termed  “HeLa  +  Ct,”  was  aliquotted  and  stored  at  -­‐‑80°C.  The  
same  procedure  was  carried  out  using  an   identical  HeLa  culture   that  was  not   infected  
with  C.  trachomatis,  with  final  samples  being  designated  “HeLa”.    
4.2.5 C. Trachomatis Lysate Activity  
To  test  for  UDP-­‐‑DAGn  hydrolase  activity  in  C.  trachomatis,  samples  of  HeLa  +  Ct  
were   tested   for   lipid   X   formation   using   two   slightly   modified   versions   of   the  
autoradiographic   assay   described   below.      The   first   revised   condition   left   out   the   non-­‐‑
radioactive   form   of   the   substrate   (100   µμM   UDP-­‐‑DAGn)   of   the   reaction   in   order   to  
increase  assay  sensitivity.    DDM  was  also  omitted  due  to  the  high  amount  of  detergent  
already   present   in   the   lysate   samples.   The   second   condition  was   identical   to   the   first  
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except  1  mM  EDTA  was  used  in  place  of  1  mM  MnCl2.    Both  reactions  contained  20  mM  
HEPES  pH  8.0,  0.5%  (w/v)  BSA,  and  1,000  cpm/µμL  [β-­‐‑32P]  UDP-­‐‑DAGn.    Thawed  HeLa  +  
Ct   and  HeLa   samples  were   assayed   in   parallel   under   these   two   conditions,  with   final  
concentrations   of   protein   and   TX-­‐‑100   in   all   assays   being   1.5   mg/mL   and   0.33%   w/v,  
respectively.      
4.2.6 Generation of C41ΔHEc 
A  P1  vir  lysate  was  prepared  from  W3110AΔHEc  employing  the  top  agar  method  
and   used   to   infect   E.   coli   C41   harboring   pKJB2   (C41EcH).      After   incubation  with   the  
phage  and  subsequent  outgrowth,   cells  were  plated  on  LB-­‐‑agar   containing  Kan,  Amp,  
and   5   mM   sodium   citrate   and   grown   for   18   h   at   37°C.      Resulting   colonies   were   re-­‐‑
purified  twice  on  the  aforementioned  LB  plates  to  remove  any  remaining  phage.    Colony  
PCR   utilizing   the   KOD   method   with   primers   5002_For   and   5002_Rev   were   used   to  
amplify  the  region  upstream  and  downstream  of  lpxH  in  these  bacteria;  oligonucleotide  
products  were  sequenced  to  determine  the  presence  of  the  kan  cassette.  This  strain  was  
designated  C41ΔHEc.      
4.2.7 Construction of pDEST C. trachomatis Genomic Library  
Each  clone   from  a  C.   trachomatis  ORFeome   library  harbored   in  E.  coli   (158)  was  
inoculated   into   an   individual   well   of   a   microtiter   plates   containing   200   uL   of   LB  
supplemented  with  Kan.      Resulting   cultures   (~1000)  were   incubated   for   18   h   at   37°C,  
shaking   at   220   rpm.      Next,   several   representative   library   pools   were   generated   from  
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combining  100  uL  samples  of  ~44  clones.    These  pools  were  then  centrifuged  and  mini-­‐‑
prepped  to  obtain  library  plasmids.    Each  pool  yielded  ~10  µμg  of  DNA.    Approximately  
1.5  µμg  of  DNA  from  each  pool  was  combined  to  yield  “pDONR_Ctlib.”  
Gateway  technology  was  employed  to  transfer  the  ORF  inserts  in  pDONR_CtLIb  
into   pDEST17   to   generate   pDEST_CtLib.   Three   separate   Gateway®   LR   Clonase®  
(Invitrogen,  Carlsbad,  CA)   reactions  were   carried   out   according   to   specifications   from  
the  manufacturer  except  reaction  incubation  was  24  h  at  25°C.    The  number  of  reactions  
was  chosen  to  ensure  10-­‐‑fold  coverage  of  the  ORFeome  contained  in  the  pDONR  vector  
sample.    Transformations  of  1  µμL  aliquots  from  each  reaction  into  chemically  competent  
C41(DE3)   were   repeated   until   all   three   reactions   had   been   consumed   (~26   total  
transformations).     Each  resulting  cell  sample  was  grown  in  1  mL  of  LB  for  1  h  at  37°C  
and  plated  on  LB-­‐‑agar  supplemented  with  Amp.    (Specifically,  each  transformation  was  
spread  on  two  LB-­‐‑agar  plates:  the  first  plate  contained  only  100  µμL  of  the  transformation  
while   the   second   contained   the   remaining   900   uL).      After   growth   at   37°C   for   18   h,  
>20,000   resulting   colonies   (ensuring   20,000-­‐‑fold   coverage)   were   collected   and   pooled  
into  a  250  mL  culture  of  LB  containing  Amp.    The  pool  of  bacteria  was  grown  for  2  h  at  
37°C,   after  which   1  mL   samples  were   taken   for   glycerol-­‐‑stock   storage.      The   final   cell  
sample  containing  pDEST_CtLib  was  termed  C41_CtLib.      
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4.2.8 Generation of Screening Strain HY1  
To   generate   a   temperature-­‐‑controlled   lpxH   expression   strain,   pKJB5   was   first  
transformed  into  chemically  competent  BL21(DE3)  cells,  yielding  strain  HY0.    Next,  HY0  
was   infected  with  a  P1  vir   lysate  prepared   from  C41ΔHEc  using   the   top-­‐‑agar  method.    
The  C41ΔHEc  strain  was  chosen  to  produce  the  viral  material,  as  it  was  more  similar  to  
the  background  of  the  recipient  HY0  than  W3110AΔHEc,  thus  increasing  the  efficiency  
of  the  infection.    After  incubation  with  the  C41ΔHEc  lysate,  HY0  cells  were  outgrown  for  
7  h  at  30°C.     This  temperature  was  chosen  due  to  the  temperature  sensitive  replicon  in  
pKJB5.      Cells  were   then   spread   on   LB-­‐‑agar   containing   Kan,   Cam,   and   5  mM   sodium  
citrate.     Resulting  colonies,   termed  strain  HY1,  were  re-­‐‑purified  twice  on  plates  similar  
to  those  on  which  they  were  initially  grown.    To  confirm  kan  insertion,  two  colony  PCR  
experiments  utilizing  the  KOD  protocol  were  carried  out  on  4  HY1  colonies  (HY1  col  1  
through   HY1   col   4)   and   results   were   compared   to   those   from   BL21(DE3)   and  
W3110AΔHEc   via   agarose   gel.      The   first   experiment   employed   primers   5002_For   and  
5002_Rev   to   amplify   the   area   of   the   genome   surrounding   kan   insert.      The   second   also  
used   5002_For,   but   additionally   contained   p21   to   ensure   that   a   product   was   only  
generated   if   kan   was   present.      As   a   final   verification,   the   products   from   the   first  
experiment  were   sequenced   to   ensure   the  HY1   clones   contained   kan   in   the   context   of  
lpxH.      
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4.2.9 Confirmation of Temperature-Sensitive Phenotype for HY1  
HY1   col   1   through   HY   col   4   were   used   to   inoculate   four   separate   5   mL   LB  
cultures   supplemented  with  Kan  and  Cam.     Cultures  were   incubated  at  30°C   for  20  h,  
shaking  at  220   rpms,   then  measured   for   their  OD600.     The  equivalent  of  ~109   cells  were  
taken  from  each  culture  and  resuspended  in  1  mL  LB  to  generate  a  sample  with  OD600  of  
1.      Eight   serial   dilutions   of   every   sample   were   made   in   LB,   each   decreasing   cell  
concentration  10-­‐‑fold.    A  3  µμL  aliquot  from  each  of  the  resulting  dilutions,  ranging  from  
101  to  108  fold  decrease  in  cell  concentration  from  the  original  sample,  was  spotted  on  an  
LB-­‐‑agar  plate   supplemented  with  Kan  and   then   incubated  at   30°C.     This   spotting  was  
repeated   a   second   and   third   time   on   identical   plates   that  were   incubated   at   37°C   and  
44°C,   respectively.   After   24   h,   plates   from   all   three   temperatures   were   compared   for  
growth.  
4.2.10 Complementation Screen  
To  screen  the  C.   trachomatis  ORFeome  for   lpxH  complementation,   first  a  sample  
of  C41_CtLib  outgrowth  was  mini-­‐‑prepped  to  obtain  an  aliquot  of  pDEST_CtLib.    Next,  
300   ng   of   pDEST_CtLib   was   transformed   into   chemically   competent   HY1   cells   to  
generate  HY1_CtLib.      After   outgrowth   in   1.7  mL   of   LB   for   3   h   at   30°C,   three   500   µμL  
aliquots  of  HY1_CtLib  were  plated  on  separate  LB-­‐‑agar  plates  supplemented  with  Amp  
and   then   incubated  at  either  30°C,  37°C,  or  44°C.     This  was   repeated  with   three  50  µμL  
aliquots   of   the   same   outgrowth,   resulting   in   two   HY1_CtLib   samples   for   each  
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temperature   (500  µμL  and  50  µμL  platings).      In  parallel,  HY1  was  also   transformed  with  
equal  amounts  of  pKJB2  and  pET16b  to  generate  HY1_EcH  and  HY1_VC,  respectively.    
These  cells  were  outgrown  and  plated  in  500  µμL  and  50  µμL  amounts  at  30°C,  37°C,  and  
44°C  as  described  for  HY1_CtLib.     Plates  were  assessed  for  growth  after  24  h  and  final  
colony  number  of  each  of  the  18  plates  was  recorded  after  48  h.          
To   efficiently   analyze   complementation   screen   results,   colony   PCR   was  
performed   on   a   representative   sample   of   HY1_CtLib   colonies   surviving   at   high  
temperatures.    This  sample  was  comprised  of  all  colonies  (85  total)  present  on  the  plates  
containing  50  µμL  of  HY1_CtLib  outgrowth  after  incubation  at  37°C  and  44°C.    PCR  was  
carried  out  using  the  TAQ  method  with  T7_for  and  T7_rev  primers  to  amplify  the  ORF  
insert  of  the  pDEST_CtLib  plasmid  harbored  by  each  colony.    The  size  of  each  resulting  
oligonucleotide  product  was  analyzed  using  gel  electrophoresis.    Identical  PCR  reactions  
were   also   carried   out   for   three   surviving  HY1_VC   colonies   (two   from   37°C,   one   from  
44°C)  to  serve  as  a  control.    Finally,  a  selection  of  PCR  products  (41  total)  reflecting  the  
distribution   of   ORF   lengths   were   purified   and   sequenced   using   T7_for   and   T7_rev  
primers.      
4.2.11 Independent Confirmation of Screen Hits from Library 
Plasmids   
The  ORF  appearing  at  the  highest  frequency  in  the  analyzed  HY1_CtLib  colonies,  
Ct461,  was  tested  independently  for   lpxH  complementation.    To  do  so,  the  E.  coli  strain  
harboring  Ct461  in  pDONR221  (pDONR_461)  from  the  C.  trachomatis  ORFeome  library  
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(158)  was  used  to  inoculate  5  mL  of  LB  supplemented  with  Kan.    This  culture  was  grown  
for   18  h  at   37°C,   shaking  at   220   rpm,  and   then  mini-­‐‑prepped   to  obtain  plasmid  DNA.    
Resulting   pDONR_461   was   mixed   with   pDEST17   in   a   Gateway®   LR   Clonase®  
(Invitrogen)   reaction   following   the   manufacturer’s   protocol.      Plasmid   product   was  
transformed  into  chemically  competent  DH5α  cells,  outgrown  for  1  h  at  37°C  in  LB,  and  
plated  on  LB-­‐‑agar  plates  containing  Amp.    After  18  h  of  incubation  at  37°C,  a  resulting  
colony  was  used   to   inoculate   5  mL  of  LB   supplemented  with  Amp.     This   culture  was  
grown   for   18   h   at   37°C,   shaking   at   220   rpm,   and   then   mini-­‐‑prepped   to   obtain   the  
plasmid  pDEST_461.     The   same  procedure  was   repeated   for   the  ORF  appearing  at   the  
second   highest   frequency,   Ct733,   to   obtain   pDEST_733.      Sequencing   with   T7_for   and  
T7_rev   primers   was   used   to   confirm   successful   insertion   of   the   desired   ORF   into  
pDEST17  vectors.      
Plasmids  pDEST_461,  pDEST_733,  and  pKJB2  were  transformed  into  chemically  
competent  HY1  cells  to  generate  HY1_461Lib,  HY1_733Lib,  and  HY1_EcH,  respectively.    
After  outgrowth  at  30°C   in  1  mL  of  LB,   three  250  µμL  aliquots  of   each  cell   sample  was  
plated  on  LB-­‐‑agar  supplemented  with  Amp.    Each  plate  from  each  strain  was  incubated  
at  a  different  temperature  (30°C,  37°C,  or  44°C)  for  24  h  and  then  assessed  for  growth.    
4.2.12 Cloning of C. trachomatis Genes  
Amplification   of   Ct461   from   pDEST_461   was   accomplished   using   the   KOD  
method   of   PCR   with   primers   Ct461_For   and   Ct461_Rev.   These   primers   incorporated  
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codons   for   the   N-­‐‑terminal   region   of   the   protein   that   were   truncated   from   the   gene  
during  construction  of  the  original  pDONR  library  (158).    They  also  added  Nde1  and  SalI  
restriction  sites  to  the  5’  and  3’  ends  of  the  gene.    PCR  products  were  purified  using  gel  
extraction.        
To  generate  an  expression  vector  with  a  C-­‐‑terminal  His10  tag  that  was  cleavable  
by   Tobacco   Etch   Virus   (TEV)   protease,   additional   nucleotides   were   added   to   pET21b  
(Novagen/EMD   Chemicals)   to   encode   for   the   7   amino   acids   of   the   protease   site  
(ENLYFQG)  (124)  and  the  4  additional  histidine  residues  needed  to  elongate  the  affinity  
tag.   This  was   accomplished  using  QuikChange   (Stratagene,   La   Jolla,  CA)  mutagenesis  
with  primers  designed   to   insert   the   additional   nucleotides   3’   to   the  HindIII   restriction  
site  in  pET21b.  The  reaction  was  carried  out  using  the  manufacturer’s  protocol  with  an  
additional  supplement  of  3%  (w/v)  dimethyl  sulfoxide.  Following  nucleotide   insertion,  
the  resulting  plasmid,  pHSC,  was  confirmed  by  sequencing  and  transformed  into  DH5α  
for  storage.      
Insertion  of  amplified  Ct461   into  pHSC  was  accomplished  by  digestion  of  both  
the   PCR   fragment   and   the   vector   with  Nde1   and   SalI   (New   England   Biolabs)   under  
conditions   described   by   the   manufacturer.   After   treatment   of   pHSC   with   antarctic  
phosphatase   (New  England   Biolabs)   under   conditions   described   by   the  manufacturer,  
digested  Ct461  was  inserted  into  the  plasmid  with  T4  ligase  (Invitrogen)  as  directed  by  
the   manufacturer.   The   ligation   product,   p461,   was   transformed   into   chemically  
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competent   DH5α   E.   coli   for   storage.   Sequencing   with   T7_for   and   T7_rev   primers  
confirmed  the  appropriate  insertion  of  Ct461into  pHSC.  
The   same   cloning   procedure   was   carried   out   substituting   Ct461_Rev   with  
Ct461thru_Rev.  This  primer  generated  a  form  of  Ct461  lacking  a  stop  codon  upstream  of  
the  SalI   site,   therefore   ligation   into   pHSC   created   a   construct   encoding   for   a  His10   tag  
cleavable  by  TEV-­‐‑protease  at   the  C-­‐‑terminus  of   the  protein.     This  plasmid  was   termed  
p461t  and  transformation  into  C41(DE3)  to  yield  CtG_t10.      
Amplification   of   Ct733  was   also   accomplished   using   the  KOD  method   of   PCR  
with   primers   Ct733_For   and   Ct733_Rev.   Like   the   corresponding   Ct461   primers,   these  
oligonucleotides   incorporated   truncated   N-­‐‑terminal   codons   as   well   as  Nde1   and   SalI  
restriction   sites.      Following   the   aforementioned  method   of   digestion   and   ligation   into  
pHSC,  the  resulting  plasmid  product  was  designated  p733  and  transformed  into  DH5α  
E.  coli  for  storage.    
4.2.13 Assessment of HY1 Temperature Complementation  
4.2.13.1  Agar  Plates  
To  test   the  ability  of   full   length  Ct461  and  Ct733   to  complement   lpxH   in  E.  coli,  
p461  and  p733  was   transformed  into  chemically  competent  HY1  to  yield  HY1_461  and  
HY1_733,   respectively.     Successful   transformants  were  selected   for   survival  at  30°C  on  
LB-­‐‑agar  supplemented  with  Kan,  Amp,  and  Cam.    After  24  h,  a  resulting  colony  of  each  
strain  was  re-­‐‑purified  under  the  same  conditions.      
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Single  colonies  from  HY1_461,  HY1_733,  HY1_EcH,  and  HY1_VC  grown  at  30°C  
for  48  h  on  LB-­‐‑agar  containing  Amp  and  Cam  were  dissolved   in  8  µμL  of  LB.        A  2  µμL  
aliquot  of  each  colony  sample  was  spotted  onto  the  same  LB-­‐‑agar  plate  containing  Amp  
and  Kan.    These  spots  were  spread  over  a  section  of  the  plate,  after  which  the  plate  was  
placed  at   30°C.     A  duplicate  plate  was  generated   from   the   same   colony   resuspensions  
and  placed  at  44°C.    Following  48  h  incubation,  plates  were  assessed  for  growth.      
4.2.13.2  Growth  Curve  in  Liquid  Media  
To   create   an   additional   positive   control   for   temperature-­‐‑sensitive   growth,  
chemically   competent   BL21(DE3)      was   transformed   with   pKJB2   and   pMAK705   and  
plated  at  30°C  on  LB-­‐‑agar  supplemented  with  Amp  and  Cam.     A  resulting  colony  was  
repurified  under  the  same  conditions  and  then  subjected  to  infection  with  P1  vir   lysate  
prepared  from  C41ΔHEc.    After  incubation  with  the  phage,  cells  were  outgrown  at  30°C  
to   retain   the  pMAK705  plasmid,   and   then  plated   at   the   same   temperature   on  LB-­‐‑agar  
containing   Amp,   Cam,   Kan,   and   5   mM   sodium   citrate.      Resulting   colonies   were   re-­‐‑
purified   twice   under   the   same   conditions.      This   procedure   resulted   in   the   creation   of  
strain  HY2_VC.      
For   the   growth   curve,   single   colonies   of   HY1_461,   HY1_733,   HY2_VC,   and  
HY1_VC  were  used  to  inoculate  5  mL  of  LB  media  supplemented  with  Amp  and  Cam.    
Resulting  cultures  were  grown  at  30°C,  220  rpms  for  20  h  and  then  diluted  to  a  OD600  of  
0.05  in  50  mL  of  LB  containing  Amp  and  Cam.    Incubation  at  30°C,  220  rpms  continued  
  133  
until  cultures  reached  mid-­‐‑log  phase.    At  this  time,  cells  from  each  strain  were  pelleted  
with  centrifugation  at  3,500  ×  g,  resuspended   in  LB   lacking  antibiotic,  and  diluted   to  a  
OD600   of   0.01   in   25  mL  of  pre-­‐‑warmed  LB   containing  Amp.      These   cultures  were   then  
grown   at   44°C,   220   rpm   using   a   water   bath   shaker.      The   OD600   of   each   strain   was  
recorded  every  30  min.    When  cultures  reached  an  OD600  of  ~0.3,  they  were  back-­‐‑diluted  
10-­‐‑fold   into   fresh  pre-­‐‑warmed  LB   supplemented  with  Amp.     Accumulated  growth,   as  
measured  by  OD600,  was  plotted  over  time  using  a  log  scale.      
4.2.14 Generation and Characterization of W3110AΔHCtG  
For   ligation  of  Ct461   into  pBAD33,  p461  was  digested  with  XbaI  and  SalI   (New  
England  Biolabs)  according  to  the  manufacturer’s  protocol.    Digestion  with  XbaI  allowed  
for   retention   of   the   ribosome   binding   site   upstream   of   the   Ct461   start   codon.      The  
desired   product   was   isolated   from   the   parent   plasmid   by   gel   electrophoresis   and  
subsequent  extraction  of  the  band  corresponding  to  ~1200  bp.    A  sample  of  pBAD33  was  
also   digested   with   XbaI   and   SalI,   gel   purified,   and   then   treated   with   antarctic  
phosphatase   (New   England   Biolabs)   under   recommended   conditions.      T4   ligase  
(Invitrogen)   was   employed   to   insert   the   Ct461   fragment   into   pBAD33   with   reaction  
conditions   as   outlined   by   the   manufacturer.   The   ligation   product,   pBAD33_461,   was  
transformed   into   chemically   competent   DH5α.   Sequencing   with   Ct461_For   and  
Ct461_Rev   confirmed   the   plasmid   construction.      Ct733  was   also   ligated   into   pBAD33  
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using   the   aforementioned   procedure,   substituting   p733   for   p461.      The   resulting  
construct,  pBAD33_733,  was  confirmed  using  Ct733_For  and  Ct733_Rev.  
Plasmids   pBAD33_461   and   pBAD33_733   were   transformed   into   chemically  
competent  W3110A  to  yield  W3110ACtG  and  W3110A733,  respectively.    A  P1  vir  lysate,  
prepared   from  W3110AΔHEc   using   the   top-­‐‑agar  method,  was   employed   to   transduce  
the  kan  cassette  into  W3110ACtG.    After  phage  incubation,  cells  were  outgrown  at  37°C  
for  3  h  and  then  plated  on  LB  agar  containing  Cam,  Kan,  0.02%  (v/v)  arabinose,  and  5  
mM   sodium   citrate.      Resulting   colonies   were   repurified   twice   under   the   same  
conditions;   the   subsequent   strain   was   denoted   W3110AΔHCtG.      To   confirm   kan  
insertion,   colony   PCR   employing   the   TAQ   protocol   was   carried   out   with   primers  
5002_For  and  p21.    Results  were  compared  to  those  from  W3110A  and  W3110AΔHEc  via  
agarose  gel.    Additionally,  the  region  upstream  and  downstream  of  the  kan  insertion  was  
amplified  using  the  KOD  colony  PCR  method  with  primers  5002_For  and  5002_Rev,  and  
products   were   sequenced   to   verify   the   identity   of   the   antibiotic   cassette.   A   similar  
infection   using  W3110A733   as   a   host   strain  was   attempted,   but   did   not   generate   any  
surviving  transductants.     For  growth  comparison,  single  colonies  of  W3110AΔHEc  and  
W3110AΔHCtG  were  dissolved  in  8  uL  of  LB,  and  then  2  µμL  aliquots   from  each  strain  
were  spotted  on  LB-­‐‑agar  plates  supplemented  with  Cam,  Kan,  and  0.02%  arabinose  or  
just  Cam  and  Kan.      Spots  were   spread  over  a  portion  of   the  plate   to   evenly  distribute  
bacteria  and  then  incubated  at  37°C  for  24  h.              
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4.2.15 Ct461 Expression 
Preparation   of   Ct461   cell   free   extract   (Ct461   CFE)   began   with   inoculating   an  
overnight   culture   of   LB   with   a   single   colony   of   CtG_t10.   This   overnight   culture   was  
subsequently  used  to  inoculate  250  mL  of  LB  supplemented  with  ampicillin  to  an  OD600  
of   0.02.  Cultures  were   incubated   at   30   °C  with   aeration   at   220   rpm  until   they   reached  
OD600  of  0.7-­‐‑0.8,  then  induced  for  expression  by  the  addition  of  1  mM  IPTG  and  grown  
for   an   additional   4   to   5   h   until   the   OD600   reached   ~4.   Cells   from   the   growths   were  
pelleted  by  centrifugation  at  5,000  ×  g,  washed  with  35  mL  of  cold  PBS,  and  then  stored  
at   -­‐‑80  °C.  For   lysis,   the   frozen  pellet  was   thawed,  resuspended   in  25  mL  of   ice-­‐‑cold  20  
mM  HEPES  pH   8.0,   and  passed   twice   through   a   French  pressure   cell   (SIM-­‐‑AMINCO;  
Spectronic  Instruments)  at  18,000  psi.  The  debris  from  the  resulting  lysate  was  removed  
by  centrifugation  at  10,000  ×  g  and  the  subsequent  supernatant  was  collected  as  cell-­‐‑free  
extract  (CFE)  and  stored  at  -­‐‑80  °C.    The  same  protocol  was  carried  out  to  obtain  VC  CFE  
and   D59A   CFE,   except   VC_t10   and   D59A_t10   were   used   for   culture   inoculation,  
respectively.      
4.2.16 UDP-DAGn Hydrolase Activity Assay in Cell-Free Extracts   
Autoradiographic   assays   for   hydrolase   activity  were   similar   to   that   previously  
described  (40,157),  but  with  slight  modification.    Reactions  mixtures  were  a  final  volume  
of   12.5  µμL   in   0.6  mL  polypropylene   tubes   and   contained   20  mM  HEPES  pH  8.0,   0.5%  
(w/v)   BSA,   0.035%   (w/v)   DDM,   1   mM   MnCl2,   100   µμM   UDP-­‐‑DAGn   (prepared   as  
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previously   described   (127)),   1,000   cpm/µμL   [β-­‐‑32P]   UDP-­‐‑DAGn,   and   protein   or   lysate  
sample.    All  reaction  components  besides  the  protein  sample  were  mixed  to  a  volume  of  
10  µμL  and  equilibrated  at  30  °C  for  10  min,  after  which  2.5  µμL  of  protein  was  added  to  
start  the  reaction.  Final  protein  concentrations  in  the  assays  ranged  from  0.05  mg/mL  to  
1.0  mg/mL  and  were   adjusted   as  necessary   to  maintain   linear   activity  within   the   time  
frame  being  tested.     If  required,  samples  were  diluted  in  a  buffer  identical  to  the  assay  
mixture  but  lacking  any  lipid  substrate  or  DDM  before  addition  to  the  reaction.    HiLpxH  
was   obtained   as   described   in   Chapter   2.      Aliquots   of   1.5   µμL   were   taken   from   the  
reactions  at  various  time  intervals  and  spotted  onto  20  cm  ×  20  cm  glass-­‐‑backed  silica  gel  
thin  layer  chromatography  (TLC)  plates  (EMD  Chemicals,  Darmstadt,  Germany).  These  
plates   were   developed   in   a   25:15:4:2   chloroform:   methanol:   water:   acetic   acid   tank  
system,   dried,   exposed   to   phosphoscreens,   scanned,   and   quantified   as   previously  
described  (40,157).  
4.2.17 Generation of Ct461 point mutant D59A 
QuikChange  (Stratagene)  mutagenesis  was  used  to  make  alanine  point  mutants  
of  a  conserved  aspartate  within  Ct461.  The  method  was  carried  out  as  described  above,  
with  p461t  serving  as  template  DNA.  Primers  D59A_For  and  D59A_Rev  were  employed  
to   generate   the   desired   alanine   substitution   and   sequencing  with   T7_For   and   T7_Rev  
primers  was  used  to  confirm  the  mutations.  The  mutated  p461t  vector,  pGD59AT,  was  
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transformed   into   chemically   competent   E.   coli   C41(DE3)   to   create   expression   strains  
D59A_t10.    Mutant  cell  free  extract  (D59A  CFE)  was  obtained  as  described  above.  
4.3 Results 
4.3.1 UDP-DAGn Hydrolase Activity is Present in C. trachomatis 
Lysates  
It  is  well  established  that  C.  trachomatis  produces  lipid  A  (153),  however  there  are  
no   orthologs   for   the   known   enzymes   capable   of   catalyzing   the   fourth   step   of   the  
molecule’s  biosynthetic  pathway,  the  hydrolysis  of  UDP-­‐‑DAGn  to  form  lipid  X  (81,159).    
In  order  to  confirm  the  presence  of  this  activity  despite  the  absence  of  a  protein  currently  
known  to  encode  this  function,  we  assessed  C.  trachomatis  lysates  for  lipid  X  formation.    
HeLa  cells  were  infected  with  C.  trachomatis  EBs  and  incubated  for  30  h,  allowing  the  C.  
trachomatis   to   transition   to   the  RB   state,   form   inclusions,  multiply,   and   transition  back  
into  the  EB  state.    After  this  time,  the  bacteria  and  host  cells  were  harvested  and  lysed  to  
obtain  a  lysate  sample  termed  “HeLa  +  Ct”.    A  culture  of  uninfected  HeLa  cells  was  also  
grown  and  lysed  in  parallel  to  serve  as  a  control  lysate  (“HeLa”).      These  samples  were  
then  analyzed  for  UDP-­‐‑DAGn  activity  using  an  autogradiographic  assay.    
Over  the  time  course  tested,  HeLa  +  Ct  lysate  showed  linear  production  of  lipid  X    
(Fig.  24).     This  formation  was  not  seen  when  HeLa  lysate  was  assayed  under  the  same  
conditions.      Furthermore,   replacement   of   MnCl2   with   EDTA   in   the   in   vitro   system  
corresponded   to   decrease   in   activity   and   loss   of   linear   product   formation,   indicating  
observed  hydrolysis  was  metal  dependent  (Fig.  24).    Such  dependence  is  a  characteristic  
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of  the  other  known  UDP-­‐‑DAGn  hydrolases,  LpxH  (157)  and  LpxI  (159).    Overall,  the  in  
vitro  autoradiographic  data   led  to  the  conclusion  that  C.  trachomatis   indeed  contains  an  
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Figure  24:  UDP-­‐‑DAGn  Hydrolase  Activity  in  C.  trachomatis  Lysates  
(A)   Scan   of   phosphoscreen   exposed   to   silca  TLC  plate   from  UDP-­‐‑DAGn  hydrolase   assay   of  C.  
trachomatis   lysates   in   the   presence   of   Mn2+.      “HeLa   +   Ct”   denotes   presence   of   bacteria   while  
“HeLa”   represents   lysate   of   host   cell   alone.      Bands   corresponding   substrate   (UDP-­‐‑DAGn)   and  
product  (Lipid  X)  are  denoted.    (B)  Percent  of  UDP-­‐‑DAGn  converted  to  lipid  X  by  C.  trachomatis  
lysates   at   specific   time   points   under   assay   conditions  with  Mn2+   (HeLa   +   Ct)   and  with   EDTA  
(HeLa   +  Ct   +   EDTA).  Also   depicted   is   activity   of   host  HeLa   lysates   absent   of   bacteria   (HeLa).    
Equal  amount  of  protein  was  utilized  in  all  assay  conditions.    Data  was  fit  to  a  linear  curve  and  
showed   an   R2   value   of   0.954,   0.701,   and   0.319   for   HeLa   +   Ct,   HeLa   +   Ct   +   EDTA,   and   HeLa  
samples,  respectively  .  Product  conversion  was  calculated  by  quantifying  intensity  of  lipid  X  as  a  
percentage   of   the   total   intensity   of   each   lane   and   then   subtracting   the   background   conversion  
calculated  from  a  no  enzyme  control.      
  
4.3.2 Genetic Complementation Screen for UDP-DAGn Hydrolase 
Identification 
4.  3.  2.  1  Screen  Design  
To   identify   the   gene   that   encoded   for   the   observed   production   of   lipid   X,   we  
designed  a  complementation  screen.     The  enzyme  LpxH  is  well  established  to  catalyze  
the  hydrolysis  of  UDP-­‐‑DAGn  for  the  biosynthetic  process  of  lipid.  As  lpxH  is  essential  in  
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E.  coli,  we  sought  to  find  a  C.  trachomatis  gene  capable  of  permitting  survival  of  an  lpxH  
knockout.     Overall,   this   strategy   relied  on   the   creation  of  C.   trachomatis   genetic   library  
that  could  be  expressed  in  E.  coli  and  the  construction  of  a  strain  in  which  the  expression  
of  lpxH  was  disrupted.    
To  construct  the  library,  we  utilized  a  collection  of  E.  coli  clones  harboring  each  
C.  trachomatis  ORF  (CtORF)  in  pDONR221  (158).    The  plasmids  from  each  of  these  clones  
were   purified,   pooled,   and   then   transferred   to   pDEST17   using  Gateway®   technology.    
This   vector   contains   a   T7   promoter   region   and   ribosome   binding   site   5’   to   the   ORF-­‐‑
insert,  allowing  for  expression  of   the  C.   trachomatis  DNA  in  DE3-­‐‑strains  of  E.  coli.     The  
product  of  the  Gateway®  reaction  was  transformed  into  C41(DE3)  E.  coli  and  plated  on  
ampicillin,   as   resistance   to   the   antibiotic   implied   presence   of   a   CtORF-­‐‑containing  
pDEST17  vector.    To  ensure  ample  coverage  of  the  1,000-­‐‑clone  library,  20,000  ampicillin  
resistant  colonies  were  used  to  obtain  the  final  C.  trachomatis  pDEST  library  pool.    
The   essentiality   of   lpxH   meant   that   any   disruption   of   the   gene   had   to   be  
complemented   in   order   for   the   bacteria   to   maintain   viability.      This   complementation  
would   need   to   be   controllable   to   permit   survival   as   a   read-­‐‑out   for   the  C.   trachomatis  
library  screen.     We  chose   temperature   to   regulate   lpxH  expression,  as   this  method  had  
been  previously  reported  to  permit  tight  control  of  the  gene  (82).    The  plasmid  pKJB5,  a  
temperature-­‐‑sensitive  construct  containing  E.  coli  lpxH,  was  transformed  into  BL21(DE3).    
This  background  strain  was  chosen  to  permit  eventual  T7  expression  of  library  DNA.    P1  
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vir   transduction   was   used   to   replace   the   chromosomal   copy   of   lpxH  with   kan   in   this  
strain,  thus  creating  HY1.      
Analysis   of   HY1   was   necessary   to   confirm   the   appropriate   genotype   and  
phenotype.     Through  PCR,   the  strain  was  verified  to   lack  a  genomic  copy  of   the  UDP-­‐‑
DAGn  hydrolase.  Amplification  of   the  500  base  pairs  flanking  the  replaced   lpxH   in  the  
HY1   chromosome   yields   a   larger   product   than   that   generated   from   a   wild-­‐‑type  
BL21(DE3)  strain  (Fig.  25A).    This  increase  in  size,  which  corresponds  to  the  presence  of  
kan   in   that   region,   is   also   seen   in   the   previously   characterized   deletion   strain  
W3110AΔHEc   (159).      PCR   with   primers   specific   to   kan   creates   an   oligonucleotide  
product   in   HY1   and  W3110ΔHEc   and   not   BL21(DE3)   (Fig.   25A).      HY1   colonies   were  
tested  for  a  temperature-­‐‑sensitive  phenotype  by  dilution  plating  of  identical  cultures  at  
30°C,  37°C,  and  44°C.    Cells  maintain  viability  at  low  temperature  due  to  expression  of  
lpxH   from   pKJB5;   however,   an   increase   in   temperature   halts   replication   of   pKJB5,  





































































Figure  25:  Confirmation  of  Genotype  and  Phenotype  of  HY1  
(A)  The  top  panel  depicts  colony  PCR  results  from  amplification  of  genome  500  bp  upstream  and  
downstream  of  lpxH  with  5002_For  and  5002_Rev  of  indicated  E.  coli  strains.    For  wild-­‐‑type  strain  
BL21(DE3),  product  size  reflects  to  presence  of  lpxH,  as  confirmed  by  sequence  analysis.    A  shift  if  
band  size   is  observed   for  W3110AΔHEc,   correlating   to   the   replacement  of   lpxH  with   the   larger  
kan.      Tested   colonies   of   HY1   (col   1   through   col   4)   all   yield   bands   matching   the   size   of  
W3110AΔHEc,   signifying   lpxH:kan.      Identical   results   are   displayed   in   the   bottom   panel,   albeit  
internal   kanamycin   primer   p21   replacing   5002_Rev.      In   this   case,   the   600   bp   product   is   only  
generated   if   kan   is   present   in   the   context   of   lpxH.      (B)   Temperature   dilution   plating   of   four  
representative   HY1   colonies.      Equal   amounts   of   tested   colonies   were   serially   diluted   and  
subsequently  plated  at  30°C,  37°C,  and  44°C.  Dilution  begins  at  101  fold  and  increases  by  10-­‐‑fold  
from  left  to  right,  ending  in  108.      
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4.3.2.2  Screen  Implementation    
Using  HY1  and  our  generated  C.  trachomatis  pDEST  library,  we  implemented  the  
complementation   screen.      HY1   was   transformed   with   pDEST_CtLib   to   generate  
HY1_Lib.      Two   different   amounts   of   HY1_Lib   were   plated   and   incubated   as   a   set   at  
either  37°C  or  44°C.    While  optimal  deactivation  of  pKJB5  occurs  at  44°C  (82),  37°C  was  
included  to  ensure  successful  expression  of  protein  from  the  library  plasmids.    The  two  
cell   amounts   distributed   on   the   paired   plates   differed   by   10-­‐‑fold   (500   µμL   of  
transformation   versus   50   µμL)   to   facilitate   accurate   counts   of   resulting   colonies.      To  
ensure  adequate  coverage  of  the  library,  another  set  of  HY1_Lib  plates  was  incubated  at  
30°C.    As  the  low  temperature  would  permit  survival  of  all  bacteria  harboring  a  pDEST  
plasmid  regardless  of  complementation  ability,  the  number  of  plasmids  screened  could  
be   directly   determined   from   the   number   of   resulting   colonies   at   30°C.      This   two  
dilutions-­‐‑three   temperatures   plating   procedure   was   repeated   with   HY1   transformed  
with  pKJB2  (HY1_Ec)  and  pHSC  (HY1_VC)  to  serve  as  additional  controls.      
Screen  results  can  be  seen  in  Fig.  26.    For  all  strains  tested,  incubation  of  the  more  
concentrated   plating   sample   at   30°C   yielded   a   lawn   that,   based   on   the   number   of  
bacteria  appearing  on  the  more  dilute  plating  sample,  was  estimated  to  contain  ~25,000  
colonies.     As   the   library  contained  ~1000  clones   (158),   this  number  ensured  20,000-­‐‑fold  
coverage   of   the  C.   trachomatis  ORFeome.      A   lawn   also   appeared   at   44°C   for   HY1_Ec  
plates   (data   not   shown),   confirming   that   the   presence   of   lpxH   on   pKJB2   rendered   the  
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bacteria   insensitive   to   temperature   shift.      A   clear   dependence   on   growth   temperature  
was  observed  for  HY1_Lib  and  HY1_VC;  there  was  marked  decrease  in  colony  number  
on   the   more   dilute   plates   at   37°C   for   both   strains   and   even   further   reduction   in  
surviving   bacteria   at   44°C   (Fig   26A).   This   was   also   observed   for   samples   in   which   a  
higher  number  of  bacteria  were  originally  plated  (data  not  shown).  
As  HY1_VC’s  only  functional  copy  of  the  essential  gene  lpxH  in  is  harbored  in  a  
temperature   sensitive   plasmid,   it   was   assumed   that   residual   survival   at   high  
temperatures   was   due   to   mutations   in   the   plasmid   that   rendered   it   heat   resistant.    
HY1_Lib   was   also   susceptible   to   these   mutations;   however   there   was   a   noticeable  
increase   in   the   number   of   viable   colonies   for  HY1_Lib   over  HY1_VC   for   both   plating  
amounts,  especially  at  44°C  (34  versus  9,  respectively  for  the  more  dilute  platings  (Fig.  
26B).      Furthermore,   the   HY1_Lib   colonies   were   non-­‐‑uniform   in   size   and   appeared   at  
different  rates  compared  to  those  of  HY1_VC.    Together  this  suggested  that  UDP-­‐‑DAGn  


























Figure  26:  Enhanced  Temperature  Complementation  of  HY1_Lib  
(A)  LB  agar  plates  from  growth  of  50  µμL  of  HY1_Lib  and  HY1_VC  transformations  at  three  tested  
temperatures.      Plates   were   supplemented   with   ampicillin   for   selection.      (B)   Quantification   of  
colonies   appearing   on   plates   in   (A).   Increase   in   colony   number   is   observed   for  HY1_Lib   over  
HY1_VC  at  37°C  and  further  distinction  in  survival  is  evident  at  44°C.          
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4.3.3 Assessment of Screen Results by PCR  
To  differentiate  specific  lpxH  complementation  in  temperature-­‐‑resistant  colonies  
of  HY1_Lib  over  non-­‐‑specific  background,  we  analyzed  the  CtORFs  harbored  in  the  host  
bacteria:   Presumably,   actual   complementation   could   only   be   carried   out   by   a   specific  
ORF,  and  thus  clones  harboring  this  ORF  should  appear  at  a  higher  frequency  compared  
to   clones   in  which   survival  was  mediated   by   a  mutation   in   the   temperature   sensitive  
plasmid.     A  sample  of  HY1_Lib  colonies  surviving  at  37°C  and  44°C  were  subjected  to  
colony   PCR   with   T7   primers   aimed   to   amplify   the   region   of   the   pDEST   plasmid  
containing  C.  trachomatis  DNA.    This  sample  was  comprised  of  all  85  colonies  appearing  
on   plates   containing   the   10-­‐‑fold  more   dilute   sample   of   bacteria   (colonies   seen   in   Fig.  
26A).    The  sizes  of  resulting  products  were  assessed  via  agarose  gel  electrophoresis,  thus  
allowing   for   an   efficient   way   to   determine   the   distribution   of   ORF   lengths   found   in  
screen  hits.     Nearly   40%  of   the   colonies   tested   contained  an  ~1100  bp   insert   (Fig.   27A,  
green  arrow),  4-­‐‑fold  higher  than  the  occurrence  of  any  other  sized  band  (Fig.  27B).    The  
high  frequency  of  this  insert  suggested  it  specifically  conferred  viability  to  lpxH  deletion  
strains,   therefore   making   it   the   most   likely   candidate   for   encoding   the   UDP-­‐‑DAGn  
hydrolase.      Sequencing   of   14   of   the   1100   bp   PCR   products   revealed   the   insert  







































Figure  27:  Colony  PCR  Analysis  of  Complementation  Screen  
(A)   PCR   results   from   amplification   of   88   temperature-­‐‑resistant   HY1_Lib   colonies   with   T7_For  
and   T7_Rev.      All   reactions   were   performed   in   parallel   with   results   being   analyzed   on   three  
separate   1%   agarose   gels   (I,   II,   and   III).      The   first   lane   in   each   row   of   each   gel   contains  
HyperLadder  1  kb  (Bioline,  Taunton,  MA).    Green  arrows  point  to  bands  designated  as  1100  bp  in  
size.    (B)  Occurrence  of  various  band  sizes  shown  in  (A).    All  bands  were  estimated  for  size  based  
on  their  position  compared  to  the  ladder  and  to  each  other.    The  total  number  appearing  at  each  
individual  size  was  divided  by  the  entire  sum  of  bands  analyzed  to  determine  %  of  occurrence  in  
the  colonies  sampled.          
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4.3.4 Temperature Complementation Verification Identifies Candidate 
UDP-DAGn Hydrolase Gene 
As   a   final   verification   of   the   specificity   of   the   ability   of   Ct461   to   complement  
lpxH,   the   gene   was   independently   assessed   for   temperature   rescue   of   HY1.      The  
appropriate   E.   coli   clone   from   the   C.   trachmatis  ORFeome   library   was   used   to   obtain  
pDONR_461,   which   was   then   used   to   generate   pDEST_461.      This   plasmid   was  
transformed   into   the   screening   strain   to   yield   HY1_461Lib.      In   a   plating   procedure  
similar  to  that  carried  out  for  the  library  screen,  HY1_461Lib  exhibited  robust  survival  at  
both   30°C   and   44°C   (Fig.   28).      In   parallel,   the   ORF   appearing   at   the   second   highest  
frequency   in   the   screen,   Ct733   (~1500   bp   PCR   product),   was   also   tested   for  
complementary   in   the   same  way  with   strain  HY1_733Lib.      This   strain  was  not   able   to  
efficiently  survive  at  the  higher  temperature  (Fig.  28)  indicating  its  appearance  in  library  
results  was   likely  due   to  mutations   in   the   temperature   sensitive  plasmid  and  not  ORF  
function.    Thus,  it  was  concluded  that  the  ORF  appearing  at  the  highest  frequency  in  the  
library  screen  is  able  to  complement  lpxH  function  in  E.  coli.      
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Figure  28:  Confirmation  of  HY1  Complementation  of  Screen  Hits  
LB  agar  plates  of  HY1  transformed  with  individual  plasmids  from  the  pDEST  library  and  grown  
at  30°C  and  44°C.    The  two  strains  depicted,  HY1_461Lib  and  HY1_733Lib,  represent  individual  
transformation   of   library   pDEST   plasmids   occurring   the   first   and   second   most   frequently,  
respectively,  in  analysis  of  temperature  resistant  HY1_Lib.    Identical  plating  of  HY1_EcH  is  also  
shown  at  30°C  and  44°C  as  a  control.    Equal  amounts  of  bacteria  were  plated  at  each  condition  for  
each   strain,   as   determined   by   OD600.      The   agar   media   was   supplemented   with   ampicillin   for  
selection.            
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4.3.5 Ct461 Displays In Vivo UDP-DAGn Hydrolase Function in HY1 
Analysis   revealed   Ct461   encodes   for   a   37   kD   uncharacterized  
metallophosphoesterase.    The  full-­‐‑length  protein  product  of  the  ORF  is  predicted  to  have  
an  N-­‐‑terminal   transmembrane  helix,  however   this   region  was   truncated   from  the  ORF  
during   construction   of   the   pDONR   library   (158).   These   trimmed   codons   were   added  
back  to  the  N-­‐‑terminal  region  of  Ct461  and  the  full-­‐‑length  gene,  harbored  in  p461,  was  
used  for  subsequent  assessment.      It  was  also  noted  that  Ct733  was  shortened  at  the  N-­‐‑
terminal   region   during   the   generation   of   the   library   due   to   the   presence   of   a   similar  
predicted   transmembrane   domain   (158);   the   complete   version   of   the   gene   was  
constructed   in   p733.      While   Ct733   was   not   suspected   to   be   capable   of   UDP-­‐‑DAGn  
hydrolase  activity,  it  was  used  as  a  control  in  further  experiments  to  test  the  specificity  
of  Ct461  function.    
To   confirm   the   ability   of   full-­‐‑length   Ct461   to   perform   UDP-­‐‑DAGn   hydrolase  
activity   in  E.   coli,  p461  was   transformed   into  HY1,   creating  HY1_461.     This   strain  was  
assessed  for  temperature  sensitivity  on  LB-­‐‑agar.  It  displayed  survival  at  both  30°C  and  
44°C,   similar   to   HY1_Ec,   and  was   healthier   in   growth   at   44°C   compared   to   HY1_VC  
(Fig.   29A).      HY1_733,   HY1   transformed   with   p733,   displayed   a   phenotype   similar   to  
HY1_VC  (Fig.  29A).  
As   a   more   definitive   assessment   of   the   capability   of   Ct461   to   rescue   lpxH  
deficiency,  growth  of  HY1_461  at  44°C  was  monitored  in  liquid  media  and  compared  to  
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control   strains.      Parallel   cultures   of   HY1_461,   HY1_VC,   HY1_733,   and  HY2_VC  were  
inoculated   at   30°C   and   allowed   to   reach   mid-­‐‑log   phase.      After   dilution   to   the   same  
OD600,   the  cells  were  shifted  to  44°C.     Linear  growth,  as  tracked  by  accumulated  OD600,  
was  observed  for  all  four  strains  until  300  min,  after  which  HY1_VC  and  HY1_733  lose  
viability   (Fig.   29B).      Presumably,   this   arrest   in   survival   correlates   to   the   loss   of   the  
temperature-­‐‑sensitive  lpxH  plasmid,  as  these  strains  no  longer  contain  a  complement  for  
the  chromosomal  absence  of  the  gene.    HY2_VC  and  HY1_461,  however,  do  not  plateau  
in  growth  (Fig.  29B)  as  presence  of   temperature   insensitive  plasmids  (pKJB5  and  p461,  







































Figure  29:  Ct461  Rescues  HY1  at  44°C  
(A)  LB  agar  plates  depicting  growth  of  each  HY1_VC,  HY1_461,  HY1_733,  and  HY1_EcH  at  30°C  
and  44°C.     Equal  amounts  of  bacteria  were  streaked  onto  solid  media  supplemented  with  Amp  
and   Kan   for   each   respective   HY1   strain   at   each   temperature.      (B)   Growth   curve   of   HY1_VC,  
HY2_VC,  HY1_461,  and  HY1_733  in  liquid  media  at  44°C.    Cultures  of  each  strain  were  grown  to  
mid-­‐‑log  phase  in  LB  supplemented  with  ampicillin  and  chloramphenicol  at  30°C  and  then  back-­‐‑
diluted  to  OD600  0.01  into  pre-­‐‑warmed  LB  supplemented  with  ampicillin.    To  maintain  log-­‐‑phase  
growth,  cultures  were  back-­‐‑diluted  10-­‐‑fold  upon  reaching  OD600  0.3-­‐‑0.4.    Cumulative  growth  was  
determined   from   OD600   measurements   taken   at   designated   time   intervals   and   plotted   on   a  
logarithmic  scale.  
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4.3.6 Ct461 Rescues lpxH::kan Viral Transduction in W3110A 
Temperature-­‐‑independent  verification  of  Ct461’s   functional  properties  was  also  
completed  using  P1  vir   transduction.      Full   length  Ct461  was   ligated   into  pBAD33  and  
then   transformed   into  W3110A,  generating  W3110A461.  Transduction  of   lpxH::kan   into  
the  strain  yielded  W3110AΔHCtG.    Colony  PCR  of  W3110AΔHCtG  with  an  internal  kan  
primer   and   a   primer   specific   to   the   region   of   the   chromosome   upstream   of   lpxH  
generated  a  product   that  was  of  equal   size   to   that   seen   for  W3110ΔHEc   ,   a  previously  
created   lpxH::kan   strain   (Fig.   30A).      In   contrast,   identical   PCR   analysis   of   wild-­‐‑type  
W3110A   yielded   no   oligonucleotide.      W3110AΔHCtG   was   viable   on   LB-­‐‑agar,   and  
showed   enhanced   growth   when   supplemented   with   arabinose,   which   induced  
production   of   Ct461   from   the   pBAD   plasmid   (Fig.   30B).      This   lpxH::kan   transduction  

























Figure  30:  Ct461  Complements  lpxH::kan  in  W3110A  E.  coli  
(A)  Colony  PCR  results  of  various  W3110A  strains  employing  5002_For  and  p21  primers.    Based  
on   the   sequence   of   indicated   primers,   products   are   only   generated   if   tested   strain   harbors   a  
lpxH::kan   genotype,   as   indicated   by   the   band   around   600   bp   for   the   previously   characterized  
W3110AΔHEc.      W3110AΔHCtG   displays   a   similar   result,   while   wild-­‐‑type   W3110A   lacks   any  
such   oligonucleotide   artifact.      (B)   Survival   of  W3110AΔHCtG   and  W3110AΔHEc   at   37°C   after  
streaking   on   LB   agar   supplemented  with   ampicillin   and   chloramphenicol.      In   the   right   panel,  
growth  medium  has   been   additionally   supplemented  with   0.02  %   (w/v)   arabinose   to   stimulate  
expression   of   the   pBAD33-­‐‑derived   plasmid   harbored   by   both   W3110AΔHCtG   and  
W3110AΔHEc. 
  
4.3.7 Expression of Ct461 Corresponds to Enhanced Lipid X 
Production In Vitro  
After  establishing  the  ability  of  Ct461  to   function  as  a  UDP-­‐‑DAGn  hydrolase   in  
vivo,   we   sought   to   assess   the   in   vitro   activity   of   the   ORF.      Ct461   was   cloned   into   an  
expression  vector,  which  generated  a  C-­‐‑terminal  His-­‐‑tag  on   the  protein  product.     This  
vector,   p461t,   was   transformed   into   C41(DE3)   to   produce   CtG_t10.      Cell   free   extracts  
(CFE)   were   prepared   from   CtG_H10   grown   in   the   presence   of   IPTG   (denoted   Ct461  
CFE)  and  then  tested  for  lipid  X  production  using  an  autoradiographic  TLC-­‐‑based  assay.    
Over  the  tested  time  course,  Ct461  CFE  produced  more  product  than  equal  amounts  of  
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CFE  prepared  from  vector  control  strain  VC_t10  (Fig.  31A).    This  corresponded  a  specific  
activity   of   47.0   nmol/mg/mL   for  Ct461  CFE   versus   0.9   nmol/mg/mL   for  VC  CFE   (Fig.  
31B).      Futhermore,   the   species  generated   in  Ct461   reactions  migrated   the   same  as   that  
created  by  HiLpxH  (157),  confirming  its  identity  as  lipid  X.      
To   ensure   the   observed   hydrolysis   was   unambiguously   due   to   the   enzymatic  
activity,   an   alanine   point   mutation   was   constructed   in   a   highly   conserved   aspartate  
residue,  D59,  of  Ct461.    Based  on  Ct461’s  homology  to  calcineurin-­‐‑like  phosphoesterases,  
this  residue  is  hypothesized  to  play  an  important  role  in  protein  catalysis  (see  Chapter  5  
for  further  discussion).    CFE  samples  from  C41(DE3)  cells  expressing  this  mutant  protein  
(D59A  CFE)  displayed  similar   levels  of  UDP-­‐‑DAGn  hydrolysis  as   that  seen  for  VC_t10  
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Figure  31:  Expression  of  Ct461  Enhances  UDP-­‐‑DAGn  Hydrolysis  In  vitro    
(A)  Scan  of  phosphoscreen  exposed  to  a  silca  TLC  plate  from  an  assay  of  cell-­‐‑free  extracts  (CFE)  
prepared  from  VC_t10  (VC  CFE),  CtG_t10  (Ct461  CFE),  and  D59A_t10.    Protein  concentration  in  
each   reaction   was   ~1  mg/mL.      Reactions   lacking   protein   sample   (No   enzyme)   and   containing  
purified  LpxH   (HiLpxH)  were   included  as  negative   and  positive   controls,   respectively.      Bands  
corresponding  to  UDP-­‐‑DAGn  substrate  and  lipid  X  product  are  denoted.    (B)  Comparison  of  the  
specific  UDP-­‐‑DAGn  hydrolase  activity  for  the  samples  described  in  (A).     Values  determined  for  
individual   samples   are   0.9   nmol/mg/mL,   47.0   nmol/mg/mL,   and   1.3   nmol/mg/mL   for  VC  CFE,  
Ct461  CFE,  and  D59A  CFE,  respectively,  and  were  calculated  from  autoradiographic  assay  data  
as  previously  described.  
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4.4 Discussion 
Lipid   A   is   a   crucial   part   of   the   outer   membrane   of   numerous   Gram-­‐‑negative  
bacteria  (6,7).     For  many  bacteria,   its  biosynthesis   is  necessary  for  survival,  making  the  
enzymes   of   the   lipid   A  metabolic   pathway   potential   antibiotic   targets   (6,7).      In   other  
bacteria,   lipid   A   is   not   essential,   but   nonetheless   plays   an   imperative   role   in   the  
development  of  the  organism.    For  example,  in  the  pathogen  C.  trachomatis,  inhibition  of  
lipid   A   synthesis   by   targeting   LpxC   correlates   with   inability   of   the   bacteria   to  
differentiate   from   the   RB   state   back   into   the   infectious   EB   state   (20).      While   the  
generation   of   the   saccharolipid   is   of   obvious   importance,   the   pathway   of   lipid   A  
biosynthesis  in  C.  trachomatis  was  not  completely  understood.    Lipid  A  of  C.  trachomatis  
is  very  similar  to  that  E.  coli  (153),  and  unsurprisingly,  the  two  bacteria  share  orthologs  
for   nearly   all   of   the   biosynthetic   enzymes.      The   once   missing   piece   was   an   enzyme  
capable  of  the  fourth  step,  UDP-­‐‑DAGn  hydrolysis.    Thus  we  sought  to  identify  the  gene  
responsible   for   this   function   in   C.   trachomatis   through   implementation   of   a  
complementation  screen  in  E.  coli.      
4.4.1 UDP-DAGn Hydrolase Activity in C. trachomatis Lysates 
Confirms Existence of Functionality   
Despite   the   lack   of   a   UDP-­‐‑DAGn   hydrolase   homolog,   C.   trachomatis   was  
hypothesized   to   contain   an   enzyme   capable   of   the   production   of   lipid   X.      Using   a  
slightly  modified  version  of  our  previously  described  autoradiographic  assay  (157),  we  
were   able   to   demonstrate   linear,   metal-­‐‑dependent   UDP-­‐‑DAGn   hydrolase   activity   in  
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lysates  of  HeLa  cells  infected  with  C.  trachomatis;  this  activity  was  not  present  in  lysates  
of  HeLa  cells  alone.     While   lipid  X  production  was  evident,   it  was  at  a  very   low  level.    
This  may  be  due   to  only  a   small  amount  of  C.   trachomatis  protein  being  present   in   the  
assayed   sample   compared   to   HeLa   protein,   as   samples   were   prepared   directly   from  
infected   cultures.      Furthermore,   it   is   possible   that   not   all   of   the  C.   trachomatis   in   the  
sample  were  expressing  protein  capable  of  UDP-­‐‑DAGn  hydrolase  activity.    Specifically,  
as   cultures   were   harvested   30   h   post   infection   when   RBs   were   asynchronously  
differentiating  back   into  EBs   (109),  bacteria  of  both   stages  were  present   in   the   sample.    
Since   LpxC   inhibitors   did   not   alter   replication   of   RBs   and   EBs   are   not   capable   of  
duplication   (20),   the   lipid  A  biosynthetic  pathway  may  only  be  active   in  C.   trachomatis  
when   RBs   are   transitioning   to   EBs,   effectively   limiting   the   possibility   of   seeing   UDP-­‐‑
DAGn  hydrolase  in  our  sample.      
Overall,  while  detecting  UDP-­‐‑DAGn  hydrolase  activity   in  C.   trachomatis   lysates  
indicates   in   vitro   evidence   of   functionality,   it   also   highlights   the   limitations   with  
studying   this   functionality   in  C.   trachomatis   directly.      Activity   is   very   low,   making   it  
difficult  to  assess  any  significant  changes  in  lipid  X  production  due  to  over-­‐‑expression  of  
certain   genes.      Moreover,   over-­‐‑expression   of   such   genes   would   be   tedious,   as   this  
technology   has   only   been   recently   developed   in   C.   trachomatis   and   is   still   not   well  
understood  (120).          
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4.4.2 Novelty of UDP-DAGn Hydrolase Identification Method is 
Advantageous for Functional Screening of C. trachomatis Genes  
Having  in  vitro  evidence  of  lipid  X  production  in  C.  trachomatis,  it  was  especially  
pertinent   to   search   for   a   C.   trachomatis   gene   encoding   for   UDP-­‐‑DAGn   hydrolase  
function.      Limitations   of   genetic   tools   in   C.   trachomatis   made   it   necessary   to   employ  
heterologous   expression   in   E.   coli.   As   UDP-­‐‑DAGn   hydrolysis   is   essential   in   E.   coli,  
functionality   of   C.   trachomatis   genes   could   be   easily   assessed   through   their   ability   to  
rescue   viability   of   an   lpxH   mutant.      This   strategy   relied   on   generation   of   HY1,   a  
conditional-­‐‑lethal  ΔlpxH  strain  with  a  temperature-­‐‑controlled  rescuing  copy  of  lpxH.    It  
was   additionally   necessary   to   create   a   library   of   C.   trachomatis   DNA.   With   use   of  
Gateway®  technology,  we  engineered  an  existing  ORFeome  library  (158)  for  controlled  
expression   in   E.   coli.      Together,   HY1   and   the   pDEST-­‐‑library   were   effectively   used   to  
identify  a  C.  trachomatis  ORF  capable  of  UDP-­‐‑DAGn  hydrolysis.        
The   overall   strategy   of   employing   E.   coli   to   screen   for   functionality   of   C.  
trachomatis   genes   has   been   previously   reported   for   identifying   enzymes   involved   in  
meso-­‐‑diaminopeimelic   acid   (m-­‐‑DAP)   synthesis   (115),   which   is   important   for  
peptidoglycan  assembly  and  lysine  production.    Like  with  lipid  A,  the  m-­‐‑DAP  pathway  
was  well  characterized  in  E.  coli,  but  orthologous  genes  for  some  enzymatic  steps  were  
missing  was  missing   in  Chlamydiales.      Investigators  generated  a  C.   trachomatis  genetic  
library  through  restriction  digestion  of  genomic  DNA  to  test  for  complementation  of  an  
E.  coli  m-­‐‑DAP  auxotroph,  and  were  able  to  identify  a  candidate  ORF  that  was  confirmed  
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to   play   a   unique   role   in   m-­‐‑DAP   biosynthesis   through   subsequent   biochemical  
experiments.      Additionally,   this   strategy   has   been   employed   for   identification   of   S-­‐‑
adenosylmethionine   (SAM)   transporters   in   C.   trachomatis   (116).      Once   again,   C.  
trachomatis   lacked   genes   homologous   to   previously   characterized   transporters   despite  
showing   evidence   of   SAM-­‐‑dependent   methylation   reactions.      As   this   transport  
functionality,   encoded  by  metK,   is   essential   in  E.   coli,  a   conditional-­‐‑lethal  ΔmetK   strain  
had  to  be  created  for  complementation  screening.    Investigators  used  an  ara-­‐‑promoter  to  
facilitate  tight  control  of  the  rescuing  copy  of  metK,  thus  allowing  for  hits  to  be  identified  
by  plating  on  glucose.  
While   generally   similar   to   the   aforementioned   methods,   the   UDP-­‐‑DAGn  
hydrolase  screening  method  has  novel  aspects.     First,  the  UDP-­‐‑DAGn  hydrolase  screen  
employed  a  temperature-­‐‑sensitive  replicon  to  control  the  conditional-­‐‑lethal  ΔlpxH  strain  
instead   of   an   ara   promoter   (115).      Use   of   an   ara-­‐‑promoter   was   investigated,   however  
complete   shut-­‐‑down   of   lpxH   expression   was   not   achievable,   as   colonies   were   still  
capable  of  survival  even  when  fucose  was  present  in  the  media.    This  problem  of  leaky  
expression   of   essential   genes   from   the   ara  was   also   described   for   the   SAM   transport  
experiments   and   was   eventually   circumvented   by   mutation   of   the   metK   start   codon  
(115).      Our   alternative   use   of   temperature   as   a   regulator   provided   a   straightforward  
method   for   controlling   gene   expression   that   did   not   rely   on   additional   agents   being  
supplemented  to  the  media.  
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Second,  the  pDEST-­‐‑library  provided  for  a  thorough,  expression-­‐‑optimized  screen  
of   the   C.   trachomatis  ORFeome   that   would   not   be   possible   with   a   library   created   by  
restriction   digestion   of   genomic   DNA.      The   UDP-­‐‑DAGn   hydrolase   screen   library  
contained  a  clone  of  every  individual  ORF  in  C.  trachomatis,  whereas  the  aforementioned  
library   screens   utilized   a   pUC18-­‐‑harbored   library   created   by   restriction   digestion  
(115,116),  meaning   some   library  plasmids   contained  partial  ORFs.      Isolating  each  ORF  
separately   prevents   the   possibility   of   false   negatives   due   to   partial   gene   products.    
Additionally,   the   pDEST-­‐‑library   was   harbored   in   a   plasmid   containing   a   ribosome-­‐‑
binding   site   specific   for   expression   in   E.   coli.      This   is   an   advantage   over   restriction-­‐‑
created   libraries   in  which  expression   is  contingent  on   the  native  promoter  of   the  DNA  
sequence,  which  may  not  be  read  efficiently  in  E.  coli.    Finally,  expression  of  the  pDEST-­‐‑
library   was   controllable,   as   T7-­‐‑dependent   expression   could   be   upregulated   through  
addition  of  IPTG  or  left  at  low  levels  in  the  absence  of  inducer.    Such  control  was  not  an  
option  with  the  pUC-­‐‑based  library  previously  described  (115,116).    
A  third  unique  aspect  of  the  UDP-­‐‑DAGn  hydrolase  screen  was  the  method  used  
to  validate  hits.     The   temperature-­‐‑controlled   replicon,  while  more  efficient   than  use  of  
the  ara  promoter,  still  allowed  survival  of  HY1  at  low  frequency.    As  it  was  necessary  to  
screen   20,000   colonies   to   ensure   adequate   coverage   of   the   library,   even   this   slight  
background  was   visible.      Thus,   it  was   necessary   to   discern  which   surviving  HY1_Lib  
colonies   were   actual   hits   with   specific   UDP-­‐‑DAGn   hydrolase   complementation   and  
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which   simply  had   residual   temperature   resistance.     PCR  with  T7  primers  provided  an  
effective   and   time-­‐‑efficient   method   for   assessing  C.   trachomatis  ORFs   harbored   viable  
colonies;  it  allowed  for  determination  of  the  variety  of  ORFs  present,  making  it  possible  
eliminate  those  occurring  at  a  low  frequency.    
It   should   be   noted   that   a   more   direct   approach   at   the   library   screen   was  
attempted   using   P1   transduction.      In   this   scheme,   C41(DE3)   harboring   pDEST_CtLib  
would   be   infected   with   P1   phage   carrying   lpxH::kan.      Resulting   colonies   capable   of  
growth  on  kanamycin  would  be  assumed  to  have  an   lpxH  deletion,  and  their  ability  to  
survive  could  be  attributed  to  the  presence  of  a  CtORF  library  plasmid  capable  of  LpxH  
function.     Unfortunately   this   strategy  proved   to   be   ineffective.     A   small   population  of  
C41(DE3)  library  transformants  were  noted  to  be  kanamycin  resistant,  presumably  due  
to   the   presence   of   unreacted   pDONR_CtLib   in   the   Gateway®   reaction   product.      This  
contaminating  resistance  made  it  impossible  to  use  kanamycin  to  screen  for  lpxH  knock-­‐‑
outs,   as   described   for   the   P1   strategy.      Substitution   of   a   restriction-­‐‑enzyme   generated  
library   would   have   circumvent   the   issues   caused   by   the   incompleteness   of   the  
Gateway®   reaction.      However,   as   discussed   above,   there   were   many   advantages   to  
employing  the  pDEST  library  with  each  individual  ORF  under  controllable  expression.    
Thus  we   chose   to   employ   the   temperature-­‐‑controlled   strategy   that   accommodated   for  
use  of  the  optimized  library.          
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4.4.3 Classification of Ct461 as UDP-DAGn Hydrolase is Supported by 
In Vivo and In Vitro Evidence  
With  use  of  HY1  and  the  pDEST-­‐‑harbored  library,  we  identified  Ct461  as  a  likely  
candidate   for   the  C.   trachomatis   UDP-­‐‑DAGn  hydrolase.      The   significant   enrichment   of  
the   1100   bp   insert   corresponding   to   Ct461   in   temperature   resistant   HY1_Lib   colonies  
indicates   its   specific   complementation   of   lpxH.      Sequencing   of   other   PCR-­‐‑amplified  
inserts   of   various   sizes   revealed   a   range   of   ORFs,   most   of   which   correspond   to  
hypothetical  proteins  (Table  13).     While  some  appear  multiple  times,  their  frequency  is  
much  less  than  seen  for  Ct461.     Moreover,  even  the  ORF  insert  occurring  at  the  second  
highest   frequency,   Ct733,   was   not   able   to   complement   HY1   temperature   sensitivity  
independently.      Together,   this   suggests   that   the   low-­‐‑frequency  ORFs   identified   in   the  
screen  were  capable  of  survival  due  to  mutations  in  the  temperature  sensitive  replicon  of  
the  pKJB5  plasmid  and  not  complementation  events.    Those  occurring  multiple  times  are  
most  likely  clones  of  the  same  surviving  HY_lib  colony  and  do  not  reveal  independent  
occurrence  of  survival.    
Besides   the   high   frequency   occurrence   of   Ct461   in   the   library   screen,   it   shows  
other   evidence   of   UDP-­‐‑DAGn   hydrolase   function.      When   tested   independently   for  
temperature  rescue  of  HY1,  the  ORF-­‐‑harboring  strain  displayed  robust  survival  both  on  
plates  and  in  liquid  culture.    This  complementation  was  not  temperature  dependent,  as  
the  presence  of   the  gene  allowed   for  generation  of  an   lpxH  knock-­‐‑out   in  E.   coli  W3110  
using  P1  vir  transduction.    The  phenotype  of  complementation  of  lpxH  in  E.  coli  was  also  
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observed  with   lpxI,   thus   corroborating   it   as   a  metric   by  which   to   discern  UDP-­‐‑DAGn  
hydrolase   activity.      Complementation   has   also   proved   effective   in   discerning   non-­‐‑
specific   hydrolases   from   biologically   relevant   ones,   as   Cdh,   a   protein   shown   to  
hydrolyze   UDP-­‐‑DAGn   in   vitro,   cannot   complement   lpxH   in   vivo   (40,82,89,91,92).      
Furthermore,   as  discussed   above,   the   function  of   other  C.   trachomatis   genes  have  been  
characterized  by  their  ability  to  rescue  mutants  of  orthologous  E.  coli  genes.    Currently,  
there   is   no   method   for   gene   knock-­‐‑outs   available   in   C.   trachomatis,   making  
complementation   tests   in  a  heterologous   system  one  of   the  only  available  methods   for  
determining  gene  function.      
Use   of   the   established   assay   for  UDP-­‐‑DAGn   hydrolase   activity   provided   for   a  
method   by   which   to   assess   the   function   of   Ct461   in   vitro.      E.   coli   induced   for   over-­‐‑
expression  of  Ct461  clearly  indicate  an  enhancement  in  lipid  X  production.    This  increase  
is   not   as   significant   as   that   seen  when   LpxH   or   LpxI   is   over-­‐‑expressed,   however   the  
difference  can  be  attributed   to   inefficient  expression  of  Ct461,  as  protein  production   is  
not  visible  by  SDS-­‐‑PAGE  (data  not  shown).    The  enriched  in  vitro  activity  is  not  detected  
when  Ct461  with   a  mutation   in   a   likely   catalytic   residue   is   over-­‐‑expressed,   providing  
further   evidence   that   increased   in   vitro   lipid   X   production   observed   in   the   cell-­‐‑free  
extract  can  be  credited  to  Ct461  activity.      
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Table  12:  Sequencing  Results  of  C.  trachomatis  UDP-­‐‑DAGn  Hydrolase  Screen  
  
Band Size 
(bp) ORF Encoded protein 
#   
Occurrences 
%   
Frequency 
550 848 Hypothetical protein 1 2 
600 814 Pututive membrane protein 1 2 
600 255 Hypothetical protein 1 2 
900 611 Hypothetical protein 1 2 
900 383 Hypothetical protein 1 2 
900 130 ABC amino acid transporter ATPase, GlnQ 1 2 
1000 720 NifU 1 2 
1000 583 Gp6D 2 5 
1100 851 Methionine aminopeptidase 1 2 
1100 461 Metallophosphoesterase 16 39 
1100 406 Hypothetical protein 1 2 
1100 451 Phophatidate cytidylyltransferase 1 2 
1400 776 8-amino-7-oxonanoate synthetase, BioF 1 2 
1500 733 Membrane protein 9 22 
1500 132 Hypothetical protein 2 5 
1600 197 Oligopeptide binding protein, oppA_3 1 2 
  Total sequenced: 41  
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4.4.4 Ct461 is a Unique Membrane-Associated CLP enzyme 
Sequence   analysis   revealed   Ct461   encodes   for   a   37   kD   uncharacterized  
metallophosphoesterase.   The   protein   is   categorized   to   be   part   of   the   calcineurin-­‐‑like  
phosphoesterase   (CLP)   superfamily   (Pfam00149),   which   utilizes   divalent   cations   for  
hydrolysis  of  phosphoester  bonds  (103,105).  The  observation  of  EDTA-­‐‑inhibition  of  lipid  
X  production   in  C.   trachomatis   lysates  supports   the  classification  of   the  bacteria’s  UDP-­‐‑
DAGn  hydrolase  as  a  metalloenzyme.    The  sequence  of  Ct461  has  no  similarity  to  that  of  
LpxI   orthologs   (Table   13).      The   classification   of   Ct461   as   a   CLP   places   it   in   the   same  
superfamily  as  LpxH,  however  Ct461  contains  the  more  common  “GNHD”  family  motif  
in   contrast   to   the   LpxH-­‐‑specific   “GNRD”   sequence.      Besides   the   common  CLP   family  
motif,  Ct461  and  LpxH  show  very  limited  sequence  identity  (Table  13)  (see  Chapter  5  for  
additional  discussion).  
  
Table  13:  Alignment  Statistics  of  Ct461  vs.  LpxH  and  LpxI  
Name % Query Coverage E-value 
% Identity 
(Clustal W) 
Ct461 100 0 100 
LpxH 21 0.8 11 




Homologs   of   Ct461   are   found   across   other   Chlamydia   species   (see   Chapter   5).    
Alignment   reveals   the   clear   presence   of   the   CLP   motif:  
DXH(X)~25GDXXDR(X)~25GNHD/E  (where  X   is  any  residue).     The  residues  of   this  motif  
have   been   shown   to   be   the   main   contributors   to   catalysis   in   CLP   enzymes,   playing  
important  roles  in  metal  and  water  coordination  (103,106).    Studies  of  other  enzymes  of  
this   type   indicate   the   first   aspartate   residue   of   the  motif   coordinates   one   of   the  metal  
cofactors   (150),   thus   mutations   in   this   residue   severely   inhibit   activity   (103,106).      As  
discussed   above,   a   mutation   in   the   corresponding   aspartate   in   Ct461   (D59),   nearly  
abolished   observed   activity   in   cell   lysates.      Not   only   does   this   mutation   provide  
evidence  that  detected  hydrolase  activity  can  be  attributed  to  Ct461,  but  it  also  suggests  
that  Ct461  is  performing  catalysis  in  a  way  similar  to  other  CLP  enzymes.        
Hydropathy   analysis   of   Ct461   predicts   an  N-­‐‑terminal   transmembrane   domain.    
During  construction  of  the  pDONR  C.  trachomatis  library  from  which  our  pDEST  library  
was   generated,   this   region   of   the   ORF   was   truncated   to   circumvent   any   issues   with  
expression   (158).      Interestingly,   even   with   the   missing   transmembrane   portion,  
pDEST_461  was  capable  of   lpxH  complementation.     It  is  likely  the  truncated  Ct461  was  
still  able  to  produce  lipid  X,  as  the  residues  comprising  the  CLP  motif  are  not  predicted  
to   be   part   of   this   domain.      Furthermore,   as   EcLpxH  has   no   predicted   transmembrane  
structure,  a  non-­‐‑membrane  bound  Ct461  was  still  able  to  interact  with  the  other  proteins  
in  the  E.  coli  lipid  A  biosynthetic  pathway.    It  should  be  noted  that  full-­‐‑length  Ct461  was  
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also   able   to   complement   lpxH,   indicating   that   the   E.   coli   pathway   could   also  
accommodate   for   full   membrane   association   at   the   fourth   step.      This   highlights   the  
flexible  and  modular  nature  of  lipid  A  biosynthesis.          
4.4.5 Conclusion 
With  evidence  from  in  vivo  complementation  and  in  vitro  lipid  X  production,  we  
conclude  that  Ct461  encodes  for  a  specific  UDP-­‐‑DAGn  hydrolase  in  C.  trachomatis.    This  
protein,  which  will  be  henceforth  referred   to  as  LpxG,  completes   the  puzzle  of   lipid  A  
biosynthesis   in  C.   trachomatis   and   arms   us   with   information   to   make   more   definitive  
conclusions  about  the  role  the  molecule  plays  in  the  physiology  of  this  bacteria.    Further  
biochemical  and  genetic  characterization  of  LpxH  is  described  in  the  following  chapter.      
While   the   discovery   of   LpxG   is   an   important   result   of   our   work,   an   equally  
important   outcome   was   the   development   of   a   strategy   to   screen   for   functionality   of  
uncharacterized   C.   trachomatis   genes   using   E.   coli.      The   lack   of   genetic   tools   in   C.  
trachomatis   paired   with   its   distant   evolutionary   relationship   to   well-­‐‑characterized  
organisms  like  E.  coli  have  left  many  mysteries  surrounding  the  functional  identification  
of   genes   in   the   organism.      Despite   their   phylogenetic   differences,   the   molecular  
structures  of  the  products  of  metabolic  pathways  in  E.  coli  and  C.  trachomatis  are  similar,  
making   it   possible   to  use   the   former   as   a  heterologous   expression   system  of   the   latter  
(115,116,160).      
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Our   screening   strategy   that   involves   a   genomic   library   with   each   ORF   on   a  
separate   plasmid   and   is   optimized   for   controlled   expression   in  E.   coli   could   prove   an  
efficient  method  for  further  characterization  of  C.  trachomatis  genes.     Use  of  this  library  
also  allows  for  simple  assessment  of  hit  ORFs  through  visualization  of  T7-­‐‑amplified  PCR  
products.      Finally,   for   investigations   of   functions   which   are   essential   in   E.   coli,  
temperature   controlled   conditional-­‐‑lethal   strains   could   be   utilized   for   straightforward  
modulation  of  gene  expression.    Together,  these  attributes  of  the  UDP-­‐‑DAGn  hydrolase  
screen  make  it  an  advantageous  method  for  further  application  in  the  characterization  of  




5. Initial Biochemical Characterization of LpxG, a Third 
UDP-2,3-Diacylglucosamine Hydrolase 
5.1 Introduction 
The   identity   of   the   lipid   A   molecule   residing   in   the   outer   leaflet   of   the   outer  
membrane   can   differ   greatly   among   Gram-­‐‑negative   bacteria   due   to   the   presence   of  
species-­‐‑specific  modification  enzymes  that  make  changes  to  the  structure  of  lipid  A  after  
it   is  synthesized  (6,20).     This  results   in  an  outer  membrane  optimized  for  the  bacteria’s  
niche   environment   (6,29).      Despite   the   variation   in   the   modification   enzymes   across  
Gram-­‐‑negative   bacteria,   the   proteins   responsible   for   constructing   nascent   lipid   A   are  
highly   conserved.      Specifically,   orthologs   for   LpxA,   LpxC,   LpxD,   and   LpxB,   which  
catalyze  the  first,  second,  third,  and  fifth  steps  of  the  pathway,  respectively,  are  in  nearly  
all  Gram-­‐‑negative  bacteria  known  to  produce  lipid  A  (81).      
The   conservation   of   aforementioned   steps   is   reflected   in   the   preserved  
disaccharide  structure  of  the  lipid  A.    LpxA  (95,161),  LpxC  (38,162),  and  LpxD  (39)  work  
in  sequence   to   transform  the   initial  UDP  N-­‐‑acetylglucosamine   into  a  di-­‐‑acylated  sugar  
nucleotide,   UDP-­‐‑2,3-­‐‑diacylglucosamine   (UDP-­‐‑DAGn).      This   molecule   serves   as   one  
substrate   for   glycosyl   transferase,   LpxB   (90,127).      The   second   substrate   for   LpxB,   2,3-­‐‑
diacylglucosamine   1-­‐‑phosphate   (lipid   X),   is   formed   from   the   hydrolysis   of   the  
pyrophosphate   bond   in   UDP-­‐‑DAGn.      The   joining   of   lipid   X   and   UDP-­‐‑DAGn   forms  
disaccharide   2’3’-­‐‑diacylglucosamine-­‐‑(1’6)-­‐‑2,3-­‐‑diacylglucosamine   1-­‐‑phosphate   (also  
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known  as  disaccharide  monophosphate,   or  DSMP),   thus   yielding   the   structure   for   the  
canonical  conjugated  carbohydrate  backbone  of  lipid  A  (6).      
Based   on   the   current   understanding   of   LpxB   mechanism,   the   only   way   for  
production  of  a  disaccharide  linkage  is   through  use  of  a   lipid  X  substrate  (90,127).     No  
known   LpxB   ortholog   is   thought   to   be   capable   of   joining   UDP-­‐‑DAGn   molecules.    
Therefore,  the  hydrolysis  of  UDP-­‐‑DAGn  to  form  lipid  X  is  an  important  chemical  step  in  
the   lipid   A   pathway.      Interestingly,   the   enzyme   that   catalyzes   this   hydrolysis   is   not  
conserved   throughout  Gram-­‐‑negative   bacteria   (6,81).      Some   bacteria,   namely   the   β,   γ,  
and   ε   subsets   of   proteobacteria,   utilize   LpxH   for   the   formation   of   lipid   X   (40).   Other  
bacteria,   such   as   α   proteobacteria,   have   LpxI   orthologs   that   are   responsible   for  
hydrolyzing  UDP-­‐‑DAGn  (41).    Finally,  some  bacteria  known  to  produce  lipid  A  contain  
neither   LpxH   nor   LpxI,   suggesting   the   possibility   for   a   third   protein   capable   of  
producing  lipid  X  (see  Chapter  4).  
Due   to   their   shared   enzymatic   ability,   LpxH   and   LpxI   can   be   classified   as  
functional  orthologs  (41).    LpxI  can  complement  a  knock-­‐‑out  of  lpxH  in  E.  coli,  indicating  
that  the  LpxI  can  work  synergistically  with  lipid  A  biosynthetic  enzymes  from  an  LpxH-­‐‑
containing  species  (41).  Furthermore,  both  enzymes  have  been  shown  to  co-­‐‑purify  with  
their   product,   lipid   X   (96)   (Young   and  Raetz;   unpublished   data),   suggesting   a   similar  
mechanism   of   delayed   product   release.      In   the   in   vitro   environment,   LpxH   and   LpxI  
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show   similar   pH   rate   profiles   (41,157)   and   neither   appear   to   obey   surface   dilution  
kinetics  (discussed  further  in  Chapter  2).          
While  similarities  between  LpxH  and  LpxI  exist,  there  are  also  many  differences.    
The   two   proteins   have   no   shared   sequence   homology:   LpxH   belongs   to   a   well-­‐‑
characterized   family  of   calcineurin-­‐‑like  phosphoesterase   (CLP)   enzymes   (40,157)  while  
LpxI   display   unique   motifs   that   are   not   found   in   other   protein   families   (41).      LpxH  
catalyzes   hydrolysis   through   the   addition   of   a  water  molecule   on   the   α-­‐‑phosphate   of  
UDP-­‐‑DAGn  (40)  while  LpxI  attacks  the  β-­‐‑phosphate  (41).    Both  enzymes  are  thought  to  
have  some  interaction  with  the  inner  membrane,  however  LpxI  appears  to  be  much  less  
hydrophobic  than  LpxH  based  on  cell   lysate  fractionation  (41,157).     Finally,  while  both  
enzymes  are  activated  by  metal  ions,  LpxH  shows  a  very  strong  dependence  on  Mn2+  for  
catalysis  (157)  whereas  LpxI  prefers  Mg2+  and  is  activated  by  a  lesser  extent  (41).      
We  have  recently  identified  a  third  enzyme  capable  of  UDP-­‐‑DAGn  hydrolysis  in  
C.  trachomatis,  LpxG  (see  Chapter  4).     LpxG  expression  can  complement  a  knock-­‐‑out  of  
lpxH   in  E.   coli  and   corresponds  with   an   increase   in  UDP-­‐‑DAGn  hydrolysis   activity   as  
determined  by  autoradiographic  assay,  thus  classifying  LpxG  as  a  functional  ortholog  of  
LpxH   and   LpxI.      In   order   to   better   understand   how   the   enzymatic   properties   of   this  
newly   identified   protein   compare   to   its   operative   counterparts,   we   carried   out   initial  
purification   and   biochemical   characterization   of   C.   trachomatis   LpxG   (CtLpxG).      We  
report   the   use   of  mass   spectrometry   to   assess   the   enzyme’s  mechanism   of   hydrolytic  
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attack.      Based   its   homology   to   CLP   metalloenzymes,   we   investigated   the   metal  
dependence   of   CtLpxG   and   found   Mn2+   stimulates   enzyme   activity   35-­‐‑fold.    
Additionally,  we  provide  initial  evidence  that  CtLpxG  behaves  like  a  CLP  enzyme,  as  a  
point   mutation   in   the   conserved   metallophosphoesterase   motif   abrogates   activity.    
Finally,  we  compare  the  ability  of  CtLpxG,  EcLpxH,  and  CcLpxI  to  perform  UDP-­‐‑DAGn  
hydrolysis  in  vivo  with  heterologous  expression  in  an  lpxH  knock-­‐‑out  of  E.  coli.    Overall,  
this  work  provides  a   foundation  for  more  detailed  enzymatic  characterization  of  LpxG  
and   allows   for   initial   comparison   of   the   new   hydrolase   to   its   known   functional  
orthologs,  LpxH  and  LpxI.    Continued  work  aimed  at  fully  understanding  the  enzymatic  
and  evolutionary  relationships  among  LpxG,  LpxH,  and  LpxI  would  provide  important  
insight   into   the   variation   of   the   lipid   A   pathway.      Additionally,   these   three   enzymes  
could  serve  as  a  model  system  for  the  study  of  functional  orthologs.  
5.2 Materials and Methods 
5.2.1 Chemicals and Reagents 
The   4-­‐‑(2-­‐‑hydroxyethyl)-­‐‑1   piperazineethanesulfonic   acid   (HEPES),   phosphate-­‐‑
buffered  saline   (PBS)  components,  HCl,   salts,  ampicillin,   isopropyl-­‐‑β-­‐‑D-­‐‑thiogalactoside  
(IPTG),   fatty   acid-­‐‑free   bovine   serum   albumin   (BSA),   Triton   X-­‐‑100   (TX-­‐‑100)  
ethylenediaminetetraacetic  acid  (EDTA),  and  dithiothreitol  (DTT)  were  purchased  from  
Sigma-­‐‑Aldrich   (St.   Louis,   MO).   Methanol,   chloroform,   pyridine,   and   acetic   acid   were  
obtained   from   EMD   Science   (Gibbstown,   NJ).   Radioactive   γ-­‐‑32Pi   was   purchased   from  
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PerkinElmer   (Waltham,   MA).      Unless   otherwise   noted,   protein   concentration   was  
determined   either   by   BCA   Assay   or   Bradford   Assay   (Thermo   Scientific,   Waltham,  
Massachusetts)   depending   on   compatibility   with   buffer   components.   Both   of   these  
methods  were  carried  out  as  described  by  the  manufacturer.        
5.2.1 Bacterial Strains and Growth Conditions 
The  bacterial  strains  used   in   this  study  are   listed   in  Table  14.     Growth  medium  
for   liquid  culture  was  Luria  broth  (LB),  containing  5  g/L  yeast  extract,  10  g/L  tryptone,  
and  10  g/L  NaCl.    LB  supplemented  with  7.5  g/L  of  bacto  agar  was  used  for  solid  phase  
growth.     All  media   components  were  purchased   from  Difco   (Detroit,  MI).     Antibiotics  
were   used   at   the   following   concentrations:   100   µμg/mL   ampicillin   (Amp),   50   µμg/mL  
kanamycin  (Kan),  25  µμg/mL  chloramphenicol  (Cam).        
  
Table  14:  Strains  Used  in  the  Characterization  of  LpxG  
Strain Description Source or Reference 
C41 E. coli, F− ompThsdsB(rB−mB−) gal dcm (DE3) Δ(srl-recA)306::Tn10 (125) 
CtG_t10 C41 harboring p461T Chap. 4 
D125A_t10 C41 harboring pD125AT Chap. 4 
W3110A E. coli, F- aroA::Tn10 msbA+ , TetR (155) 
W3110AΔHEc W3110A lpxH::kan harboring pBAD33Ec (41) 
W3110AΔHCc W3110A lpxH::kan harboring pBAD33Cc (41) 
W3110AΔHCtG W3110A lpxH::kan harboring pBAD33461 Chap. 4 
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5.2.2 CtLpxG Expression and Purification 
A  typical  prep  of  CtLpxG  began  with  inoculating  an  overnight  culture  of  LB  with  
a   single   colony  of  CtG_t10   (created   as  described   in  Chapter   4).   This   overnight   culture  
was  subsequently  used   to   inoculate  250  mL  of  LB  supplemented  with  ampicillin   to  an  
OD600   of   0.02.   Cultures   were   incubated   at   30   °C   with   aeration   at   220   rpm   until   they  
reached  OD600  of  0.7-­‐‑0.8,  then  induced  for  expression  by  the  addition  of  1  mM  IPTG  and  
grown   for   an   additional   4   to   5   h   until   they  OD600   reached   ~4.   Cells   from   the   growths  
were  pelleted  by  centrifugation  at  5,000  ×  g,  washed  with  35  mL  of  cold  PBS,  and  then  
stored  at   -­‐‑80   °C.  For   lysis,   the   frozen  pellet  was   thawed,   resuspended   in  25  mL  of   ice-­‐‑
cold   20   mM   HEPES   pH   8.0,   and   passed   twice   through   a   French   pressure   cell   (SIM-­‐‑
AMINCO;   Spectronic   Instruments)   at   18,000   psi.   The   debris   from   the   resulting   lysate  
was   removed   by   centrifugation   at   10,000   ×   g   and   the   subsequent   supernatant   was  
collected  as  cell-­‐‑free  extract  (CFE)  and  stored  at  -­‐‑80  °C.    
Cell-­‐‑free  extract  was  thawed  and  diluted  to  5  mg/mL  with  20  mM  HEPES  pH  8.0.  
A   stock   solution   of   20%   (w/v)   n-­‐‑dodecyl-­‐‑β-­‐‑D-­‐‑maltoside   (DDM,   Avanti   Polar   Lipids,  
Alabaster,  AL),  was  used  to  bring  the  cell-­‐‑free  extract  to  a  final  detergent  concentration  
of  1%  (w/v).     Additional  stock  solutions  were  added  to  the  sample  to  obtain  NaCl  and  
glycerol   concentrations   of   300  mM   and   10%   (v/v),   respectively.      All   subsequent   steps  
were  carried  out  at  4  °C.  The  resulting  solution  was  then  mixed  by  inversion  for  1  h  and  
then   subjected   to   ultracentrifugation   at   100,000   ×   g   for   45   min.   The   supernatant   was  
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removed  and  diluted  with  the  appropriate  stocks  to  make  a  25  mL  solution  of  ~5  mg/mL  
protein,  20  mM  HEPES  pH  8.0,  300  mM  NaCl,  10%  glycerol,  and  20  mM  imidazole.  This  
solution  was  loaded  by  gravity  onto  a  packed  column  of  1  mL  of  Ni-­‐‑NTA  resin  (Qiagen)  
that  had  been  pre-­‐‑equilibrated  in  20  column  volumes  of  load  buffer  (20  mM  HEPES  pH  
8.0,   300  mM  NaCl,   10%  glycerol,   20  mM   imidazole,   0.01%  DDM).   The   loaded   column  
was  next  washed  with  an  additional  10  column  volumes  of  load  buffer  followed  by  a  20  
column   volume   wash   with   load   buffer   supplemented   with   30   mM   imidazole   (final  
imidazole   concentration   of   50  mM).      Elution   of   the   protein  was   accomplished   by   five  
separate   1   column  volume  washes  with   a   solution   of   20  mM  HEPES  pH   8.0,   300  mM  
NaCl,  10%  glycerol,  0.01%  DDM,  and  300  mM  imidazole.    Each  wash  was  collected  in  a  
separate   tube.      Elution   fractions   were   subjected   to   SDS-­‐‑PAGE   analysis   and   the   two  
containing  the  majority  of  the  protein  (usually  second  and  third  elutions)  were  pooled  to  
obtain   a   final   sample   of   CtLpxG,   referred   to   below   as   LpxG.      This   sample   ranged   in  
concentration  from  0.15-­‐‑0.5  mg/mL  and  was  kept   in  a  buffer  of  20  mM  HEPES  pH  8.0,  
300  mM  NaCl,  10%  glycerol,  0.01%  DDM,  and  300  mM  imidazole.  
Expression  and  purification  of  CtLpxG  mutant  D59A  were  carried  out  according  
to   the   same   procedure   described   above,   except   D59A_t10   (created   as   described   in  
Chapter  4)  was  used  in  place  of  CtG_10.    Resulting  purified  protein  was  termed  D59A.      
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5.2.3 CtLpxG Activity Analysis  
.    Autoradiographic  assays  for  hydrolase  activity  were  similar  to  that  previously  
described   in  Chapter   2,   but  with   slight  modification.     Reactions  mixtures  were   a   final  
volume  of  12.5  µμL  in  0.6  mL  polypropylene  tubes  and  contained  20  mM  HEPES  pH  8.0,  
0.5%   (w/v)   BSA,   0.035%   (w/v)  DDM,   1  mM  MnCl2,   100   µμM  UDP-­‐‑DAGn   (prepared   as  
previously  described   (127),  1,000  cpm/µμL   [β-­‐‑32P]  UDP-­‐‑DAGn,  and  protein  sample.     All  
reaction   components   besides   the   enzyme   were   mixed   to   a   volume   of   10   µμL   and  
equilibrated  at   30   °C   for  10  min,   after  which  2.5  µμL  of   enzyme  was  added   to   start   the  
reaction.   If   necessary,   enzyme   samples  were   diluted   in   a   buffer   identical   to   the   assay  
mixture   but   lacking   any   lipid   substrate   or  DDM  before   addition   to   reaction  mixtures.    
Aliquots  of  1.5  µμL  were   taken  from  the  reactions  at  various   time   intervals  and  spotted  
onto  20  cm  ×  20  cm  glass-­‐‑backed  silica  gel  thin  layer  chromatography  (TLC)  plates  (EMD  
Chemicals,   Darmstadt,   Germany).   These   plates   were   developed   in   a   25:15:4:2  
chloroform:  methanol:  water:  acetic  acid  tank  system,  dried,  exposed  to  phosphoscreens,  
scanned,  and  quantified  as  previously  described  in  Chapter  2.  
5.2.4 Metal Dependence of CtLpxG  
To  analyze  the  metal  dependence  of  CtLpxG,  a  modified  autoradiographic  assay  
described   aboce   was   employed.   First,   a   concentrated   stock   of   EDTA  was   added   to   a  
sample  of  LpxG  to  obtain  a  final  chelator  concentration  of  50  µμM  EDTA;  the  protein  was  
then   incubated   on   ice   for   30   min.      Next   the   sample   was   diluted   10-­‐‑fold   into   various  
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reaction  mixtures  similar  to  those  described  above  except  that  1  mM  MnCl2  was  replaced  
by  no  di-­‐‑  or  trivalent  metal  ion,  2  mM  NaCl,  or  each  of  the  following  chloride  salts  at  1  
mM:  Ca2+,  Co2+,  Cu2+,  Fe3+,  Mg2+,  Mn2+,  Ni2+,  and  Zn2+.    Conditions  in  which  the  replacing  
component  was  2  mM  NaCl  or  1  mM  EDTA  were  also  included  as  controls.      
5.2.5 Mass Spectrometry Analysis of LpxG Reaction 
The   products   of   an   LpxG   reaction   were   analyzed   by   mass   spectrometry,  
employing   a   similar  method   as   used   for   analysis   of   LpxI   (41).   Briefly,   50   µμL   reaction  
mixtures  consisting  of  100  µμM  UDP-­‐‑DAGn,  1  mM  MnCl2,  20  mM  HEPES  (pH  8.0),  and  
0.06   mg/mL   of   LpxG   were   prepared   in   the   presence   of   either   100%   H216O   or   an  
H218O/H216O  mixture  (70:30,  v/v)  (Sigma-­‐‑Aldrich,  St.  Louis  MO).  After  incubation  for  2  h  
at   30°C,   the   reactions   were   quenched   by   conversion   to   a   1.9   mL   single-­‐‑phase,   acidic  
Bligh-­‐‑Dyer  system  (126).    A  10  µμL  aliquot  of  this  material  was  analyzed  by  reverse-­‐‑phase  
liquid   chromatography   and  mass   spectrometry   (LC/MS)  using   a   Shimadzu  LC   system  
(comprising  a  solvent  degasser,   two  LC-­‐‑10A  pumps,  and  a  SCL-­‐‑10A  system  controller)  
coupled  to  a  TripleTOF  5600  quadrupole   time-­‐‑of-­‐‑flight   tandem  mass  spectrometer   (AB  
SCIEX,   Framingham,  MA).  MS   instrumental   settings   for   negative   ion   ESI   and  MS/MS  
analysis   of   lipid   species  were   as   follows:   ion   spray   voltage   (IS)   =   -­‐‑4500  V;   current   gas  
(CUR)  =  20  psi  (pressure);  gas-­‐‑1  (GS1)  =  20  psi;  declustering  potential  (DP)  =  -­‐‑55  V;  and  
focusing  potential  (FP)  =  -­‐‑150  V.  The  MS/MS  analysis  used  nitrogen  as  the  collision  gas.  
Data   analysis  was  performed  using   the  Analyst  TF1.5   Software.  LC  was  operated  at   a  
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flow  rate  of  200  µμl/min  with  a   linear  gradient  as   follows:  100%  of  mobile  phase  A  was  
held  isocratically  for  2  min,  and  then  linearly  increased  to  100%  mobile  phase  B  over  14  
min,   and   held   at   100%   B   for   4   min.   Mobile   phase   A   consisted   of  
methanol/acetonitrile/aqueous  1  mM  ammonium  acetate  (60/20/20,  v/v/v).  Mobile  phase  
B   consisted   of   100%   ethanol   containing   1   mM   ammonium   acetate.   A   Zorbax   SB-­‐‑C8  
reversed-­‐‑phase  column  (5  µμm,  2.1  ×  50  mm)  was  obtained  from  Agilent.    
5.2.6 Qualitative Comparison of UDP-DAGn Hydrolase 
Complementation   
To  qualitatively  assess  the  ability  of  Ct461  to  complement  an  lpxH  deletion  in  E.  
coli   compared   to   the   other   known   UDP-­‐‑DAGn   hydrolases,   single   colonies   of  
W3110AΔHEc   (41),   W3110AΔHCc   (41),   and   W3110AΔHCtG   (see   Chapter   4)   were  
dissolved   in  8  uL  of  LB.     From  this   sample,  2  µμL  aliquots  were   taken   from  each  strain  
and   spotted   on   LB-­‐‑agar   plates   supplemented  with  Cam,  Kan,   and   0.02%   arabinose   or  
Cam   and   Kan.      Spots   were   spread   over   a   portion   of   the   plate   to   evenly   distribute  
bacteria.    Following  incubation  at  37°C  for  24  h,  plates  were  compared  for  growth.    
5.3 Results 
5.3.1 Purification of CtLpxG 
In   order   to   further   characterize   LpxG,   a   tagged   construct   of   the   protein   was  
purified   using  NiNTA   chromatography.      CtlpxG  was   cloned   into   a   pET21   vector   that  
encoded   for   a   TEV-­‐‑protease-­‐‑cleavable   histidine   tag   at   the   C-­‐‑terminus   of   the   protein.    
This  construct  was  transformed  into  C41(DE3)  to  generate  CtG_H10.      Cell  free  extracts  
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(CFE)   from  CtG_H10  grown  in   the  presence  of   IPTG  were   incubated  with  1%  DDM  to  
solubilize  over-­‐‑expressed  CtLpxG  from  the  membrane.     After  centrifugation  to  remove  
any  insoluble  components,  the  resulting  supernatant  was  loaded  onto  a  NiNTA  column  
(“Load”   Fig.   32A).      An   initial   low   imidazole   wash   was   used   to   remove   non-­‐‑specific  
species   from   the   resin   (“Wash”   Fig.   32A)   and   subsequent   elution   with   accomplished  
with  high  imidazole  (“Elute”  Fig.  32A).    As  evident  by  SDS-­‐‑PAGE  analysis,  this  sample  
was  primarily  comprised  of  a  37  kD  species,  which  corresponds  to  the  molecular  weight  
of  CtLpxG.    The  resulting  LpxG  sample  (pool  of  Elute  2  and  3,  Fig.  32A),  was  assayed  for  
UDP-­‐‑DAGn   hydrolysis   and   showed   time-­‐‑dependent   formation   lipid   X.      UDP-­‐‑DAGn  





























Figure  32:  Gel  Purification  of  LpxG  
(A)   SDS-­‐‑PAGE   analysis   of   samples   from   purification   of   CtLpxG   as   outlined   in  Materials   and  
Methods.  Fractions  include  cell-­‐‑free  extract  (CFE)  of  CtG_t10;  CFE  after  detergent  solubilization,  
which  was   loaded  onto   the  NiNTA  colum  (Load);   flow   through  of   the  column   load   (FT);  wash  
with  50  mM   imidazole   (Wash);   and  elution  with  300  mM   imidazole   (Elute),  which  was   carried  
out  in  five  separate  1  mL  fractions  and  labeled  correspondingly.    The  band  appearing  around  37  
kD  corresponds  to  partially  purified  CtLpxG.    Elute  fractions  2  and  3  were  pooled  to  obtain  the  
LpxG   sample   used   in   further   analysis.      (B)   Identical   purification   as   described   above,   except  
beginning  with  cell-­‐‑free  extract  from  D59A_t10.    Elute  fractions  2  and  3  were  pooled  to  yield  final  
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Figure  33:  Activity  Analysis  of  Purified  LpxG  
(A)  Scan  of  phosphoscreen  exposed  to  silca  TLC  plate  from  an  assay  of  LpxG  and  D59A  isolated  
from  NiNTA  purification.      Protein   concentration   in   each   reaction  was   ~0.05  mg/mL.      Reaction  
lacking  protein  sample  (No  enzyme)  was  included  as  a  negative  control.    Bands  corresponding  to  
UDP-­‐‑DAGn   substrate   and   lipid   X   product   are   denoted   with   arrows.      (B)   Comparison   of   the  
specific  UDP-­‐‑DAGn  hydrolase  activity  for  the  samples  described  in  (A).     The  determined  value  
for  LpxG  was  47.0  nmol/min/mg  and  for  D59A,  1.3  nmol/min/mg,  both  of  which  were  calculated  
from  autoradiographic  assay  data  as  previously  described.    
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5.3.2 Determination of LpxG Hydrolytic Attack Mechanism by Mass 
Spectrometry 
While   the   other   known  UDP-­‐‑DAGn   hydrolases   both   catalyze   the   formation   of  
lipid   X,   they   do   so   through   different   methods:   LpxH   attacks   the   α   phosphate   of   the  
substrate  (40)  whereas  LpxI  attacks  at  the  β  position  (41).    To  confirm  which  hydrolytic  
mechanism  LpxG  employs,  purified  enzyme  was  used  to  convert  UDP-­‐‑DAGn  to  lipid  X  
in  the  presence  of  H216O  as  well  as  an  H218O/H216O  mixture  (70:30,  v/v).    The  lipid  X  and  
UMP  products  were  extracted  using  an  acidic  single-­‐‑phase  Bligh-­‐‑Dyer  system  (126),  as  
was   reported   for   analysis   of   CcLpxI   reaction   products   (41).      A   sample   of   the   LpxG  
reaction   extraction   was   separated   by   reverse-­‐‑phase   liquid   chromatography,   and   then  
analyzed   by   ESI-­‐‑MS   in   the   negative   ion   mode.      The   UMP   product,   with   a   predicted  
[M−H]-­‐‑  at  m/z  332.029,  was  detected  between  minutes  2.2  and  2.5.  For  the  H218O-­‐‑labeled  
reaction,  ∼70%  of  the  UMP  product  contained  18O,  as  shown  by  the  presence  of  a  much  
more  intense  peak  at  m/z  335.031  versus  m/z  332.027  (lower  panel,  Fig.  34A).    The  lipid  X  
product,  predicted  to  have  a  [M-­‐‑H]-­‐‑  at  m/z  710.424,  also  eluted  between  minutes  2.2  and  
2.5.     No  mass   shift   in   the   lipid  X  peak  was  observed   in   the   reaction  carried  out   in   the  
presence   of   H218O   (Fig.   34B).      Thus,   we   conclude   that   CtLpxG   catalyzes   the   attack   of  
water  exclusively  on  the  α–phosphorus  atom  of  UDP-­‐‑DAGn.        
  184  























































Figure  34:  Mass  Spectrometric  Characterization  of  LpxG  Reaction  Products  
An   LpxG-­‐‑catalyzed   UDP-­‐‑DAGn   hydrolysis   reaction   was   carried   out   in   the   presence   of   70%  
H218O.     Results  were  analyzed  by  LC/MS  and  compared  those  obtained  in  the  presence  of  100%  
H216O.    (A)  UMP  generated  by  LpxG  in  the  presence  100%  H216O  was  detectable  at  m/z  323.0328  
(upper   panel).      This   peak   was   also   present   in   the   isotopically   labeled   reaction   (lower   panel),  
however   a   second  peak   corresponding   to   incorporation   of   18O   into  UMP  was   also   observed   at  
325.031  (red  trace).    (B)  Lipid  X  generated  by  LpxG  appeared  the  same  m/z  value  of  710.42  in  both  
labeled  (upper  panel)  and  unlabeled  (lower  panel)  reactions.          
 
5.3.3 CtLpxG Displays Mn2+ Dependence In Vitro 
All   activity   assessments   in   initial   LpxG   discovery   were   carried   out   in   the  
presence   of  Mn2+,   however  we   sought   to   further   investigate   the  metal   dependence   of  
CtLpxG.      Sample   of   the   purified   enzyme   were   incubated   with   EDTA   to   chelate   any  
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metal  co-­‐‑purifying  with  the  protein.    LpxG  was  then  diluted  into  autoradiographic  assay  
conditions   in  which   the   1  mM  MnCl2  was   replaced  with   the   following   chloride   salts:  
Ca2+,   Co2+,   Cu2+,   Fe3+,   Mg2+,   Mn2+,   Ni2+,   and   Zn2+.   Assay   conditions   where   the   di-­‐‑   or  
trivalent  metal  salt  was  replaced  by  2  mM  NaCl  or  no  metal  additive  were  also  included  
as  controls.    The  remaining  assay  protocol  was  carried  out  as  previously  described  and  
specific   activity   was   calculated   for   each   reaction.      The   Mn2+   assay   condition   showed  
activity   that  was  35-­‐‑fold  greater   than   the   condition  with  no  metal   (Fig.   35).        The  Co2+  
condition  also  enhanced  activity;  however,  the  increase  (3  fold)  was  substantially  lower  
than  that  seen  when  Mn2+  was  present.  The  activity  of  the  enzyme  showed  no  increase  in  
the   presence   of   NaCl,   indicating   that   the   ionic   strength   of   the   reaction   was   not  
responsible   for  any   stimulation  observed.     Overall,   results   indicated   that  Mn2+  was   the  

















































Figure  35:  In  vitro  Metal  Dependence  of  LpxG  
LpxG   treated   with   EDTA   was   assayed   under   standard   conditions   supplemented   with   either  
metal,  NaCl,  or  no  metal.  Resulting  specific  activity  was  calculated  and  compared  to  the  specific  
activity  of  the  no  metal  control.    
  
5.3.4 Point Mutation of a Conserved Residue Abrogates LpxG Activity 
A   protein-­‐‑protein   BLAST   search   of   other   Chlamydia   species   reveals   LpxG  
orthologs   in  several  other  organisms  (Fig.  36).     Alignments  of   these  sequences  reveal  a  
clear   DXH(X)~25GDXXDR(X)~25GNHD   motif   (with   X   indicating   any   amino   acid)  
(highlighted  in  black,  Fig.  36)  that  is  characteristic  of  the  enzymes  in  the  calicinuerin-­‐‑like  
phosphoesterase   (CLP)  superfamily   (103,105).     Proteins  with   this  classification  utilize  a  
cluster  of  two  metal  ions  to  facilitate  hydrolysis,  with  the  residues  of  the  conserved  motif  
coordinating   the   cofactors   (103).     Additionally  present   in  LpxG   is   a  UUXGHXH  motif  
(Fig.  36),  with  U  representing  hydrophobic  residues,  also  present   in  a  sub-­‐‑class  of  CLP  
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enzymes   (102,145).      Alanine   mutations   of   motif   amino   acids   have   been   shown   to  
severely  abrogate  activity  (106),  confirming  their  importance  in  enzyme  function.          
To  assess   the  classification  of  LpxG  as  a  CLP  enzyme,  a  point  mutant  of  one  of  
the  aforementioned  conserved  motif  residues  was  generated  and  tested  for  activity.    The  
mutation,  D59A   (star,   Fig.   36),   substituted   the   aspartate   in   the   block   I  DXH  motif   for  
alanine.     A  sample  of  LpxG  containing   this  mutation  was  overexpressed   in  E.   coli  and  
purified  using  the  same  procedure  described  for  wild-­‐‑type  protein  (Fig.  32B).    When  the  
D59A   from  of  CtLpxG  was   assayed   for   in   vitro  hydrolysis   of  UDP-­‐‑DAGn,   it   exhibited  
extremely  reduce  levels  of  lipid  X  production  compared  to  the  wild-­‐‑type  protein  (D59A,  
Fig.  33A).    This  corresponded  to  nearly  a  40-­‐‑fold  decrease  in  specific  activity  compared  
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Chlamydophila pecorum   
Figure  36:  Alignment  of  LpxG  Orthologs    
Listed   are   the   LpxG   orthologs   found   in   the   Chlamydiacae   family.      Residues   are   colored   by  
percent   identity,   with   darkness   of   shade   corresponding   to   degree   of   conservation.      The   four  
blocks   of   the   CLP  motif   are  marked   in   black,  with   the   specific   amino   acid   patterns   and   block  
numbers   denoted   below.      “X”   represents   any   amino   acid   and   “U”   denotes   any   hydrophobic  
residue.      Sequences  were  obtained   from   the  NCBI   server   and  alignment  was   carried  out  using  
Clustal  W  (163).  
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5.3.5 Comparison of CtLpxG, CcLpxI, and EcLpxH UDP-DAGn 
Hydrolase Complementation in E. coli  
Autogradiographic  assay  provides  an  efficient  method  for  comparing  the  in  vitro  
activity  of  LpxG  to  the  previously  characterized  UDP-­‐‑DAGn  hydrolases,  LpxH  and  LpxI  
(Fig.   37A).      To   compare   the   in   vivo   efficiencies   of   these   enzymes,  CtlpxG,  EclpxH,  and  
CclpxI  were  assessed  for  their  relative  abilities  to  complement  an  lpxH  deletion  in  E.  coli  
W3110A.    The  UDP-­‐‑DAGn  hydrolase  genes  were  ligated  into  pBAD33  vectors  capable  of  
arabinose-­‐‑enhanced  expression  (see  Chapter  4)(41).    After  P1  transduction  removed  the  
chromosomal   copy   lpxH,   the   resulting   W3110AΔHCtG,   W3110AΔHEc,   and  
W3110AΔHCc   were   all   able   to   maintain   viability,   albeit   at   differing   degrees.      When  
grown   on   LB-­‐‑agar   supplemented   with   no   arabinose,   W3110AΔHEc   exhibited   much  
more   robust   growth   than   in   the   presence   of   0.02%   (w/v)   arabinose   (Fig.   37B).      This  
indicates   that   increase   in  EclpxH  expression   can  be   toxic   in   the  background   tested.      In  
contrast,  W3110AΔHCtG   grew   better   when   supplemented   with   0.02%   arabinose   (Fig.  
37B),   suggesting   increase   in   CtlpxG   levels   helps   cells   better   compensate   for   the   lpxH  
deletion.      The   phenotype   of   W3110AΔHCc   was   relatively   consistent   regardless   of  
arabinose  concentration  (Fig.  37B):  cells  deficient   in   lpxH  are   insensitive   to  alternations  
in  CclpxI  expression  levels.          
  190  













LpxG C. trachomatis Mn 0.01
LpxH H. influenzae Mn 10000





Figure  37:  In  vivo  Comparison  of  UDP-­‐‑DAGn  Hydrolase  Activity  
(A)  Comparison  of   reported   in   vitro  activity   for  orthologs  of  LpxG,  LpxH,  and  LpxI.     Range  of  
specific   activity   reflects   reported   Vmax   values   for   LpxH   and   LpxI,   and   the   highest   observed  
specific   activity   for  LpxG   (reported   above).      (B)   Survival   of  E.   coli  W3110A  harboring   lpxH:kan  
insertions,  rescued  with  each  individual  UDP-­‐‑DAGn  hydrolase.    W3110AΔHCtG,  W3110AΔHEc,  
and  W3110AΔHCc  were  grown  at  37°C  after  streaking  on  LB  agar  supplemented  with  ampicillin  
and  chloramphenicol.      In   the   right  panel,  growth  medium  has  been  additionally  supplemented  
with  0.02  %   (w/v)  arabinose   to   stimulate  expression  of   the  pBAD33-­‐‑derived  plasmid  harboring  
the  complementing  UDP-­‐‑DAGn  hydrolase  in  all  tested  strains.  
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5.4 Discussion 
While  the  product  of  UDP-­‐‑DAGn  hydrolysis,   lipid  X  (164),  was  the  first  lipid  A  
biosynthetic  intermediate  to  be  isolated,  an  enzyme  capable  of  producing  lipid  X  was  the  
last  to  be  discovered  (40).    Even  when  the  gene  for  LpxH,  the  UDP-­‐‑DAGn  hydrolase  in  
E.  coli,  was  identified,  orthologs  of  the  enzyme  were  missing  in  a  variety  of  other  lipid-­‐‑A  
production  bacteria  (40).    Discovery  of  a  second  UDP-­‐‑DAGn  hydrolase,  LpxI  (41),  added  
some  pieces  to  the  puzzle  of  lipid  X  production  in  Gram-­‐‑negative  organisms.    LpxH  and  
LpxI   have   been   characterized   for   their   enzymatic   properties   (40,41)   and   have   a   very  
unique  relationship,  as  they  perform  the  same  function  but  share  no  sequence  homology  
and   are   never   found   in   the   same   organism.   Despite   the   amassing   details   about   the  
known   UDP-­‐‑DAGn   hydrolases,   there   was   still   an   incomplete   understanding   lipid   X  
formation,   as   several   groups   of   lipid   A-­‐‑producing   bacteria   contain   neither   LpxH   nor  
LpxI   (81).      Recent   discovery   of   LpxG   in  C.   trachomatis   helped   to   elucidate   how   these  
bacteria  are  capable  of  lipid  A  biosynthesis  despite  containing  orthologs  for  the  known  
UDP-­‐‑DAGn  hydrolases  (see  Chapter  4).      
5.4.1 Membrane Domain of LpxG Compels Purification Optimization 
and Hypotheses on Localization of C. trachomatis Lipid A Pathway 
In  the  work  described  in  this  chapter,  we  show  that  CtLpxG  can  be  purified  from  
E.   coli  with   use   of   NiNTA   chromatography,   resulting   in   nearly   a   40-­‐‑fold   increase   in  
observed   UDP-­‐‑DAGn   hydrolase   specific   activity   than   seen   in   cell   free   extracts.    
Furthermore,   a   point   mutation   in   a   conserved   residue   of   LpxG   abrogates   activity,  
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indicating   the   specificity   of   observed   lipid   X   production.      While   evidence   of   active  
purified  protein   is   clear,   the   low  yield  of  protein   and   contaminating   impurities  merits  
further  optimization  of  isolation  procedures.    
One   difficulty   in   expression   and   purification   of   CtLpxG   is   the   existence   of   a  
single  N-­‐‑terminal  transmembrane  domain.    This  makes  it  necessary  to  include  detergent  
during   all   steps   of   purification,   which   may   alter   the   stability   of   the   protein   during  
isolation.      Interestingly,   while   a   truncated   version   of   LpxG   lacking   the   N-­‐‑terminal  
domain  is  still  able  to  complement   lpxH  in  vivo  (see  Chapter  4),  over-­‐‑expression  of  this  
construct   did   not   yield   properly   folded   LpxG   (data   not   shown).      The   addition   of   a  
stabilizing   tag   or  moiety   to   the  N-­‐‑terminal   region   of   the   truncated   construct,   such   as  
maltose-­‐‑binding  protein,  may   alleviate   expression  problems   creating   opportunities   for  
further  purification  and  enzymatic  studies.      
The  existence  of  a  transmembrane  domain  is  a  feature  not  seen  in  the  other  UDP-­‐‑
DAGn   hydrolases   (40,41),   as   evident   by   the   plot   of   membrane   probability   in   Fig.   38.    
Lipid  X  production  is  hypothesized  to  take  place  at  the  periphery  of  the  inner  membrane  
due  to  the  hydrophobic  nature  of  the  molecule  and  the  location  of  subsequent  pathway  
enzymes  (6).      In  fact,  structural  evidence  suggests   that   the  macromolecular  mechanism  
of  LpxI   involves   interaction  with   the  membrane   for  deposition   (96)   (Fig.  11).        Despite  
this   observation,   LpxI   can   be   stably   purified   without   use   of   detergent   and   does   not  
display  surface  dilution  kinetics  (41),   indicating  that  membrane  interaction  is  transient.    
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LpxH  has  slightly  more  hydrophobic  character   than  LpxI,  as  protein  yield   is   increased  
when   a   detergent   solublization   step   is   used   in   purification   (157).      Nonetheless,   LpxH  
shows   no   evidence   of   surface   dilution   kinetics   in   vitro   (157),   once   again   suggesting  
temporary  membrane  association.    This  makes  LpxG  the  first  UDP-­‐‑DAGn  hydrolase  that  
has  permanent  association  with  the  membrane.          
The   unique   nature   of   the   integration   of   LpxG   into   the   inner   membrane   is  
especially  intriguing  when  assessing  the  characteristics  of  the  other  lipid  A  biosynthetic  
enzymes  in  C.  trachomatis.    While  the  C.  trachomatis  orthologs  for  LpxA,  LpxC,  and  LpxD,  
and   LpxK   all   are   predicted   to   have   topologies   similar   to   those   found   in   E.   coli,   the  
hyrdopathy  plot   for  LpxB,   the   fifth   enzyme   in   the  pathway,  differs  greatly   among   the  
bacteria.      E.   coli   LpxB   is   382   amino   acids   in   length   and   shows   no   evidence   of  
transmembrane   regions,   as   indicated   by   the   low   probability   of   membrane-­‐‑bound  
residues  (Fig.  38).    C.  trachomatis  LpxB  is  607  amino  acids,  200  of  which  are  predicted  to  
make  up  a  6  N-­‐‑terminal   transmembrane  domains   (Fig.  38).     This   feature  appears   to  be  
unique  to  the  family  Chlamydiaceae,  as  the  N-­‐‑terminal  membrane  domain  is  not  seen  in  
LpxB   orthologs   within   the   Chlamydiae   phylum.      The   membrane   integration   of   C.  
trachomatis  LpxB  may  explain  why  a  similar  feature  is  observed  in  LpxG.    Furthermore,  
the   bilayer   localization   of   the   fourth   and   fifth   biosynthetic   enzymes   may   play   an  

















































Figure  38:  Topology  of  Fourth  and  Fifth  Lpx  Enzymes  
(A)   Probability   of   transmembrane   localization   (Membrane   Probability)   versus   amino   acid  
number  for  the  UDP-­‐‑DAGn  hydrolases  that  catalyze  the  fourth  step  of  lipid  A  biosynthesis  in  E.  
coli,  C.  trachomatis,  and  C.  crescentus.     Values  were  determined  using  the  TMHMM  Server  2.0  on  
the  Center  for  Biological  Sequence  Analysis  website  (http://www.cbs.dtu.dk/services/TMHMM/).    (B)  
The  same  data  as  described  in  (A),  except  for  LpxB  orthologs  that  are  responsible  for  the  fifth  step  
of   lipid   A   biosynthesis   in   the   aforementioned   bacterial   species.      Sequences   for   both   sets   of  
predictions  were  obtained  from  the  NCBI  server.  
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5.4.2 Hydrolytic Mechanism Suggests Conservation of α-attack in 
CLP Enzymes 
It  had  been  previously  established  that  LpxH  and  LpxI  have  different  methods  of  
hydrolysis,  with  LpxH  attacking  the  α  phosphate  (40)  and  LpxI  the  β  phosphate  (41)  of  
UDP-­‐‑DAGn.      Employing   the   mass   spectrometry   strategy   used   for   identifying   the  
hydrolytic   mechanism   for   LpxI,   we   determined   the   method   of   attack   for   LpxG.      As  
evident   by   the   deposition   of   water   on   the   UMP   group,   LpxH   appears   to   proceed  
through  the  same  α  attack  as  LpxH  (Fig.  39).     This  is  not  surprising,  as  both  LpxH  and  
LpxG   appear   to   be   members   of   the   CLP   superfamily.      Hydrolysis   of   pyrophosphate  
bonds,   as   seen   in   the   formation   of   lipid   X,   was   a   type   of   chemistry   not   previously  
attributed   to   CLP   enzymes   until   recently,   when   EPR   spectroscopy   and   mutagenesis  
were   used   to   confirm   the   classification   of   LpxH   as   part   of   this   superfamily   (Chapter  
3)(157).      The  discovery  of  LpxG  and   elucidation  of   its  hydrolytic  mechanism  provides  
further  information  about  this  subclass  of  CLP  pyrophosphatase  enzymes  and  suggests  

















































































































































Figure  39:  Hydrolytic  Mechanisms  of  Known  UDP-­‐‑DAGn  Hydrolases  
  
5.4.3 LpxG’s Identification as a CLP Enzyme Allows for Direct 
Comparison with LpxH 
LpxG   displays   a   clear   CLP   motif   indicative   of   enzymes   that   employ   divalent  
cations  to  facilitate  catalysis  (103,105).    Moreover,  LpxG  activity  appears  to  be  dependent  
on   a  metal   cofactor,   as   negligible   in   vitro  UDP-­‐‑DAGn  hydrolysis   is   detected  when   no  
such  species  is  present.    Specific  activation  in  lipid  X  production  is  observed  when  LpxG  
is  assayed  in  the  presence  of  Mn2+,  making  it  the  most  likely  candidate  for  the  enzyme’s  
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cofactor  in  vivo.    This  is  a  property  shared  between  LpxG  and  LpxH,  as  the  latter  enzyme  
shows   significant   activation   in   the   presence   of  Mn2+   and   contains   two   closely   spaced  
Mn2+  binding  sites  (157).    Metal-­‐‑dependent  hydrolysis  is  also  observed  with  LpxI,  albeit  
with  Mg2+(41).  
The  CLP  motif   in  LpxG  can  be  clearly  detected   through  alignment  of  orthologs  
from  various  Chlamydia  species  as  well  as  Chlamydiacea  family  members.      As  previously  
discussed,  these  conserved  residues  have  been  shown  to  serve  as  a  scaffold  for  the  metal  
cofactors   and   ordered   water   molecules   that   are   vital   to   hydrolysis   in   other   CLP  
enzymes.     A  mutation   in   first   residue   in   the  N-­‐‑terminal  section  of   this  motif  abolished  
LpxG  activity,  suggesting  that  it  also  relies  on  the  conserved  CLP  residues  to  carry  out  
enzymatic  function.     This  corresponding  mutation  in  LpxH,  which  also  displays  a  CLP  
motif,  reduced  activity  by  200,000-­‐‑fold,  speaking  to  the  importance  of  the  first  aspartate  
in  the  CLP-­‐‑mediated  hydrolysis  of  UDP-­‐‑DAGn  (Chapter  3)(157).    In  other  CLP  enzymes,  
the   residue   in   this  position  of   the  motif  directly  coordinates  one  of   the  metal   cofactors  
(150,152).          
The  metal   dependence   of   LpxG   and   importance   of   a  motif   residue   for   activity  
further  corroborates  the  classification  of  LpxG  as  member  of  the  CLP  family.    It  should  
be  noted  that  despite  this  family  similarity  with  LpxH,  the  two  proteins  are  distinct,  as  
evident   by   the   high   E-­‐‑value   (0.8)   of   their   alignment   (Table   13).      A   specific   difference  
between  LpxG  and  LpxH  is  seen  in  one  of  the  blocks  of  the  conserved  CLP  motif.  LpxH  
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orthologs   display   a   unique   LpxH-­‐‑specific   GNRD   sequence   in   block   III   of   the   motif  
(Chapter  3)(157)  while  LpxG  orthologs  display  GNHD,  which  is  canonical  in  other  CLP  
enzymes  (157).    Structural  studies  of  a  well-­‐‑known  CLP  enzyme,  bacteriophage  λ  serine-­‐‑
threonine  protein  phosphatase,  indicate  the  histidine  in  the  GNHD  motif  coordinates  the  
Mn-­‐‑bridging  water  molecule   (Fig.   23)(150).     Mutation   to   an  arginine  would   retain   this  
functionality  and  may  even  increase  stability  of  the  metal  complex.    Additionally,  as  an  
arginine   residue  has   been   shown   to   be   imperative   in   binding  uridine   in  deoxyuridine  
triphosphate   pyrophosphatase   (dUTPase)   (165,166),   it   is   possible   the   variance   of   the  
LpxH  motif  increases  substrate  affinity.    Interestingly,  the  block  III  histidine  is  also  seen  
in   LpxH2,   a   hypothesized   ancestor   of   LpxH   (81).      While   LpxH2   from   Pseudomonas  
aeruginosa   does   not   have   UDP-­‐‑DAGn   hydrolase   function   in   vivo   in   E.   coli   (82),   it   is  
thought  that  lpxH  is  a  product  of  a  gene  duplication  of  lpxH2  within  the  Proteobacteria  
lineage  before  the  β  and  γ  divergence  (81).    Mutation  of  histidine  to  arginine  in  the  third  
block  of   the  CLP  motif  may  have   facilitated   the  optimization  of  LpxH  for  UDP-­‐‑DAGn  
hydrolysis.      Study  of  the  effect  of  a  similar  mutation  in  LpxG  would  aid  in  determining  
if  such  a  substitution  enhances  catalysis.          
5.4.4 LpxG is Distinct from Other YkuE Related Proteins 
Within  the  CLP  family,  LpxG  is  characterized  as  a  member  of   the  YkuE-­‐‑related  
proteins.     YkuE   is   a  metallophosphoesterase  originally   characterized   in  Bacillus   subtilis  
that  has  been  reported  to  have  monophosphoesterase  activity  and  co-­‐‑purify  with  equal  
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molar  ratios  of  Mn2+  and  Zn2+(167).    YkuE  also  displays  a  twin  arginine  motif  and  studies  
indicate  it  is  transported  to  the  cell  wall  of  B.  subtilius  through  the  Tat  system  (167).    Its  
function  is  not  known,  however  the  enzyme  is  hypothesized  to  play  a  role  in  phosphate  
acquisition  from  the  extracellular  environment  (167).    A  homolog  of  YkuE,  YaeI,  exists  in  
E.  coli;   it  also  displays  a  RR  motif   (Fig.  40).     CtLpxG  is  very  homologous  to  both  YkuE  
and  YaeI,  with  their  alignments  having  an  E-­‐‑value  of  4  ×  10-­‐‑26  and  7  ×  10-­‐‑22  respectively;  
furthermore,  LpxG   is  annotated  as  YaeI   in   some  C.   trachomatis  genomes.     Yet,  CtLpxG  
lacks   the   twin   arginine  motif,   as   does   every  LpxG  ortholog   in   the  Chlamydiales   family  
(Fig.  36),  making  it  very  unlikely  the  protein  serves  the  same  functionality  as  YkuE  and  
YaeI.    The  ability  of  LpxG  to  complement  lpxH  in  E.  coli  corroborates  that  the  protein  is  
not  transported,  as  lipid  A  biosynthesis  takes  place  in  the  cytosol  and  in  the  inner  leaflet  
of  the  inner  membrane  (6).    Moreover,  because  of  the  essential  nature  of  lpxH  in  E.  coli,  it  
can  be  assumed  that  YaeI,  which  is  not  essential,  has  no  UDP-­‐‑DAGn  hydrolase  function  
in   vivo.      Thus,   despite   bioinformatic   annotation   and   sequence   similarity,   LpxG   is   a  
unique  protein  in  the  YkuE  sub-­‐‑family  that  functions  as  an  UDP-­‐‑DAGn  hydrolase.      
  
YaeI   1 -MMISRRRFLQ-----AATATLAAGSGFGYIHYLEPGWLELTHQHIA--FFKDKAAPFKILFLADLH 59 
YkuE   1 MKKMSRRQFLKGMFGALAAGALTAGGGYGYARYLEPHMIETTEHTIKSSLIPHGFDGFKIVQFSDAH 67 
CtLpxG 1 -MFVSVGITAS-----LTTILAAPVLTWVWANHLEPNLLRVTRLNWNLPKKFAHLHGLRIVQISDLH 54   
Figure  40:  N-­‐‑terminal  Alignment  of  YkuE-­‐‑Related  Proteins  
Alignment  of  the  first  ~60  amino  acids  of  E.  coli  YaeI,  B.  subtilus  YkuE,  and  C.  trachomatis  LpxG.    
The   twin   arginine  motif,   signature   of   substrates   of   the   Tat   secretion   system,   is   highlighted   in  
green.    Block  I  of  the  CLP  family  motif  is  highlighted  in  orange.    Sequences  were  obtained  from  
the  NCBI  server  and  alignment  was  carried  out  using  Clustal  W  (163).  
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5.4.5 Evaluation of Differences in LpxG, LpxH, and LpxI May Reveal 
Variances in Lipid A Pathway Across Bacteria 
The  unique  characteristics  of   the  known  UDP-­‐‑DAGn  hydrolases  extend  to  their  
observed   catalytic   capabilities.   Comparison   of   the   in   vitro   hydrolysis   of   the   three  
proteins   reveals   orders   of   magnitude   differences,   with   EcLpxH   exhibiting   a   103  
enhancement   in   activity   over  CcLpxI,   and  CcLpxI   exhibiting   another   103   enhancement  
over   CtLpxG   (Fig.   37).      This   may   reflect   assay   optimization,   as   E.   coli   activity   was  
originally   reported   in   the   range   of   LpxI   (40).   However,   optimization   of   UDP-­‐‑DAGn  
hydrolysis  for  LpxH  was  mainly  attributed  to  presence  of  metal  (Chapter  2),  which  has  
been  accounted  for   in  LpxG  and  LpxI.     The  variation  in  catalytic  activities  may  also  be  
accredited   to   substrate   specificity   of   the   enzymes   for   the   type   of   lipid  A   seen   in   their  
representative   bacteria.      Specifically,   the   in   vitro   substrate   utilized   in   the   experiments  
was  obtained   from  E.   coli  and   contains   two  hydroxymyristate   acyl   chains  whereas   the  
UDP-­‐‑DAGn  from  C.  trachomatis  contains  a  20-­‐‑  and  a  14-­‐‑carbon  acyl  chain,  with  only  the  
former   being   hydroxylated.      It   has   been   shown   that   Lpx   enzymes   can   be   extremely  
attuned  to  such  differences,  particularly  in  acyl  chain  length  (168-­‐‑170).      
Variation  of  observed   in  vitro  activity  may  explain  the  difference   in  phenotypes  
of   W3110AΔH   strains   complemented   with   ara-­‐‑controlled   LpxH,   LpxI,   or   LpxG.    
Hydrolytic  proficiency  seemed  to  positively  correlate  with  cell  viability  in  the  absence  of  
arabinose  and  negatively  correlate  in  its  presence.    It  is  likely  that  abundance  of  a  more  
proficient  EcLpxH  results  in  toxicity  (seen  in  other  lipid  A  biosynthetic  enzymes,  such  as  
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LpxC)  whereas  a  greater  amount  of  CtLpxG  is  necessary  to  sustain  pathway  flux  due  to  
its   lower   activity.      This   observation  may   be   due   to   issues   with   protein   expression   of  
CcLpxI   and   CtLpxG,   however,   paired   with   the   in   vitro   disparity,   it   may   hint   at   the  
nature  of   the   lipid  A  pathway  in  their  respective  parental  bacteria.      In  fact,   it  has  been  
proposed   that  E.   coli  and   other   organisms   containing   LpxH  orthologs   (Proteobacteria)  
resemble   the   most   optimized   form   of   the   pathway   (81),   thus   making   it   unsurprising  
these  organisms  contains  the  most  proficient  UDP-­‐‑DAGn  hydrolase.    Additionally,  as  C.  
trachomatis  do  not  rely  on  lipid  A  biosynthesis  for  replication  (20),  it  is  not  unreasonable  
that   there  would  be   less  pressure  on   this  organism   to  develop  a  highly  efficient  UDP-­‐‑
DAGn  hydrolase.              
5.4.6 LpxG: Ancestral or Adaptive? 
Casting   LpxG   in   the   role   of   UDP-­‐‑DAGn   hydrolase   in   C.   trachomatis   is   an  
intriguing   one   to   ponder   from   an   evolutionary   standpoint.      First   to   consider   is   its  
similarity  to  LpxH.    It  has  been  proposed  that  LpxH  evolved  from  LpxH2,  as  discussed  
above.    It  might  be  possible  that  LpxG  is  part  of  this  lineage,  representing  an  ancestor  of  
LpxH2.    This  hypothesis  is  supported  by  the  evolutionary  age  of  Chlamydia  compared  to  
other  bacterial  phyla.     Early   lipid  A  biosynthesis  may  have  been  carried  out  by  LpxG.    
Modifications   to   the   pathway   on   the   molecular   and   biological   level   could   have  
necessitated  more  efficient  chemistry  at  the  fourth  step,  leading  to  evolution  of  LpxH2.    
As  lipid  A  biosynthesis  is  not  essential  in  Chlamydia,  selective  pressure  for  optimization  
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of  synthesis  may  not  have  occurred,  thus  causing  the  bacteria  to  retain  LpxG.    Crucial  to  
this   hypothesis   of   a   three-­‐‑part   lineage  would   be   identifying  LpxH2   orthologs   that   are  
capable   of   UDP-­‐‑DAGn   hydrolysis   in   vivo.      Currently,   only   the   ortholog   from  
Pseudomonas   aeruginosa   has   been   assessed   for   complementation   activity.      As   this  
organism   also   contains   LpxH,   the   LpxH2   ortholog   may   have   evolved   a   different  
function,   thus   making   it   necessary   to   evaluate   an   LpxH2   ortholog   from   a   bacterium  
lacking   a   known   UDP-­‐‑DAGn   hydrolase.      Mutational   studies   in   conjunction   with  
detailed   bioinformatic   analysis   of   all   three   orthologs   could   be   used   to   further   dissect  
their  relation.    
A   second   possibility   in   the   evolution   of   LpxG   as   a   UDP-­‐‑DAGn   hydrolase   is  
genome  condensation.     C.  trachomatis  contains  a  very  small  genome  (~1  MB)  with  signs  
of   incomplete  biosynthetic  pathways.     Many  of   these  pathways  have  been   found   to  be  
functional,  either  through  acquisition  of  intermediates  from  the  host  cell  or  presence  of  
distinct   enzymes   specialized   to   fill   metabolic   gaps   (115).      It   is   possible   that   the  
evolutionary-­‐‑conserved  UDP-­‐‑DAGn  hydrolase  was  lost  in  C.  trachomatis  due  to  genome  
condensation,  causing  another  hydrolase  to  adapt  to  produce  lipid  X.     LpxI  is  the  most  
likely   candidate   for   the  original  hydrolase   in  C.   trachomatis  ancestors,   as  homologs   for  
the  protein  are  found  within  Simkaniaceae,  another  family  in  the  Chlamydiae  phylum.    In  
the   case  of   this   ‘re-­‐‑purposing’  of  LpxG  as  an  UDP-­‐‑DAGn  hydrolase,   it   is  possible   that  
the  protein  retains  a  secondary  function  in  vivo.    The  similarity  between  YaeI  and  LpxG  
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(discussed  above)  may  indicate  a  possible  ancestral  relationship,  with  the  later  diverging  
from  the  former  in  C.  trachomatis  due  to  need  for  a  UDP-­‐‑DAGn  hydrolase.    Interestingly,  
the  strength  of  LpxG  orthologs  correlates  with  presence  of  a  membrane-­‐‑bound  ortholog  
of  LpxB.    These  could  reflect  the  evolutionary  similarity  of  the  bacteria  as  a  whole,  or  it  
may   indicate   that   development   of   a   membrane-­‐‑embedded   LpxB   necessitated  
development  or  recruitment  of  a  membrane-­‐‑bound  UDP-­‐‑DAGn  hydrolase.      
5.4.7 Conservation of LpxG in Other Bacterial Groups: More Pieces to 
the Puzzle? 
LpxG  is  found  throughout  the  family  Chlamydiaceae,  as  well  as  other  members  
of   the  Chlamydia  phylum   (Fig.   41),   completing   the  puzzle  of   lipid  biosynthesis   is   this  
particular  family.    Orthologs  for  the  protein  are  also  seen  in  in  other  bacteria  containing  
lipid  A  biosynthetic   enzymes  but   lacking  a  known  UDP-­‐‑DAGn  hydrolases   (Figs.   7,   8),  
such   as   Brachyspira   hyodysenteriae,   and   Synechococcus   sp.   PCC   6312   (Fig.   42).      These  
orthologs  are  annotated  as  uncharacterized  metallophosphoesterases  and  lack  the  twin-­‐‑
arginine  motifs  seen  in  YkuE  orthologs  as  discussed  above.      
A  more  detailed  bioinformatic  analysis  is  necessary  to  determine  if  the  discovery  
of   LpxG   fills   in   the   absence   of   necessary   pathway   enzymes   in   all   lipid-­‐‑A   producing  
Gram-­‐‑negative  bacteria.    This  could  be  complicated  by  the  ubiquitous  nature  of  the  CLP  
motif,   the   likeness   of   LpxG   to   other   proteins   with   difference   functions   (as   discussed  
above   with   YaeI),   and   the   lack   of   clustering   with   other   biosynthetic   enzymes.      Such  
problems  were  avoided  with  the  other  hydrolases.    As  LpxH  seems  to  be  a  distinct  CLP  
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enzyme  with  a  specific  modification  to  a  portion  of  the  motif  (GNRD  versus  GNHD),  it  
is  easy  to  discern  between  general  family  members  and  actual  orthologs.    Furthermore,  
LpxH  was   detected   in   organisms   in   the   Proteobacteria   phylum,  which   contain   highly  
conserved  lipid  A  biosynthetic  enzymes.    Likewise,  LpxI  is  a  completely  distinct  protein  
of   a   unique   family;   this   facilitates   ortholog   identification.      Moreover,   lpxI   is   found  
clustered  in  the  same  region  of  the  genome  as  other  lipid  A  biosynthetic  enzymes  (41).    If  
LpxG   is   not   the   final   answer   to   the   question   of   lipid   X   production   in   Gram-­‐‑negative  
bacterial,   it   is  possible  an  additional  UDP-­‐‑DAGn  hydrolases  exist.     Alternatively,  LpxB  
orthologs   in   bacterial   lacking   a   UDP-­‐‑DAGn   hydrolase   may   be   bifunctional   and   thus  
capable   of   both   the   hydrolysis   and   condensation   that   is   required   to   synthesize   the  
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Figure  41:  Alignment  of  LpxG  Orthologs  in  Chlamydia  Phylum  
Aligned   sequences   of   LpxG   orthologs   found   across   the   phylum   of   Chlamydia.      Residues   are  
colored   by   percent   identity,   with   darkness   of   shade   corresponding   to   degree   of   conservation.    
The  four  blocks  of   the  CLP  motif  are  marked  with  Roman  numerals.     Sequences  were  obtained  
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Figure  42:  LpxG  Orthologs  Found  Outside  of  Chlamydia  
Alignment   of   N-­‐‑terminal   region   and   CLP   motifs   found   in   LpxG   orthologs   of   Brachyspira  
hyodysenteriae,  and  Synechococcus  sp.  PCC  6312.     E-­‐‑values   listed  are   in  reference  to  C.  trachomatis  
LpxG  were  calculated  from  protein-­‐‑protein  BLAST  search  on  the  NCBI  website.    Sequences  were  
obtained  from  the  NCBI  server  and  alignments  were  carried  out  with  Clustal  W  (163).          
  
5.4.7 Conclusion 
The  existence  of  multiple  enzymes  being  utilized  for  the  fourth  step  of  the  Raetz  
pathway   speaks   to   the   universal   nature   of   phosphoester   hydrolysis   in   biology.    
Specifically,   the  observation  that  other  proteins  not   thought   to   function  as  UDP-­‐‑DAGn  
hydrolases   in   vivo   are   still   capable   of   lipid   X   production   in   vitro,   such   as   Cdh  
(40,82,89,91,92),  reiterates  how  enzymatic  scaffolds  can  conform  to  various  substrates  to  
perform   chemistry.      Despite   this   ubiquity,   only   particular   enzymes   have   evolved   to  
function  as  UDP-­‐‑DAGn  hydrolases  in  vivo  (41,82),  making  complementation  a  necessary  
tool  by  which  to  assess  enzyme  function.      
Even  with  the  discovery  of  LpxG,  questions  about  the  fourth  step  of  the  lipid  A  
biosynthetic  pathway  still   remain.     Namely,  why  is  so  much  diversity  seen  at   this  step  
when  the  third  and  fifth  steps  are  both  extremely  conserved?    One  possible  explanation  
may   be   the   nature   of   the   reaction   carried   out   to   produce   lipid   X.      Hydrolysis   of  
pyrophosphate   bonds,   especially   those   in   nucleotides,   is   extremely   ubiquitous   and  
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important   in  biology.     Thus,  over   time,  highly   efficient  mechanisms   for   such   reactions  
have   evolved.      The   lipid   A   pathway   may   have   adopted   these   optimized   enzyme  
scaffolds  carry  out  biosynthesis.    In  bacteria  in  which  there  was  not  significant  selective  
pressure   for   highly   efficient   lipid   A   metabolism,   earlier   versions   of   the   UDP-­‐‑DAGn  
hydrolase  exist,  as  discussed  above.          
The  relationship  of  LpxG,  LpxH  and  LpxI  make  a  very  intriguing  model  system  
by   which   to   study   enzyme   evolution   from   biochemical,   structural,   and   bioinformatic  
approaches.      Such   investigations   would   yield   important   information   about   lipid   A  
biosynthesis  as  well  as  the  plasticity  of  metabolic  processes  in  nature.        
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